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Abstract 
Teladorsagia circumcincta, an economically-important abomasal nematode of small 
ruminants in temperate regions worldwide, is currently controlled with a combination of 
anthelmintics and pasture management. Anthelmintic resistance has emerged and 
vaccination is a potential alternative control strategy, as protective immunity in sheep 
can be acquired after repeated exposure to the parasite.  Abomasal mucosal IgA 
responses in immune sheep have been correlated with delayed worm development and 
reduced faecal egg counts.  However, recombinant vaccine development against 
parasitic nematodes has had limited success, and one of the reasons may be unsuitable 
expression systems for antigen production leading to incomplete or inadequate post-
translational modifications such as glycosylation and tertiary protein folding, resulting in 
incorrect epitope structures for antibody binding.  In this thesis, to address this issue, 
“native” infective larval (L3) antigen targets of protective immune responses and 
synthetic peptide sequences which mimic structural epitopes on these antigens were 
identified.  Abomasal mucosal IgA was used as a probe to identify native immunogenic 
antigens from T. circumcincta L3.  IgA was purified from abomasal mucus of animals 
rendered immune by repeated experimental infection and a custom antibody-affinity 
column was created and used to purify antigens from an L3 somatic PBS-soluble extract.  
Affinity purified L3-antigen-specific IgA levels in sheep with varying levels of immunity 
to T. circumcincta were positively correlated (rs = 0.853, P < 0.001) with both the total 
IgA concentration in efferent gastric lymph after parasite challenge, and with the 
percentage of inhibited fourth-stage (L4) larvae present in the gastric glands of the 
immune hosts (rs = 0.534, P = 0.007).  In contrast, a negative correlation between the 
levels of affinity-purified L3 antigen-specific IgA and total T. circumcincta burden was 
observed (rs = -0.565, P = 0.004).  Proteomic analysis of the IgA-affinity purified L3 
extract identified a number of proteins which represent potential vaccine candidate 
molecules in other helminth species, including paramyosin, superoxide dismutase, 
galectin, activation-associated secreted proteins and fatty-acid retinol-binding proteins.  
As a first step towards the development of a novel vaccine based on IgA-binding peptide 
mimics of native structural epitopes, phage display libraries were used to screen 
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antibodies, from sheep rendered immune to T. circumcincta by experimental infection. 
These antibodies were affinity-purified before use and specifically bound T. 
circumcincta L3 glycans or, alternatively, surface antigens on exsheathed T. 
circumcincta L3.  Five peptide sequences which mimic L3 antigenic epitopes were 
identified and positive correlations existed between peptide-specific IgA levels and both 
the total IgA concentration in efferent gastric lymph after parasite challenge and the 
percentage of inhibited L4 present (rs > 0.621, P < 0.001 to P < 0.05).  In contrast, 
negative correlations between the levels of peptide-specific IgA and the total nematode 
burden were observed (rs > -0.528, P < 0.01 to P < 0.05).  In conclusion, the selected 
phage clones may therefore represent vaccine candidates if they could be presented to 
the ovine immune system in an appropriate fashion. 
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Chapter 1 : General Introduction 
 
1.1 Parasitic gastroenteritis 
Parasitic nematodes are a serious issue affecting livestock agriculture due to the 
economic costs associated with infection and the impact upon welfare.  In small 
ruminants, helminth infections are one of the most important causes of production losses 
worldwide (Molento, 2009).  Parasitic gastroenteritis (PGE) is caused by the presence of 
parasitic nematodes in the gastrointestinal tract and can substantially affect lamb 
productivity due to poor protein and fat deposition, anaemia, intermittent diarrhoea 
leading to weight loss or less than optimal live-weight gain (Coop and Kyriazakis, 2001; 
Sargison, Scott and Jackson, 2002; Taylor, Coop and Wall, 2007).  Sub-clinical 
infections are associated with a suppression in appetite (Greer et al., 2008; Miller and 
Horohov, 2005), which can lead to a low live-weight gain and poor body condition 
(Taylor, Coop and Wall, 2007).  Previously, it was estimated that gastrointestinal 
nematode infections cost the UK sheep farming industry in excess of £84 million per 
annum (Nieuwhof and Bishop, 2005).  These figures include costs due to poor lamb 
productivity and those associated with the treatment of infections; however, they 
exclude the costs of sub-clinical infections.    
 
1.1.1 Teladorsagia circumcincta 
Teladorsagia (Ostertagia) circumcincta, commonly known as the ‘brown stomach 
worm’, is a highly prevalent parasitic nematode of sheep in temperate regions and is the 
most important cause of PGE in these areas (Sargison, Scott and Jackson 2002; Taylor, 
Coop and Wall, 2007): T. circumcincta has been reported as the most prevalent 
gastrointestinal nematode in small ruminants in the UK (Bartley et al., 2003).  T. 
circumcincta belongs to the order Strongylida and is a member of the superfamily 
Trichostrongyloidea, along with other small ruminant nematodes; Haemonchus 
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contortus, Cooperia spp., Nematodirus spp. and Trichostrongylus spp. (Durette-Desset 
et al., 1999; Taylor, Coop and Wall, 2007).   
 
1.1.2 Life cycle 
T. circumcincta has a direct life cycle (Figure 1.1) with a definitive ruminant host, 
similar to all members of the Trichostrongyloidea family.  Eggs are released by the adult 
females that inhabit the abomasum, pass through the gastrointestinal tract and are 
deposited onto pasture in the faeces.  If conditions are favourable for survival, eggs 
hatch and develop into the first larval stage (L1) in 24 hours and then feed on bacteria 
present in the faeces.  Next, L1 undergo a first larval moult into second-stage larvae (L2), 
which also feed on bacteria.  Approximately 10-14 days later, the L2 moult to the third 
larval stage (L3) and the L2 cuticle is retained as a protective sheath; however, this 
prevents feeding (Keith et al., 1990).  Under optimal conditions L3 migrate from faeces 
onto pasture.  Optimal temperature and humidity ranges for T. circumcincta larval 
development are 18-26°C and 60% humidity (O'Connor, Walkden-Brown, and Kahn, 
2006; Urquhart et al., 1996).  In recent years, autumn and winter seasons have been 
milder and wetter, which means that average temperatures persist at 10°C for a longer 
period of the year, allowing more larvae to develop on pasture (Kenyon et al., 2009; Van 
Dijk et al., 2010).  T. circumcincta L3 have been reported to be able to survive for up to 
13 weeks at -10°C (Pandley et al., 1993).  Infective L3 are ingested by the ruminant host, 
they exsheath in the ruminoreticulum and migrate to the abomasum where they can be 
found in the gastric glands approximately 24 – 48 hours post-infection (Michel, 1974).   
Following establishment in the abomasum, L3 continue development through another 
two moults to the fourth stage larvae (L4) (approximately 5-7 days post-infection (dpi)) 
and then fifth stage larvae (L5) (approximately 10-14 dpi) which are immature adult 
worms. L4 emerge from the gastric glands onto the lumenal surface of the abomasum 
approximately 10 dpi.  Female worms become sexually mature approximately 16-21 dpi, 
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with the complete life cycle of T. circumcincta from eggs to adults being completed in 
approximately 21 days (Soulsby, 1982; Urquhart et al., 1996). 
 
Figure 1.1 Schematic representation of the life cycle of T. circumcincta.   
Images courtesy of D. McBean (Disease Control, Moredun Research Institute).  Dashed lines represent 
parasitic stages which are either ingested or deposited by the host. 
 
Under some circumstances, T. circumcincta L4 enter a process known as arrested larval 
development in the gastric gland. Specifically, in T. circumcincta, studies have shown 
that larval development can be arrested in response to pressure from the ovine immune 
system (Smith, 2007).  Arrested L4 can reside in the abomasal glands for several months 
before resuming development through the life cycle (Michel, 1974).  Repeated, 
prolonged exposure of the host to T. circumcincta can lead to protective immunity (see 
Section 1.3) but, during the lambing and lactation period, a phenomenon termed the 
‘peri-parturient relaxation’ (PPR), leads to a temporary loss of immunity in ewes.  This 
has been linked to competing protein demands in the host during late pregnancy and 
 
Chapter 1: General Introduction  22 
lactation (Houdijk et al., 2001; McAnulty et al., 2001).  The PPR in immunity and the 
associated reduction in serum IgA levels have been correlated with increased worm 
burdens in ewes, with subsequent increased egg contamination of pasture prior to turn-
out of lambs (Houdijk et al., 2001; Jeffcoate et al., 1992).  A third source of infection for 
lambs in the spring is from over-wintered infective L3.  Recently, cases of exceptionally 
high faecal egg counts in 6 month-old lambs have been reported (Kenyon et al., 2009).  
As worm burden is acquired over a number of weeks this indicates increased challenge 
on pasture, which could potentially be linked to milder, wetter winters allowing more 
larvae to overwinter on pasture.  
 
 
1.2 Disease pathogenesis 
The presence of adult nematodes on the surface of the abomasum and the emergence of 
developing L4 from the gastric glands causes severe damage to the abomasum (Balic, 
Bowles and Meeusen, 2000).  This results in an increased requirement for protein for 
tissue repair in the gastrointestinal tract.  The nutritional cost to the host to initiate an 
immune response, combined with plasma protein leakage through mucosal epithelial 
cells, results in reduced protein metabolism (Greer et al., 2008; McKellar, 1993; 
Simpson, 2000).   
During infection, abomasal mucosal damage is characterised by swollen gastric glands 
(Figure 1.2), cellular infiltration and cytolysis of the epithelial cells lining the luminal 
surface of the mucosa, resulting in loss of integrity and secretory function of the cells 
(Scott et al., 1998; Taylor, Coop and Wall, 2007).  Loss of the normal secretory cells 
leads to protein-losing gastropathy, causes hypoalbuminaemia and impacts negatively 
upon the host’s nutritional status (McKellar, 1993; Sutherland and Scott, 2010).  At 5 
dpi, coincident with L4 emergence from glands, acid secretion from the abomasum is 
reduced and the pH of the abomasal contents increases, which in turn reduces 
pepsinogen activation and increases gastrin secretion (Lawton et al., 1996; Simpson, 
2000).   
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Figure 1.2 Images illustrating the pathological damage to an abomasum from a sheep during an 
infection with T. circumcincta compared to an abomaum from a parasite-free sheep. 
The abomasum has a soft, mucous surface which is composed of longitudinal folds.  The 
abomasum from a sheep during an infection with T. circumcincta characteristically has nodules 
(‘polyps’) present on the mucosal surface of the abomasums due to the presence of L4 in the 
gastric glands.  Images kindly provided by Dr D.J. Bartley, (Disease Control, Moredun Research 
Institute). 
 
Changes in the physiology of the abomasum are also seen; mucus production is 
increased, pepsin secretion is inhibited, and gastrin levels in the serum are elevated as a 
result of loss of abomasal integrity (Simpson, 2000).  
 
1.3 Immune response 
1.3.1 Host immunity 
In mammals, the immune system is divided into the innate and adaptive immune 
responses.  The innate immune response is fast-acting, using non-specific lines of 
defence against invading pathogens and acts as a barrier to prevent infection.  The 
adaptive response takes longer to develop, is highly specific and is termed the ‘memory 
response’.  The adaptive immune response has two further sub-divisions; the cellular-
mediated and humoral response, of which the latter is involved with the production of 
antibodies specific to antigens from the invading pathogen.  The ability to mount this 
Infected Normal
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antibody driven response is maintained by B cells.  If the host immune system 
encounters the pathogen for a second time, B cells are able to trigger the production of 
antigen-specific antibodies more rapidly; this is termed the anamnestic response.   
CD4
+
 T helper cells (Th) are a source of cytokines and have receptors which are 
able to recognise antigen peptides in association with major histocompatibility complex 
(MHC) presenting cells (Goldsby et al., 2003).  Th cells can be further divided into 
subsets of cells which differ due to phenotype and function e.g. Th1, Th2 and Th17 
(Goldsby et al., 2003).  Th2 cells produce a number of cytokines including interleukin-4 
(IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6) and interleukin-10 (IL-10) which drive 
a type 2 immune response and have been shown to have an important role in the control 
of helminth infections (Urban et al., 1995).  These cytokine promote B cell proliferation, 
the secretion of immunoglobulins and mediate activation of mast cells and eosinophils 
(Goldsby et al., 2003).  
The cellular-mediated response is associated with Th1 cells and is characterised 
by an activation and infiltration of effector cells to the site of infection.  This cellular 
infiltration is in response to a specific antigen presented by a MHC molecule, and 
includes a cellular profile of macrophages and antigen-specific cytotoxic T-cells.  This 
in turn can produce interferon-γ (INF- γ), interleukin-2 (IL-2) and interleukin-3 (IL-3) 
(Goldsby et al., 2003).  These cytokines promote the production of activated 
macrophages, antibodies and mediate delayed type hypersensitivity responses and 
inflammatory reactions.  This response is often elicited against invading intracellular 
organisms, for example viruses and bacteria.   
  
1.3.2 Immunity against T. circumcincta 
Parasitic gastroenteritis is primarily a disease of lambs as immunity is acquired after 
repeated exposure to the parasite (Halliday et al., 2007; Seaton et al., 1989).  Repeated 
ingestion of larvae over a period of 8 – 12 weeks by sheep from the age of 5 months 
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results in a protective immune response (Abbott, Taylor and Stubbings, 2004).  An 
experimental infection of 5 month-old lambs with T. circumcincta, showed that over an 
8-week “trickle”-infection regime, with approximately 1,000 T. circumcincta L3 
administered weekly, animals were rendered immune to a subsequent challenge 
infection (Seaton et al., 1989).  As acquired immunity develops, the lambs prevent 
incoming L3 from establishing in the abomasum as well as provoking retardation in 
development of L4 and influencing the growth, development and fecundity of adult 
worms (Balic, Bowles and Meeusen, 2000; Seaton et al., 1989; Stear et al., 2004).   
 
1.3.3 Mechanisms of immunity 
In immune sheep, an immediate type hypersensitive reaction, characterised by mast cell 
infiltration in the abomasal mucosa, is directed against incoming L3.  It is thought to be 
responsible, in part, for preventing the establishment of incoming larvae through 
expulsion or exclusion of larvae.  This has been shown to occur as early as 2 days post-
challenge (dpc) in sheep rendered immune by an experimental trickle infection of 10,000 
T. circumcincta L3 per week for a 9-week period and subsequently dosed with a bolus of 
50,000 L3 (Smith et al., 1984).  It has been suggested that the overall burden is partly 
regulated by this immediate hypersensitivity response (Stear et al., 1995).  Continual 
exposure to nematode antigens, i.e. through grazing of contaminated pasture, induces 
and maintains the production of an antigen-specific IgA response in the abomasal 
mucosa (Smith et al., 1987).  The relationship between developmental stage, IgA-
reactive antigen profile and impact of T. circumcincta-specific abomasal IgA responses 
on abomasal worm burden has been explored using excretory/secretory (ES) products 
from ex-vivo exsheathed L3 [day 1 post infection, (1dpi)], L3/L4 (3dpi) and L4 (5dpi) and 
abomasal mucosal IgA from ewes rendered immune by trickle infection with 2,000 L3 
three times per week for 10 weeks (Smith et al., 2009).  Immunoblots demonstrated L3 
and L4 antigen-specific IgA in the abomasal mucus of immune ewes and an inverse 
relationship was observed between 3dpi ES-reactive abomasal IgA levels and worm 
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burden following challenge of sheep with 50,000 T. circumcincta L3 (Smith et al., 
2009).  The abomasal mucosal IgA response has also been implicated in impairing 
growth and retarding L4 development (Smith et al., 1985) and the proportion of larvae 
displaying arrested development is correlated with the magnitude of the local abomasal 
IgA response (Stear et al., 1995).  In a study looking at the impact of 
immunosuppression on sheep infected with T. circumcincta, sheep were trickle-infected 
with 10,000 T. circumcincta L3 weekly for a 6-week period and then subjected to a bolus 
challenge of 50,000 L3 (Smith, 2007).  In the trickle-infected animals, inhibition of L4 
development was triggered, but normal L4 development was more rapidly resumed after 
administration of an immunosuppressive corticosteroid injection than in the non-
immunosuppressed group (Smith, 2007), providing evidence that the proportion of  
arrested L4 in the abomasum is controlled by the host immune response.  In experimental 
infections with T. circumcincta, where yearling sheep were trickle-infected with 2,000 
L3 three times weekly for 2 months before challenge with 50,000 infective L3, an 
abomasal mucus IgA anamnestic response to L4 somatic antigen and L4 ES was 
observed in efferent gastric lymph at 4-5 dpi of the bolus challenge and this response 
was linked to inhibited development of L4 (Halliday et al., 2007).   In addition to effects 
on development of L4, the immune response to a persistent T. circumcincta challenge 
can impact the length of adult worms; for example, adult worms collected from the 
abomasa of sheep subjected to a trickle infection and bolus challenge of 50,000 L3, were 
1 mm shorter than those collected from sheep that were given a bolus challenge only 
(Halliday et al., 2007). 
 
Antibody responses against gastrointestinal nematodes often are of greater 
magnitude and peak earlier after a secondary infection compared to primary infections. 
For example, in sheep infected with Haemonchus contortus, serum IgG responses to 
adult ES and somatic antigens increased within 24 hours and had higher titres following 
a secondary infection compared to a primary infection (Schallig et al., 1994; 1995).  In 
experimental infections with T. circumcincta, yearling sheep were trickle-infected with 
2,000 L3 three times weekly for 2 months before challenge with 50,000 L3, an 
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anamnestic response in both L4 somatic antigen and L4 ES-specific abomasal IgA levels 
was observed at 4-5 dpi and was linked to stunted L4 growth (Halliday et al., 2007).     
Immunity acquired under experimental conditions is linked to host age, with 10 
month-old sheep having a greater proportion of inhibited L4 than 4.5 month-old lambs, 
when infected under the same trickle infection regime. Here, both groups of lambs were 
trickle-infected with 2,000 L3 five days a week for 9 weeks and then subjected to a 
50,000 L3 bolus challenge (Smith et al., 1985).  A recent study contradicts this 
observation, as no significant difference was found between yearlings and 5 month-old 
lambs in nematode burden and/or the proportion of larvae in inhibited development 
under a similar trickle infection/bolus challenge protocol (Halliday, McAllister, and 
Smith, 2010).   A possible explanation for these differences is that the 10 month-old 
sheep were less ‘resilient’ to the heavy trickle infection (2,000 L3 five times per week 
for 8 weeks) used in the 1985 trial compared to the 2010 trial (2,000 L3 three times per 
week for 8 weeks) (Halliday, McAllister, and Smith, 2010; Smith et al., 1985).   
Protective immunity to T. circumcincta can be transferred directly between 
genetically identical sheep by the transfer of lymphocytes in gastric lymph collected 
from animals rendered immune by a trickle infection regime (Smith et al., 1986).  
‘Partial’ protection was generated as evidenced by decreased worm burdens and stunted 
worm growth in recipients (Smith et al., 1986).  In this experiment, stimulation of local 
IgA and mast cell infiltration in the mucosa implicated lymphocyte involvement in 
protective immunity.  
 
T. circumcincta infection has also been associated with an increase in IgE levels 
(Huntley et al., 1998a; 1998b).  T. circumcincta L3-specific IgE responses have been 
observed to peak between 2-8 dpc in sheep which had been administered a bolus 
challenge of 50,000 L3 following a trickle infection (Huntley et al., 1998a; 1998b).  
These responses were shown to be directed towards antigens present on the cuticular 
surface of L3.  Importantly, the magnitude of the IgE response in lambs during their first 
grazing season, targeted towards T. circumcincta L3 surface antigens, was associated 
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with low cumulative faecal egg counts (Huntley et al., 2001).  A schematic overview 
detailing the current status of knowledge with regards to immunity to T. circumcincta is 
shown in Figure 1.3. 
 
 
Figure 1.3  Summary of the known mechanisms and factors influencing the immune response to 
T. circumcincta infection in sheep. 
 
1.3.4 Cellular immune response 
During T. circumcincta infection, the cellular composition of the abomasal mucosa is 
characterised by infiltrates of T cells and eosinophils (Balic et al., 2003).  The direct 
tissue damage caused by larval invasion and feeding has also been associated with 
eosinophil activation and pro-inflammatory cytokine release (De Veer, Kemp and 
Meeusen, 2007).  Histopathological analysis of immune animals (but not primary 
infected, naïve animals) indicated that eosinophils are rapidly recruited and congregate 
with lymphocytes around invading larvae (McGillivery et al., 1992; Meeusen, Balic and 
Bowles, 2005).  In previously infected sheep, following a 50,000 T. circumcincta L3 
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challenge, mast cell infiltration and an increase in mucosal pepsinogen levels were 
linked to an immediate hypersensitivity response (Smith et al., 1984).  Resistance to 
infection in previously infected animals has been associated with a secondary response.  
This has been indicated by a decrease in the proportion of CD21
+
 cells in gastric lymph 
at 5 dpc (Balic et al., 2003; Smith et al., 1984).  CD21
+
 is a marker of immature B cells 
and its presence on the surface of B cells is lost when they fully mature into 
differentiated antibody secreting cells (Braun et al., 1998).   
The kinetics measured in the cellular response and cytokine profile in immune 
animals highlight that T. circumcincta triggers a Th2 humoral response; characterised by 
up-regulation of interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-10 (IL-10) and 
interleukin-13 (IL-13) at 5 dpi (Craig et al., 2007; Miller, 1996).  An increase in the up-
regulation of cytokines associated with a Th1 cellular mediated response was also seen 
(Craig et al., 2007; Miller, 1996).  This cytokine profile included interleukin-1β (IL-1β), 
interleukin-6 (IL-6) and interleukin-18 (IL-18), aswell as the transforming-growth 
factor-β (TGF-β), associated with tissue repair and collectively this indicates that there 
was a pro-inflammatory influence on the immune response generated following 
infection (Craig et al., 2007; Miller, 1996).    
 
1.4 Control of parasitic gastroenteritis 
1.4.1 Anthelmintics 
Gastrointestinal nematode infections in small ruminants are controlled by the application 
of grazing management strategies combined with the use of broad-spectrum 
anthelmintics.  Anthelmintic treatment can be used strategically to prevent disease in 
lambs which have not yet acquired immunity to the parasites (Abbott, Taylor and 
Stubbings, 2004; Prichard et al., 2007).  There are five classes of anthelmintics licensed 
in the UK for administration to small ruminants: benzimidazoles, imidothiazoles, 
macrocyclic lactones, amino-acetonitrile derivatives (AADs) and spiroindole 
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compounds.  In the early 1960s, the first benzimidazole, thiabendazole, was introduced.  
The mode of action is linked to binding to β-tubulin, preventing microtubule formation, 
which is critical to maintain the integrity and function of parasite cells (Pritchard, 1990).  
Due to the disruption in cellular processes, cell lysis negatively impacts upon parasites 
motility and feeding (McKellar and Jackson, 2004; Mitreva et al., 2007).  The 
imidothiazole class of anthelmintics was first developed in the 1970s; these are nicotinic 
agonists causing depolarisation of neuromuscular junctions and paralysis of the parasite 
musculature, resulting in expulsion of the parasite from the host (Martin et al., 1998; 
McKellar and Jackson, 2004).  Licensing of the macrocyclic lactones in 1981 
represented an important tool in control, as these were the first anthelmintic class to have 
efficacy against both ectoparasites and endoparasites and had a level of persistence in 
their activity (Geary, 2005).  The macrocyclic lactones class is split into two groups; 
avermectins (for example ivermectin) and milbemycins (for example moxidectin).  The 
macrocyclic lactones are thought to exert their mode of action by irreversibly binding to 
gamma-aminobutyric acid- (GABA) and glutamate-gated chloride (GluCl) channels 
resulting in paralysis of pharyngeal and somatic muscle cells, which in turn causes 
immobility of the worms (Blackhall et al., 1998; Feng et al., 2002; Martin et al., 1998; 
Wolstenholme et al., 2004).  One of the most recent classes of anthelmintic to be 
introduced is AADs, which have as a target nicotinic acetylcholine receptors (Kaminsky 
et al., 2008; Prichard and Geary, 2008).  Like other broad-spectrum anthelmintics, their 
mode of action is to induce paralysis of somatic muscle cells and they are efficacious 
against larval and adult stages of gastrointestinal nematodes (Besier, 2009; Kaminsky et 
al., 2008).  The latest class of anthelmintic are the spiroindoles, which are semi-synthetic 
molecules and their mode of action is to block cation ion channels in somatic muscle 
cells (Little et al., 2011), ultimately inducing paralysis of the nematode.   
 
1.4.2 Anthelmintic resistance 
The selection pressure of frequent anthelmintic treatments that has been exerted on 
parasitic nematode populations has lead to the development of resistance to some of the 
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broad spectrum classes.  Anthelmintic resistance is irreversible and is heritable between 
generations of worms (Jackson and Coop, 2000; Wolstenholme et al., 2004).  
Teladorsagia is now the predominant resistant genus in the UK (Bartley et al, 2003; 
Kaplan, 2004) and isolates of T. circumcincta which are resistant to all three classes of 
commonly used anthelmintics (benzimidazoles, imidothiazoles and macrocyclic 
lactones) have been reported (Bartley et al, 2004; Sargison et al, 2007).  The presence of 
multi-drug resistance on a farm can result in the suspension of sheep farming on the 
property until the parasite contamination on grazing pasture is removed.  It is difficult to 
ascertain the full extent of anthelmintic resistance in the UK as no routine surveillance 
surveys for resistance are conducted and it is often diagnosed after clinical signs of drug 
failure on a farm have been reported (Sargison et al., 2001; 2007).  Anthelmintic 
resistance is a major threat to livestock production worldwide; however it has a higher 
prevalence in the Southern Hemisphere (Jackson and Coop, 2000; Kaplan, 2004).  As 
the AADs have recently been licensed there are no reports of field resistance to this class 
yet; however, in vitro experiments were able to select AAD-resistant Caenorhabditis 
elegans and molecular resistance markers were identified (Kaminsky et al., 2008).  
 
1.5 Management strategies 
There are currently no effective alternatives to anthelmintics for the control of 
gastrointestinal nematodes in sheep, so other strategies are required.  A number of 
alternative control methods have been investigated, including targeted selective 
treatments, pasture management, nutritional supplementation, selective breeding and 
vaccination (Athanasiadou, Houdijk and Kyriazakis, 2008; Coop and Kyriazakis, 2001; 
Greer et al., 2007; Hoste et al., 2002; Hunt, McEwan and Miller, 2008).  Grazing 
management strategies are used as a means to reduce the selective pressure on parasites, 
to slow development of resistance mechanisms, by reducing the levels of pasture 
contamination.  A proportion of the parasite population will not be exposed to 
anthelmintics.  These parasites, often on pasture, are termed ‘in refugia’.  It is thought 
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that if a proportion of the flock were not subjected to anthelmintic treatment, the number 
of worms in refugia would be increased.  This strategy has been adapted for the control 
of H. contortus, in which small ruminants are prioritised for anthelmintic treatment by 
comparing the colour of the conjunctiva mucus membrane to a colour chart to assess the 
level of anaemia (Van Wyk and Bath, 2002).  Animals with no clinical signs of parasitic 
infection are left untreated and add to the proportion of in refugia worms on pasture.  
This selective system has been developed further in terms of targeting treatment towards 
factors influencing production and animal performance, including live weight gain, body 
condition and faecal worm egg counts (FWEC), and has shown considerable promise as 
an effective management strategy (Besier, 2008; Greer et al., 2009; Kenyon et al., 2009; 
Stafford et al., 2009).  Other grazing management strategies include co-grazing of sheep 
and cattle, age-grouped grazing and rotation of pasture (Abbott, Taylor and Stubbings, 
2004; Waller and Thamsborg, 2004). 
Selective breeding strategies have been used to ‘select’ for the individual sheep in 
a flock which have a greater resilience to parasite infection, i.e. they are able to reach 
production targets whilst infected (Stear et al., 2000).  Using genetic selection, it may be 
feasible to breed a line of animals that have greater resilience to infection and/or a better 
level of immunity.  The choice of measure used for genetic selection needs to be further 
defined, as selecting for individuals with low cumulative FWECs in isolation from other 
measures of production may be ‘hiding’ those sheep under high physiological pressure 
to maintain their level of resilience (Greer et al., 2008). 
 
 
1.6 Vaccine development  
Vaccination against gastrointestinal nematodes would be a desirable alternative control 
strategy to anthelmintic treatments.  To date, there have been few commercially 
available helminth parasite vaccines produced.  The only one available for use in 
ruminants is Bovilis® Huskvac (MSD Animal Health), which was developed for the 
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control of lungworm in cattle and is based on oral administration of live attenuated L3 
(Jarrett et al., 1955; Vercruysse et al., 2004).   
Vaccination of sheep against T. circumcincta is a possible option as a protective 
response can be acquired in the host following repeated exposure to the parasite either 
through natural field exposure or experimental infection (Smith et al., 1983; Stear et al., 
1999).  A vaccination programme could potentially be used in conjunction with existing 
strategies to prolong anthelmintic effectiveness, reduce pasture contamination and to 
protect the most susceptible sub-group of animals within a flock (Emery, McClure and 
Wagland, 1993).  Successful vaccination could allow lambs to develop immunity before 
factors such as stress, inadequate nutrition and pasture contamination puts them at high 
risk of infection (McClure, 2009).  The development of a vaccine against parasitic 
nematodes requires a detailed knowledge of the biology of the parasite, the nature of 
interactions with the host and the effective immune responses that are generated during 
infection (Knox, 2010).  The first published set of T. circumcincta vaccination 
experiments, in the late 1970’s, used a mixture of L3 and L4 ES products from ex-vivo 
worms as antigen and induced 69% reduction in worm burden in vaccinated animals 
compared to identically-challenged adjuvant-only, recipients (Rose, 1976; 1978).   
 
1.6.1 Approaches used in nematode vaccine development 
Development of vaccines against parasitic nematodes has involved targeting molecules 
from different stages of the parasite life cycle, including products excreted/secreted from 
larvae or exposed on the parasite surface, using local antibody probes (Murphy et al., 
2010; Nisbet et al., 2010a; Redmond et al., 2006; Smith et al., 2009) or the identification 
of molecules with homology to other known promising vaccine candidates (Nisbet et al., 
2009; 2010b; 2011).  A successful anti-nematode vaccine is likely to be one that will 
target several antigens expressed by various developmental stages of the parasite (Knox, 
2010). 
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1.6.1.1  L3 antigens 
The L3 represents the first stage to come into contact with the host and its immune 
system, and therefore is critical in the life cycle as it could determine if the parasite is 
established within the host or excluded from the gastrointestinal system.  One of the first 
immunogenic antigens to be identified from T. circumcincta L3 was a 31 kDa molecule 
located to the secretory organelles (McGillivery et al., 1989; 1992).  This molecule 
displayed promise as a vaccine candidate in an immunisation trial where the 31 kDa 
antigen was purified from a detergent extract of T. circumcincta L3, 400µg of the antigen 
administered with Quil A adjuvant to 6 month-old sheep and, following immunisation, 
the sheep subjected to a single bolus challenge of 42,000 T. circumcincta L3 and 
antibody responses and parasitological parameters monitored (McGillivery et al., 1992).  
Comparison of vaccinated sheep to adjuvant-only controls showed reductions in both 
FWEC and worm burdens (42%) alongside the presence of antigen-specific serum IgG 
as early as 4 days after administration of the first vaccine dose (McGillivery et al., 
1992).  However, attempts to replicate this result have been unsuccessful as cell-
mediated and antibody responses were not induced (Morton et al., 1995).  One of the 
reasons behind this is that challenge dose given was a non-natural large dose and the 
immunity afforded by the vaccination may not have been adequate to control the parasite 
infection.  Another potential vaccine candidate from T. circumcincta L3 was identified 
through the bioinformatic analysis of a stage-specific expressed sequence tag (EST) 
dataset from exsheathed T. circumcincta L3 (Nisbet et al., 2008; 2009).  This surface 
associated antigen, Tci-SAA-1, shared over 77% amino acid identity with Ac-SAA-1, a 
vaccine candidate from the canine hookworm, Ancylostoma caninum, and was localised 
to the sub-hypodermal layer below the cuticle of exsheathed T. circumcincta L3 (Nisbet 
et al., 2009).  Abomasal mucus IgA obtained from 5 month-old lambs which had been 
subjected to an experimental trickle infection (2,000 T. circumcincta L3 three times per 
week for a 10-week period) bound to the bacterial-expressed recombinant version of 
Tci-SAA-1, and anti-Tci-SAA-1 antibodies recognised a 12-14 kDa antigen present only 
in somatic and surface extracts of L3 (Nisbet et al., 2009).  Tci-SAA-1 is therefore a 
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promising vaccine candidate, primarily due to the high level of homology with A. 
caninum vaccine candidate, localisation on the surface of exsheathed T. circumcincta L3 
and the potential of the antigen to be a target for abomasal mucus IgA.  Surface antigens 
therefore possess promise as vaccine candidates; however the external surface of 
parasitic nematodes is complex and dynamic.  The outer covering of the nematode, 
termed the cuticle, is a multilayered structure with a unique structural and chemical 
composition (Blaxter et al., 1992).  A carbohydrate-rich surface coat, termed the 
‘glycocalyx’ is associated with the epicuticle and has been implicated in immune 
evasion (Maizels et al., 1993).  In addition, following ingestion of infective T. 
cirucmcincta L3, the L3 exsheath, develop and moult, and the profile of the surface 
antigens displayed alters (Keith et al., 1990).   
Surface antigens of T. circumcincta L3, have been stripped from the epicuticle 
using detergent and subsequently used in an immunisation trial to investigate their 
ability to induce a protective response in sheep against challenge (Wedrychowicz et al., 
1992; 1995).  Sheep vaccinated with L3 surface extracts in conjunction with beryllium 
hydroxide adjuvant and then challenged with a single bolus of 50,000 L3 had a 72% 
reduction in worm burden compared to adjuvant-only recipients (Wedrychowicz et al., 
1992; 1995).  Vaccination with L3 surface extracts induced a humoral response, with 
vaccinated sheep having a higher level of L3 surface antigen-specific serum IgA and IgG 
compared to control sheep (Wedrychowicz et al., 1992). However, when repeated in 
1995, the same level of protection was not seen as there were no differences in serum 
IgA responses between vaccinated and control sheep (Wedrychowicz et al., 1995).     
An L3-specific carbohydrate-larval antigen (CarLA), was found to be present on 
the cuticular surface of numerous nematode species, including Trichostrongylus 
colubriformis, T. circumcincta, H. contortus, Nematodirus americanus and Cooperia 
curticei (Harrison et al., 2003a; 2003b).  Studies with T. colubriformis found that 
antibodies specific to CarLA were strongly associated with immune-mediated rejection 
of incoming L3, suggesting that CarLA is implicated in L3 establishment in the tissue 
niche (Harrison et al., 2003a; 2008).  However, further research has revealed that there 
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is variation in the versions of CarLA antigens displayed on individual worms, i.e. 
individual larvae have different versions of CarLA (Maas et al., 2009).  The implication 
of CarLA in L3 establishment and the finding that anti-CarLA antibodies mediate 
rejection of incoming L3 into the abomasum highlight that carbohydrates displayed on 
the surface of nematode parasites have the potential to be recognised by the host 
immune system. 
 
1.6.1.2  L4 antigens 
At the L4 stage, the parasite has already established in the abomasum and a vaccine that 
targets this stage could inhibit or prevent mechanisms by which larvae survive and grow.  
In the abomasal gland, L4 parasites release ES products and these could be a critical area 
to target to interrupt interactions between the host and parasite.  Nematode ES products 
have been identified as important sources of protective antigens in other ruminant 
species (Meyvis et al., 2007).  In an attempt to identify some of the components of T. 
circumcincta L4 ES products, and hence possible vaccine candidates, a proteomic 
analysis of L4 ES products collected at 8 dpi was conducted (Redmond et al., 2006).  
Analysis revealed that the most abundant protein present in L4 ES products was the 
proteolytic enzyme cathepsin-F (Tci-CF-1) (Redmond et al., 2006).  This was a 
proposed vaccine candidate due to other members of the cathepsin family being 
validated vaccination targets in other helminth species (Dalton et al., 2003; Tort et al., 
1999) and because of the essential roles proteinases play in nematode survival and 
development, including moulting, tissue invasion, digestion and evasion of host immune 
responses.  Tci-CF-1 was a proven target of the local immune response in sheep 
subjected to a trickle infection and bolus challenge regime, as abomasal mucus IgA 
levels specific to Tci-CF-1 corresponded to the observed peak in total IgA in efferent 
gastric lymph (Redmond et al., 2006).  A later study also used a proteomics approach to 
identify key molecules in T. circumcincta L3 and L4 ES products (Smith et al., 2009) 
from worms collected at 1, 3 and 5 dpi.  Tci-CF-1 was identified in L4 ES products 
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collected from worms harvested at 3 dpi (Smith et al., 2009).  Another potential vaccine 
candidate identified by the proteomic analysis of L4 ES products was an activation-
associated-secreted protein (ASP), Tci-ASP-1 (Nisbet et al., 2010; Smith et al., 2009).  
ASPs are nematode-specific members of a diverse protein family, called SCP/Tpx-
1/Ag5/PR-1/Sct (SCP/TAPS), present in eukaryotes and a range of parasites (Cantacessi 
et al., 2009; 2012).  The first report of their existence in parasites was in the ES products 
of serum-activated L3 of the canine hookworm, A. caninum (Hawdon et al., 1996; 1999).  
They are key vaccine candidates against hookworm species and are thought to be 
important in the establishment of parasites in the host (Hawdon et al., 1999; Tawe et al., 
2000).  Tci-ASP-1 was found to be specific to the parasitic stages of T. circumcincta, 
and a bacterial-expressed recombinant version was shown to be the target of abomasal 
mucus IgA obtained from sheep rendered immune to challenge through a prolonged 
experimental trickle infection/challenge regime (Nisbet et al., 2010).   
 
1.7 Current challenges in parasitic nematode vaccine 
development  
A number of studies have reported difficulties in stimulating the same levels of 
protective immunity with recombinant vaccine candidate antigens as had been observed 
when native versions of parasite molecules or extracts were tested (Meyvis et al., 2008; 
Smith and Zarlenga, 2006).  Abomasal mucus IgA has been a useful immunological 
probe to identify a number of possible protective antigens from T. circumcincta which 
have displayed promise as potential vaccine candidates, including Tci-CF-1, Tci-ASP-1 
and Tci-SAA-1 (Nisbet et al., 2009; 2010a; 2010b; Redmond et al., 2006; Smith et al., 
2009).  These molecules, as well as five others identified as immunogenic or 
immunostimulatory during the sheep/T. circumcincta interaction, have recently been 
formulated as a recombinant cocktail which, when administered to 5-6 month-old sheep, 
induced 58-70% reductions in cumulative FWEC during a T. circumcincta trickle 
challenge (Nisbet et al., 2013).  Despite this success, the complexity of the vaccine 
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formulation may preclude its appeal for commercial exploitation.  For other species of 
parasitic nematode there has been limited success in the development of recombinant 
subunit vaccines.  There are several potential reasons likely to underlie these failures.  
Perhaps the most important are unsuitable expression systems for antigen production 
leading to incomplete or inadequate post-translational modifications; for example, 
glycosylation and tertiary protein folding, resulting in incorrect epitope structures for 
antibody binding (Geldhof et al., 2007).   
 
1.7.1 Glycosylation 
Glycosylation of nematode proteins can enhance the immunogenicity of antigens or be 
involved in the modulation of the host’s immune response (Dell et al., 1999).  In some 
cases, carbohydrate components of antigens have been implicated as having a potential 
role in antibody recognition; for example, novel glycan epitopes were identified in adult 
H. contortus ES products and the glycan specific antibody titres correlated with 
protection (Van Stijn et al., 2010; Vervelde et al., 2003).  In particular, antibody 
recognition of two glycan epitopes, Galα1-3GalNAc-R and GalNAcβ1-4(Fucα1-
3)GlcNAc-R (LDNF), was found to be significantly correlated with a protective serum 
IgG response against H. contortus in sheep immunised with adult worm ES products 
(Van Stijn et al., 2010; Vervelde et al., 2003).  Furthermore, binding of ES-antigen-
specific serum IgA and IgG decreased if ES antigens had been treated with sodium 
periodate prior to analysis by ELISA (Vervelde et al., 2003), indicating that the structure 
of the glycans were involved in antibody binding.  From this, Vervelde et al. (2003) 
concluded that ES glycan components in H. contortus were immunogenic, suggesting 
that the glycan-specific immune response may contribute to protection against nematode 
infection.  Research into a lead vaccine candidate for H. contortus, termed Haemonchus 
galactose containing glycoprotein complex (H-gal-GP) (Smith et al., 2000), identified 
the presence of the LDNF glycan on a metalloendopeptidase (MEP-3) component of H-
gal-GP (Geldhof et al., 2005).  In contrast to the work presented by Vervelde et al., 
(2003), there was no relationship found between the antibody response to the LDNF 
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glycan on H-gal-GP and the level of vaccine induced protection in lambs (Geldhof et al., 
2005).  In more detail, there was no significant correlation between the level of  
antibodies specific to the LDNF glycan found on H-gal-GP and the level of protection 
afforded in sheep immunised with native-H-gal-GP or denatured, reduced H-gal-GP 
following a challenge infection of 5000 H. contortus L3 (Geldhof et al., 2005).   
Carbohydrate residues have been found on components of ES products and 
somatic extracts from a range of parasitic nematodes including Dictyocaulus viviparus 
(Haslam et al., 2000), H. contortus (Haslam et al., 1996; Vervelde et al., 2003) and 
Toxocara canis (Maizels and Page, 1990).  N-linked glycans, in particular a glycan 
epitope termed ‘Lewis
x
’ (Galβ1-4(Fucα1-3) GlcNAc), were present in detergent extracts 
of D. viviparus (Haslam et al., 2000).  Lewis
x
 type projections on bi-, tri- and tetra-
antennary molecules were identified in an extract from adult D. viviparus, which 
potentially have an immunomodulatory role (Haslam et al., 2000).  Phosphorylcholine 
modifications of N-linked glycans represent another proposed immunomodulatory 
glycan structure and these have recently been identified in the porcine nematode Ascaris 
suum from an antigen preparation of adult worms (Poltl et al., 2007).  In general, 
parasite glycans are often more structurally complex than mammalian glycans; this is 
primarily related to parasite-specific modifications to the core glycan structures (Hein 
and Harrison, 2005; Nyame, Kawar and Cumming, 2004).  Consequently, this means 
that recombinant expression systems may not be able to manufacture the glycoprotein 
with the relevant specific modifications, for example, terminal sugar composition, 
elongation of chain length and variation in the composition of linkage patterns, that are 
required for the range of epitopes that are able to stimulate specific antibodies when the 
native molecule is presented to the host immune system (Khoo and Dell, 2001). When 
glycans prepared from the free-living nematode C. elegans were used as immunogens in 
an immunisation trial against H. contortus in sheep, no protection against challenge with 
the parasitic nematode was observed, despite extensive homology between the glycans 
that have been identified in both nematode species (Cipollo, Costello and Hirschbeg, 
2002; Haslam, Coles and Munn, 1996; Redmond, Geldhof and Knox, 2004).  
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Similarities are evident in the two nematodes’ glycosylation patterns; both having high 
mannose content and complex N-linked glycans (Cipollo, Costello and Hirschbeg, 2002; 
Haslam, Coles and Munn, 1996).  C. elegans has also been used as a heterologous 
protein expression system for H. contortus antigens, to attempt to introduce appropriate 
glycosylation and protein folding and when Hc-CPL-1 (cathepsin L cysteine protease of 
H. contortus) was expressed in C. elegans, the resultant recombinant protein was 
enzymically active and glycosylated.  However, intramuscular immunisation with this 
antigen failed to protect sheep against challenge with H. contortus (Murray et al., 2007).  
These studies reflect the complexity of both candidate antigen selection and 
heterologous expression systems in the generation of host-protective nematode vaccines. 
 
1.7.2 Conformational epitopes 
There are two classifications of epitopes on protein antigens, linear and conformational.  
These are based on the structure of the epitope and its antibody interaction (Huang and 
Honda, 2006).  A linear epitope is formed by amino acid residues that are present on the 
antigen in a linear sequence (Figure 1.4).  A conformational epitope, also known as 
structural or discontinuous, is formed when the amino acid residues are on distinct, 
separate areas of the protein antigen.  Upon tertiary protein folding, the residues are 
brought into close proximity and form the three-dimensional epitope required for 
specific antibody recognition (Figure 1.4).  
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Figure 1.4 Schematic illustration of linear and conformational epitopes. 
(Image adapted from Roitt’s Essential Immunology, 11th ed).  Green dots represent linear peptides 
connected to create a linear epitope for antibody recognition.  Red and black dots (highlighted by yellow 
ovals) are on distinct areas of the antigen.  Following tertiary protein folding they are brought into close 
proximity and represent a discontinuous, structural/conformational epitope. 
 
The relative importance of correct glycosylation in stimulating appropriate immune 
responses may be difficult to isolate from the impact of other post-translational 
modifications, such as protein folding, tertiary and quaternary structures and the 
formation of protein complexes (either homologous or heterogenous).  This is illustrated 
by studies on immunisation of cattle against the abomasal nematode, O. ostertagi, using 
activation-associated secreted proteins (ASPs) (Geldhof et al., 2008).  The proteins in 
question, Oo-ASP-1 and Oo-ASP-2, were the principal components of an enriched 
native ES preparation derived from adult O. ostertagi, which had been shown previously 
to successfully immunise cattle against challenge (Geldhof et al., 2002; 2004; Meyvis et 
al., 2007).  However, vaccination with a recombinant version of Oo-ASP-1, produced in 
a eukaryotic (baculovirus/insect cell-based) expression system, failed to induce 
protective immunity or native-antigen-specific serum antibodies in immunised calves 
(Geldhof et al., 2008).  In these studies, it was initially suggested that incorrect or 
inadequate glycosylation may be responsible for the absence of protective immunity or 
the lack of native antigen-specific antibodies after vaccination.  However, 
deglycosylation of native Oo-ASP-1 and Oo-ASP-2 antigens using peptide-N-
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(IgG1, IgG2, IgM or IgA) from native antigen-immunised calves to these proteins 
(Meyvis et al., 2008).  Further investigations demonstrated that denaturation of the 
native ASPs using the reducing agent dithiothreitol reduced their ability to be bound by 
antigen-specific antibodies, suggesting that these antibodies are directed against epitopes 
formed by secondary or tertiary structure arrangements rather than primary protein 
sequence or glycan.  This study (Meyvis et al., 2008) highlighted that the ability of 
discontinuous peptide sequences to form conformational epitopes can be essential for 
retaining antibody recognition, and confirms that tertiary or quaternary protein folding 
are critical post-translational modifications for reproducing responses manifested by 
nematode antigens in native form.   
 
1.7.2.1 Protein folding 
Further evidence to support the importance of the correct protein folding, and thus 
structural epitope formation, can be shown by investigations into the potential role of N-
linked glycans in immunologically-mediated protection against D. viviparus.  Several 
antigens from an L3 extract and adult ES products contained N-glycan residues 
(Kooyman et al., 2007).  Following deglycosylation of these antigens with PNGase F 
treatment, the degree of antibody binding by serum antibodies from vaccinated cattle 
was reduced indicating that the N-glycan residues were important for antibody 
recognition (Kooyman et al., 2007).  Further investigation of the role of N-glycans in the 
protective immune response used a comparison of serum IgG1 titres specific to L3 and 
adult ES antigens between re-infected calves (primary infection followed by challenge) 
and a primary infection (challenge control) group.  Following challenge, the antigen-
specific antibody titres increased for both groups (Kooyman et al., 2007).  On 
deglycosylation of antigens, the level of antibody recognition was significantly higher in 
the re-infected group compared to the primary infected calves, highlighting that, 
although N-glycans were responsible for the induction of a strong immune response, it 
was in fact the protein backbone that was implicated in generation of the anamnestic 
response (Kooyman et al., 2007).  Collectively, this suggests that it is essential that a 
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recombinant protein antigen is folded correctly in order to present the necessary epitopes 
for antibody binding.   
The role of conformational or structural epitopes in immunity against nematodes 
has been a focus during vaccine development against H. contortus (Munn et al., 1997; 
Smith and Smith 1996; Smith et al., 2000).  In a vaccine trial with the glycoprotein 
antigen, H11, a microsomal aminopeptidase isolated from the interstinal microvilli of H. 
contortus (Smith et al., 1994), the antigen was denatured using sodium dodecyl sulphate 
(SDS) and dithiothreitol (DTT) (Munn et al., 1997), to disrupt the epitope structure of 
the native antigen preparation, and compared with non-denatured (native) H11.  
Following vaccination of sheep and challenge infection with 10,000 H. contortus L3, 
FWECs and worm burdens were 21% and 41% higher, respectively, when the H11 
antigen was denatured compared to the untreated native antigen (Munn et al., 1997).  
This demonstrates that structural epitopes on the native antigen were important for 
antibody binding and hence facilitated the protective response induced by vaccination 
with the native antigen.   
Further evidence for the importance of structural epitopes is provided by research 
into a lead vaccine candidate for H. contortus, termed Haemonchus galactose-containing 
glycoprotein complex (H-gal-GP) (Smith et al., 2000), which was identified and 
fractionated from the brush border of adult worm gut membranes by lectin affinity 
chromatography (Smith et al., 1994).  Vaccination with native H-gal-GP antigens 
induced 90% and 70% reductions in FWECs and adult nematode burdens, respectively, 
following challenge infection of yearling sheep with H. contortus L3 compared to 
unvaccinated sheep (Smith et al., 1994; 2000).  To identify components of the complex, 
native H-gal-GP was dissociated and fractionated by gel filtration chromatography, 
revealing a high molecular weight fraction that contained four metalloendopeptidases 
(MEPs) (Smith et al., 2003a) and a low molecular weight fraction that contained pepsin-
like aspartyl proteases (Smith et al., 2003b).  When these antigen fractions were tested 
as vaccine candidates, both the MEPs and the aspartyl proteases reduced faecal egg 
output by around 50% when compared with challenge controls (Smith et al 2003a; 
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2003b).  When the MEPs were further fractionated by non-reducing SDS-PAGE and 
electro-elution, they performed less well than the urea-dissociated MEPs, in that 
vaccination resulted in only a 33% reduction in faecal egg output and 10% reduction in 
worm burden after L3 challenge (Smith et al., 2003a).  When the antibody responses 
from each group were tested by ELISA against non-denatured native H-gal-GP antigen, 
the urea-dissociated and SDS-PAGE-electroeluted MEP groups had antibody titres that 
were at least as high as the group vaccinated with non-denatured antigen (Smith et al., 
2003a).  However, it is clear from these experiments that even high titre antibody 
directed against primary antigen structure (the antibody produced in response to fully 
reduced and denatured antigen) was not sufficient to produce a protective effect against 
challenge, whereas antibodies raised specifically against non-denatured H-gal-GP 
antigen were highly protective.  This further highlights the importance of structural 
antigens in antibody binding.  These studies on H-gal-GP indicate that structural 
epitopes on an antigen complex are essential for antibody binding - the immunity 
afforded by vaccination with the complex H-gal-GP is directed against the ‘whole’ 
complex, as vaccination with individual components failed to reproduce the same level 
of protection afforded with the whole complex (Smith et al., 2003a; 2003b).   
As a result, it is necessary to investigate conformational epitopes to design more 
effective anti-nematode vaccines, and one method, that has shown potential, is to exploit 
the idea that peptide sequences can ‘mimic’ the conformation of an epitope.  These 
peptides can be identified via various applications of phage-display technology by 
panning with host-protective antibodies.  Phage-display libraries of random peptides are 
now commercially available, and phage clones of interest are identified by a technique 
known as ‘biopanning’.  Currently, the most promising application of biopanning phage-
display libraries is for the identification of conformational epitopes.  This is achieved 
through biopanning phage libraries using purified antibodies as the immobilized target to 
identify those epitopes that are specifically identified by the antibody. These epitopes 
will include some that represent primary amino acid sequence and, more frequently, 
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those that can be considered as a ‘peptidomimetic’ of conformational epitopes (Smith 
and Scott, 1993).   
 
In summary, further knowledge and exploitation of the antigenic epitope 
structure(s) of candidate nematode vaccine antigens are essential for the development of 
a successful anti-nematode vaccine.  The structural composition of conformational 
epitopes, whether involving glycans, discrete peptide composition or discontinuous 
sections of amino acids which, following folding and tertiary structure formation, come 
into close proximity, has been demonstrated to be essential in achieving protection 
against parasitic nematodes in a number of models.  As a result, it is necessary to 
investigate conformational epitopes through using phage-display libraries to design more 
effective anti-nematode vaccines. 
 
1.8 Project aims and objectives 
As a novel approach in the development of a vaccine against T. circumcincta, the aim of 
this project is to employ phage display libraries to identify peptide sequences that mimic 
the structure of native antigenic epitopes in somatic and surface extract preparations of 
T. circumcincta L3.  Thus, the objectives of the project are as follows:  
1. The immunoreactivity of antigens present in extracts of the parasitic stages of T. 
circumcincta will be investigated through immunological techniques using local 
antibody probes generated from sheep which had been previously exposed to 
infection.  Furthermore, the role of carbohydrate moieties in the generation of 
local immune responses against the parasite will be investigated. 
2. An immunoaffinity chromatography approach will be used to purify native IgA-
reactive antigens from somatic extracts of T. circumcincta L3.  A proteomic 
analysis of the purified IgA-reactive fraction will be undertaken to identify these 
proteins.  The relative immunogenicity of the selected antigens will then be 
assessed by measuring gastric lymph IgA responses in experimentally infected 
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sheep demonstrated by parasite burden analysis to have varying degrees of 
immunity.   
3. Phage display libraries will be used in an attempt to identify peptide sequences 
that mimic structural epitopes of T. circumcincta L3 antigens.  Abomasal mucus 
from sheep which had previously been infected with the parasite will be used to 
enrich two antibody pools for biopanning the libraries: 
1) IgA antibodies that bound T. circumcincta L3 somatic antigens;  
2) Antibodies that bound native antigens on the surface of live, intact 
exsheathed T. circumcincta L3. 
4. The relative immunogenicity of both the native IgA-reactive antigens and 
selected peptide sequences from the two pools of phage clones will then be 
assessed by examining local immune responses to them in sheep with varying 
levels of acquired immunity to T. circumcincta infection. 
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Chapter 2 : Immunoreactivity of Teladorsagia circumcincta 
larval antigens  
2.1 Introduction 
Gastrointestinal nematode parasites are a major constraint to the sheep farming industry 
worldwide due to economic and welfare issues.  In temperate regions of the world, one 
of the most prevalent gastrointestinal parasites is Teladorsagia circumcincta (Bartley et 
al., 2003).  This nematode is currently controlled using a combination of anthelmintic 
treatments and pasture management; however, resistance is widespread and multi-class 
resistance is being reported increasingly (Bartley et al., 2004; Sargison et al., 2007).  
With the emergence of anthelmintic resistant parasites, this has created an interest in 
developing vaccines as an alternative means of control.  Vaccination is a possible option 
because protective immunity can be induced after repeated exposure to the parasite 
through natural exposure or experimental infection (Smith et al., 1983; Stear et al., 
1999).  A number of studies have therefore focused on the immunological basis of host 
resistance to T. circumcincta infection.  The majority of these have been experimental 
studies, which have been designed to mimic the challenge on pasture (Beraldi et al., 
2008).  From these, it is evident that a protective immune response can control T. 
circumcincta infection at several stages of its development (Halliday et al., 2007; Smith 
et al., 1985).  In recent years, a number of promising vaccine candidates have been 
identified, including cathepsin-F (Tci-CF-1) (Redmond et al., 2006), activation-
associated secreted protein-1 (Tci-ASP-1) (Nisbet et al., 2010a; Smith et al., 2009) and 
L3-surface-associated antigen (Tci-SAA-1) (Nisbet et al., 2009).  Vaccine development 
strategies have involved either targeting molecules from different stages of the parasite’s 
life cycle, including the targeting of products excreted/secreted from worms or exposed 
on the parasite’s surface, with local antibody probes or the identification of molecules 
with homology to other known promising vaccine candidates.   
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A ‘hypersensitivity reaction’ characterised by mast cell infiltration in the 
abomasal mucosa is directed against incoming L3 and is thought to be responsible for 
exclusion and/or expulsion of larvae from as early as 2 days following challenge in 
previously infected sheep (Seaton et al., 1989; Smith et al., 1984).  In an initial study by 
Seaton et al. (1989), 5 month-old lambs were administered 1,000 L3 per week for a 
period of 4–12 weeks, followed by a challenge dose of 3,000 L3 and the results indicated 
that, as the duration of the exposure period increased, the number of worms recovered at 
post mortem decreased.  Evidence of an immune response targeted towards incoming L3 
has also been indicated during a trickle infection of 2,000 L3 per day, 5 days a week for 
a total of 9 weeks, before administration of a 50,000 L3 challenge (Smith et al., 1984).  
In this experiment, the 10 month-old trickle-infected sheep were necropsied at different 
time-points after challenge, and there was evidence of a rapid expulsion of incoming L3 
from as early as 2 dpc (Smith et al., 1984).  An effective immune response targeted 
towards incoming L3 would therefore potentially affect the proportion of larvae that 
establish in the abomasum (Balic et al., 2003).  The local IgA response in the abomasum 
has been proposed as an important component of protection; negative correlations have 
been found between L4 length and lymph IgA concentrations in experimental infections 
of 5 month-old lambs (Smith et al., 1985) and after natural exposure on pasture in 6-7 
month-old lambs (Strain et al., 2002).  Due to its role in protective immunity against T. 
circumcincta, abomasal mucus IgA has been used to identify a number of possible 
protective antigens (Redmond et al., 2006).      
 
Despite this work, there has been limited success in developing recombinant 
subunit vaccines against gastrointestinal nematodes of livestock (Ellis et al., 2012).  
There are many potential reasons likely to underlie these apparent failures.  Perhaps the 
most important are unsuitable expression systems for antigen production leading to 
incomplete or inadequate post-translational modifications; for example, glycosylation 
and tertiary protein folding, resulting in incorrect epitope structures for antibody binding 
(reviewed in Geldhof et al., 2007).  Glycosylation of nematode proteins can enhance the 
immunogenicity of antigens or be involved in modulation of the hosts’ immune response 
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(Dell et al., 1999) and the glycocalyx, which is a surface coat overlying the nematode 
cuticular surface, is abundant in carbohydrate (Blaxter et al., 1992).  Research has 
shown that nematode glycans have been found in immunogenic antigens of parasitic 
helminths; for example, Dictyocaulus viviparus (Kooyman et al., 2007) and 
Haemonchus contortus (Schallig and Leeuwen, 1996).  In particular, two glycan 
epitopes, Galα1-3GalNAc-R and GalNAcβ1-4(Fucα1-3)GlcNAc-R, were proposed to be 
implicated in the induction of a protective serum IgG response against H. contortus in 
sheep immunised with adult worm ES products (Van Stijn et al., 2010; Vervelde et al., 
2003).  Carbohydrate residues have also been found to be present on components of 
nematode ES products and somatic extracts and have been described in a number of 
helminths from D. viviparus (Haslam et al., 2000), H. contortus (Haslam et al., 1996; 
Vervelde et al., 2003) and Toxocara canis (Maizels and Page, 1990).  N-linked glycans, 
in particular a glycan epitope termed ‘Lewis
x
’ (Galβ1-4(Fucα1-3)GlcNAc), were 
discovered to be present in detergent extracts of D. viviparus (Haslam et al., 2000).  The 
glycan structure termed ‘Lewis
x
’ has been implicated in the promotion of a humoral 
immune response over a cellular response (Velupillai and Harn, 1994).  In a vaccination 
trial of lambs against H. contortus, following immunisation with adult H. contortus ES 
products, specific antibodies were produced against glycan components of the ES 
products (Vervelde et al., 2003).  Furthermore, the levels of serum IgA and IgG specific 
to ES antigens were seen to decrease if the ES antigens had been treated with sodium 
periodate prior to antibody probing in an ELISA (Vervelde et al., 2003), indicating that 
the structure of the glycans were disrupted by oxidation with sodium periodate.  From 
this, Vervelde et al. (2003) concluded that ES glycan components in H. contortus were 
immunogenic and also induced a T-cell-dependent response, suggesting that that the 
glycan-specific immune response may contribute to protection against nematode 
infection.   
 
Following on from this work, using stage-specific lectin binding, it was 
discovered that glycans with a high mannose component are present on the surface of T. 
circumcincta adults and sheathed L3 (Hillrichs et al., 2012).  Earlier work discovered a 
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31 kDa glycoprotein on the cuticle surface of T. circumcincta L3 (McGillivery et al., 
1989).  In addition, an immunisation trial with this L3 antigen showed that following a 
40,000 L3 bolus challenge, there was a significant reduction in both faecal egg counts 
and total worm counts in vaccinated lambs compared to unvaccinated controls 
(McGillivery et al., 1992).  Antibodies specific to the antigen were detected in the serum 
from vaccinated lambs as early as 3 weeks after the start of the immunisation regime 
(McGillivery et al., 1992).  Furthermore, an additional L3-specific carbohydrate-larval 
antigen (CarLA), was found to be present on the cuticle surface of numerous nematode 
species, including Trichostrongylus colubriformis, T. circumcincta, H. contortus, 
Nematodirus americanus and Cooperia curticei (Harrison et al., 2003a; 2003b).  Studies 
with T. colubriformis found that antibodies specific to CarLA were strongly associated 
with immune-mediated rejection of incoming L3 (Harrison et al., 2003a; 2008).  
However, further research has revealed that there is variation in the CarLA antigens 
present on individual worms (Maass et al., 2009), which further suggests that 
carbohydrates on the surface of nematode parasites are recognised by the host immune 
system. 
In this Chapter, the aim was to investigate the immunoreactivity of antigens 
present in extracts of the parasitic life-cycle stages of T. circumcincta using abomasal 
mucus and gastric lymph antibody probes generated from sheep which had been 
previously exposed to this parasite.  As glycans are thought to have an important role in 
immunity against nematodes (Dell et al., 1999), this Chapter details investigation into 
the role of carbohydrate moieties in the generation of local immune responses against T. 
circumcincta infection.  Glycosylation of antigens can influence epitope structure, so 
work presented here aimed to target antibodies directed against strucutural non-linear 
epitopes.  To achieve this, sodium periodate was used to disrupt carbohydrate structures 
by cleaving hydroxyl groups without altering the structures of polypeptide chains 
(Woodward et al., 1985).  For all immunological investigations, two kinds of antibody 
probes, generated from previously infected animals responding to a challenge infection, 
were to be used.  Abomasal mucus was obtained post mortem from the abomasum of 
previously infected sheep and efferent gastric lymph was generated following lymphatic 
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cannulation (Smith et al., 1981).  In the ovine gastrointestinal system, the efferent lymph 
duct drains all four ruminant stomachs (Smith et al., 1981).  Efferent gastric lymph is a 
suitable medium to study local reactions in the abomasum, as the other three stomachs 
(reticulum, rumen and omasum) are immunologically inert and make minimal 
contributions to the changes occurring in the gastric lymph (Smith et al., 1981).  Efferent 
gastric lymph can be collected through cannulation of the common gastric lymph duct, 
with a catheter fitted to allow collection of the gastric lymph into a sterile pouch 
(Halliday et al., 2007; Smith et al., 1981).  A sub-sample of the lymph is taken daily and 
the remaining lymphatic outflow is re-infused into the sheep by a second catheter in the 
jugular vein (Halliday et al., 2007; Smith et al., 1981).  The overall aim was to use 
antibody probes generated from the abomasal mucus and gastric lymph of sheep 
previously infected with T. circumcincta to determine if carbohydrate moieties on larval 
antigens have a role in antibody binding.     
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2.2 Materials and methods 
2.2.1 Infection protocols for production of ovine abomasal mucus and gastric 
lymph 
All experimental protocols involving the use of animals, outlined or summarized in this 
thesis, were approved by the Moredun Research Institute’s (MRI) Experimental and 
Ethical Review Committee and authorised under the UK Home Office Animals 
(Scientific Procedures) Act 1986.   
2.2.1.1 Infection protocol for production of abomasal mucus 
 
A trial had been performed prior to the current study, in which the immune responses of 
yearling sheep, which had received an experimental trickle infection of T. circumcincta 
L3, were compared to those responses of helminth-naïve yearlings (Halliday et al., 2012; 
Knight et al., 2011).  Both groups of yearlings were administered a challenge dose of 
50,000 L3 and euthanased at 2 dpc.  A summary of the experimental design which was 
used is illustrated in Figure 2.1.  The project under which was this animal experiment 
was performed was entitled Combating Endemic Diseases of Farmed Animals 
(CEDFAS), and was funded by a BBSRC grant (BB/E018610/1) awarded to Professor 
D. Knox.  All sheep used were Scotch Mules (Blackface ewe X Blue-faced Leicester 
ram), and were 8 months-old at the start of the trickle infection and 10 months-old at 
necropsy.  The sheep were raised indoors to reduce the risk of helminth exposure until 
the start of the trickle infection.   
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Figure 2.1 Design of experiments in sheep from which abomasal mucus was obtained. 
 
1Trickle infection: 2,000 T. circumcincta L3 three times per week for eight weeks.  Trickle infection 
administered to previously infected/challenged group only (Red). 
2Fenbendazole (5mg/kg) administered to both groups seven days before challenge.   
3Bolus of 50,000 T. circumcincta L3 challenge administered to both groups on day 0. 
 
A group of lambs (n=4) were trickle-infected per os with 2,000 T. circumcincta L3, three 
times per week for eight weeks (Figure 2.1, Red).  Faecal worm egg counts (FWEC) 
were performed on samples taken from the lambs at the end of the trickle infection 
programme.  Another group of lambs (n=2) had been kept in helminth-free conditions 
(Figure 2.1, Blue), and were not exposed to trickle infection.  Both groups were 
administered with fenbendazole (5mg/kg) to remove any residual worms from the 
animals before a bolus challenge.  Seven days later, both groups were challenged per os 
with a single bolus dose of 50,000 T. circumcincta L3.  All animals were killed by 
captive bolt and exsanguinated at 2 dpc, the abomasum removed and contents emptied 
before cutting along the greater and lesser curvatures.  Each half of the abomasum was 
washed in a bucket of physiological saline (kept at 37°C) to remove any remaining 
contents and debris.  The entire luminal surface of abomasal tissue was dabbed with 
sterile gauze (9.5 cm x 10 cm) pre-soaked in 3ml sterile phosphate-buffered saline 
(PBS), pH 7.2. To retrieve mucus, the gauze was inserted into the barrel of a 20 ml 
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syringe and the contents emptied into a sterile 25 ml tube.  The mucus was then 
aliquoted to 1 ml volumes and centrifuged at 3000 g for 5 min.  The supernatant was 
removed, aliquoted into fresh 1.5 ml tubes and stored at -20°C.  Worm counts were not 
performed as the main focus of the experiment was to use the abomasal tissue as 
explants. 
2.2.1.2 Infection protocol for collection of efferent gastric lymph 
 
A series of large-scale experiments had been performed prior to the current study on a 
project funded through the Veterinary Training Research Initiative (VTRI) 
(http://www.vet.ed.ac.uk/vtri) from the Department for Environment Food and Rural 
Affairs, BBSRC and by the Scottish Executive Environment and Rural Affairs 
Department.  Access was given to the biobank of samples by Dr. W. D. Smith (Moredun 
Research Institute).  Here, efferent gastric lymph was collected following cannulation of 
the common gastric lymph duct of sheep experimentally infected with T. circumcincta 
(Halliday et al., 2007).  All sheep used in the experiments were Suffolk-Dorset or 
Scottish Blackface-Leicester cross.  There were two groups: (1) trickle-
infected/challenged and (2) primary infected.  For both groups, there were two sub-
groups divided according to their age: (1) yearlings and (2) <6-month-old lambs.  All 
sheep had been reared under conditions designed to exclude accidental infection with 
helminths.  Cannulation of the common gastric lymph duct (described in Smith et al., 
1981) was performed to allow collection of efferent gastric lymph from selected sheep 
through a specific time frame.  The sheep underwent surgicial procedures to have a 
primary catheter fitted to the common gastric lymph duct (near the abomasum site) with 
a secondary catheter fitted to the jugular vein (Halliday et al., 2007; Smith et al., 1981).  
Cannulated sheep were housed individually into small pens and lymph was collected 
into a sterile, heparinised urine drainage bag supported by a harness (Smith et al., 1981).  
Eeach day bags were weighed to estimate the lymph flow rate and a 10-20 mL lymph 
sample was collected into heparinised tubes (Halliday et al., 2007).  The bag contents 
were then re-infused intravenously into the jugular vein through the secondary catheter 
under gravity (Halliday et al., 2007; Smith et al., 1981). 
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Figure 2.2 Design of experiments in sheep from which efferent gastric lymph was obtained 
1Trickle infection: 2,000 T. circumcincta L3 three times per week for eight weeks.  Trickle infection 
administered to previously infected/challenged group only (Red). 
2Levamisole (7.5mg/kg) administered to both groups seven days before challenge.   
3Bolus of 50,000 T. circumcincta L3 challenge administered to both groups on day 0. 
4Common gastric lymph duct cannulated at -3 dpc in both groups.  Efferent gastric lymph collected from -
2 to 10 dpc. 
 
The ‘trickle-infected/challenged’ sheep were infected with 2,000 T. circumcincta L3, 
three times per week for an eight-week period (Figure 2.2, Red).  A second group was 
kept helminth-free and did not receive the trickle infection (Figure 2.2, Blue).  To 
remove residual worms, all sheep were treated with levamisole (dose: 7.5mg/kg), seven 
days prior to the bolus challenge.  The common gastric lymph ducts of all animals were 
surgically cannulated and efferent lymph collected daily from -2 dpc to 10 dpc.  Three 
days after cannulation, all groups were given an oral challenge dose of 50,000 T. 
circumcincta L3.  The ‘trickle-infected/challenged’ sheep were killed on day 10 post-
challenge and abomasal adult worm counts were performed using established methods 
(Coop et al., 1977).  Gastric efferent lymph samples collected from the challenge-only 
sheep from -3 dpc to 0 dpc, were referred to as ‘helminth naïve’.   
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Project name Sample  Infection status Abbreviation 
CEDFAS Abomasal mucus Trickle infection/challenge 
Primary infection (challenge only) 
M-PI 
M-CO 
VTRI Efferent gastric lymph Trickle infection/challenge 





Table 2.1 Summary and abbreviations for samples used in immunoreactivity investigations 
Key: M = Abomasal mucus; GL = Efferent gastric lymph; PI = Previously infected by a trickle 
infection/challenge; CO = Primary infection with a single bolus challenge; N = Helminth-free naive sheep. 
 
Lymphocytes were isolated from the efferent gastric lymph through fluorescence-
activated cell sorting (FACS) using cell specific markers (see Halliday et al., 2009; 
2010).  Also, large cells or lymphoblasts were determined as those with a diameter of 
>9mm when measured by Coulter Counter, with small lymphocytes represented as those 
with a diameter of 3-9mm (Halliday et al., 2010).   
 
2.2.2 Recovery of L4 from the abomasum 
For the production of L4, six helminth-free 6-month-old Scotch Mule (Blackface ewe X 
Blue-faced Leicester ram) lambs were infected orally with 100,000 T. circumcincta L3 
and euthanised seven days later to recover the 7 day-old L4.  At post mortem, the 
abomasum was removed and the contents retrieved as described in Section 2.2.1.1.  To 
remove any remaining debris, the surface of the abomasum was washed briefly in sterile 
physiological saline.  The abomasum was pinned to a polystyrene block so that the 
abomasal folds were suspended into the fluid-filled funnel, allowing larvae to come out 
from the mucosa into the funnel.  The pinned abomasum was floated on top of a 5 l 
funnel, filled with sterile physiological saline (NaCl:H20 solution), pH 7.4, at 37°C using 
an adapted Baermann-style technique (Knox and Jones, 1990)  Larvae that gravitated to 
the bottom of tubing attached to the funnel were retrieved after 2, 4 and 6 h.  L4 were 
transferred to 50 ml conical tubes and centrifuged at 50 g for 5 min to aid settling.  The 
supernatant was aspirated, and the L4 which had settled at the bottom of the tubes were 
kept and pooled. 
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2.2.3 In vitro culture of L4 to collect excretory/secretory products 
L4 (collected as described in section 2.2.2) were washed three times in 20 ml of sterile 
PBS, pH 7.4, incubated in a waterbath at 37°C for 20 min, centrifuged at 50 g for 5 min 
between washes and the supernatant aspirated.  Following washing, the L4 were 
resuspended in 20 ml RPMI-based ‘nematode culture medium’ (for recipe see Appendix 
1), incubated at 37°C for 20 min, before being centrifuged at 50 g for 5 min to re-pellet 
the L4.  Supernatants were removed and the L4 pellets suspended in 40 ml fresh 
nematode culture medium before being transferred to 75cm
2
 cell culture flasks with 
vented cap (Corning Incorporated) and incubated at 37°C, 5% CO2 for 24 h.  Following 
the initial 24 h incubation period, the contents of larvae/media were transferred to a 50 
ml conical tube and centrifuged at 50 g for 5 min at 4°C.  The supernatants were 
removed under aseptic conditions and transferred to fresh 50 ml tubes, on ice.  The L4 
pellets were resuspended in 40 ml of fresh nematode culture medium and incubated at 
37°C, 5% CO2 for another 24 h.  Supernatants from both time-points (24 h and 48 h 
cultures) were filtered through 0.45µM syringe filters, transferred to Amicon Ultra-15 
centrifugal filter units (Millipore, UFC901096) and centrifuged at 2000 g for 20 min at 
4°C to concentrate excretory/secretory (‘ES’) products.  The ES products were 
concentrated 15-fold to approximately 1 ml volume, and buffer exchanged by washing 
and centrifuging three times in PBS to remove media contents, then centrifuged at 2000 
g for 20 min at 4°C.  Once buffer was exchanged, the ES products (approximately 1 ml) 
were dispensed into 100 µl aliquots and stored at -80°C.   
 
2.2.4 Preparation of L3 somatic antigen 
PBS-soluble somatic extracts were prepared from T. circumcincta L3 by crushing a 1ml 
aliquot of snap-frozen worms (~1 million) with a pestle and mortar (pre-chilled at -80°C) 
in the presence of liquid nitrogen.  After 10 min of grinding, 5 ml PBS were added and, 
once no particulate material was remaining, a further 5 ml of PBS were added and the 
extract mixed thoroughly.  The mixture was aliquoted into 1 ml volumes, centrifuged at 
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9000 g for 5 min at 4°C to pellet insoluble material and the supernatant retained as 500 
µl aliquots, stored at -80°C.  Protein concentrations were determined using the 
bicinchoninic acid (BCA) protein assay kit (Pierce, Thermo Scientific Ltd).  Briefly, 11 
bovine serum albumin (BSA) standards were prepared by diluting a stock solution of 
BSA in PBS to concentrations ranging from 0-2 mg/ml.  L3 somatic extracts were 
diluted 1:2, 1:5, and 1:10 in PBS and 25 µl of sample or standard were dispensed in 
triplicate into individual wells of a 96-well Microlon
®
 ELISA plate.  The BCA reagent 
was prepared by mixing the kit reagents A and B in the ratio of 50:1, respectively and 
200 µl were added to each well.  Plates were incubated at 37°C for 30 min and 
absorbance measured at 562nm on a 96-well plate reader.  Using the BSA standards, 
reference standard curves were plotted and protein concentrations of the somatic extracts 
determined. 
 
2.2.5 Preparation of L4 and adult somatic extracts 
L4 and adult somatic extract were kindly donated by Dr. Rachael Baker (MRI) and had 
been prepared by the following method.  An aliquot of ~1 million T. circumcincta L4 or 
adults, previously snap-frozen in liquid nitrogen, was homogenized in 2 ml ribolyser 
tubes (Q-BIOgene Lysing matrix D ceramic beads, Irvine, USA) for 45 secs in PBS 
containing 1mM EDTA and 1mM PMSF.  Following centrifugation at 20000 g for 20 
min, the supernatants were retained.  The protein concentrations of somatic extracts 
were determined by the BCA assay (Pierce, Thermo Scientific) as described in Section 
2.2.4. 
 
2.2.6 SDS-PAGE  
The protein profiles of L3, L4 and adult somatic extracts and L4 ES products were 
investigated by 1-dimensional (1-D) gel electrophoresis.  Using sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) the proteins were separated, 
under reducing conditions, on 4-12% gradient gels using the NuPAGE Novex Bis-Tris 
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Mini Gel System (Invitrogen Ltd, UK), according the manufacturer’s recommendations.  
For all experiments, ~10 µg of protein were loaded per well and electrophoresis 
performed using MES SDS running buffer with antioxidant (Invitrogen Ltd, UK).  
Parasite extracts or ES products were added to SDS sample buffer and sample reducing 
agent (Invitrogen Ltd, UK) and incubated at 70°C for 10 min to reduce and denature the 
proteins.  Each sample was then applied to a single well (approximately 10-20 µl of 
sample containing 10 µg of protein).  The apparatus was connected to a power supply 
and run at 200V for approximately 35 min or until the dye front reached the bottom of 
the gel.  Once run, one lane of each extract was stained with colloidal Coomassie stain 
(Simply Blue Stain, Invitrogen, UK) for 60 min at room temperature and then rinsed in 
distilled water until protein bands were visible against a clear background to allow 
estimation of the molecular weight of protein bands in the different extracts.  
 
2.2.7 Western blotting 
SDS-PAGE (Section 2.2.6) was performed on each parasite extract or ES batch, and the 
separated proteins transferred by electroblotting onto a 0.45 µM nitrocellulose 
membrane using the X-Cell-II Blot Module (Invitrogen Ltd, UK), according to the 
manufacturer’s instructions.  Successful transfer of the proteins was confirmed by 
staining of the nitrocellulose membrane in Ponceau stain (0.1% in 5% acetic acid) 
(Appendix 1) before destaining in distilled water.  Once electroblotted, the nitrocellulose 
membrane was incubated in blocking buffer, TNTT (10mM Tris, 0.5M NaCl, 0.05% 
(v/v) Tween-20, 0.01% (w/v) thiomersal, pH 7.4), to block non-specific binding sites for 
proteins.  After an overnight incubation at 4°C, membranes were washed three times in 
fresh TNTT, 10 min per wash.  The lanes were separated and then incubated with 
primary antibody (abomasal mucus or gastric lymph diluted 1:5 and 1:100 in TNTT, 
respectively) from previously infected/challenged or challenged only sheep for 2 h at 
room temperature.  Membranes were then re-washed in TNTT and incubated with the 
appropriate secondary antibody according to the specific antibody isotype under 
investigation (Table 2.2) for 1 h at room temperature.  The antibodies were diluted to the 
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required concentration in TNTT.  For IgA investigations, a conjugated tertiary antibody 
was required (Table 2.2) and incubations were conducted for 1 h at room temperature 
following washes in TNTT.  After the application of the final HRP-conjugated antibody 
(i.e. IgG, secondary; IgA, tertiary), strips were rewashed in TNTT, then incubated in 
3,3’-diaminobenzidine (DAB, Sigma Fast™, Sigma-Aldrich, UK) for colour 
development of the substrate for  approximately 5 min, then washed repeatedly in 
distilled water and left to dry. 
Isotype Secondary antibody Tertiary antibody 



















Sigma, A0452 1 in 1000 N/A N/A N/A 
Table 2.2 Antibodies used for antigen-specific ELISAs and immunoblots. 
 
2.2.7.1 Periodate treatment of immunoblots 
 
Where the analysis of carbohydrate binding was being investigated, immunoblots were 
treated with sodium periodate prior to antibody incubations.  Sodium periodate degrades 
carbohydrate moieties through oxidation of hexose sugar rings to amine-reactive 
aldehyde groups, resulting in the disruption of carbohydrate epitopes present 
(Woodward et al., 1985).  The optimal concentration of sodium periodate was 
determined to ensure that there was no degradation of the integrity of the polypeptide 
backbone of the proteins in the antigen preparation.  Thus, 5 µg of L3 somatic extract 
were separated in individual wells of a 4-12% NuPAGE gel under reducing conditions.  
Separated proteins were transferred to a polyvinylidene fluoride (PVDF) membrane.  
The PVDF membrane was soaked in methanol for 30 sec, rinsed in distilled water and 
then soaked in transfer buffer before assembled into the X-Cell-II Blot Module.  Proteins 
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were transferred to the PVDF membrane under the same conditions as detailed for 
nitrocellulose membranes in section 2.2.7.  Successful transfer of proteins to the 
membrane was confirmed with Ponceau stain as above, and the blot was cut into 
individual lanes and rinsed in distilled water before treatment for disruption of 
carbohydrate.  For the initial optimisation, strips were washed in 50mM sodium acetate, 
pH 4.5, twice for 20 min per wash.  Each strip was incubated with a different 
concentration of sodium meta-periodate (range 0–50mM) in 50mM sodium acetate for 1 
h at room temperature in the dark.  Lanes were re-washed in 50mM sodium acetate 
twice, then washed twice in TNTT, for 10 min per wash.  The strips were incubated in 
50mM sodium borohydride/TNTT for 30 min at room temperature, before three final 
washes in TNTT.  To detect the pattern of protein banding in the samples, all the strips 
were stained with Simply Blue stain (Invitrogen Ltd, UK) for 10 min at room 
temperature.  After destaining in 40% methanol to remove background staining, protein 
profiles were compared across the range of sodium periodate concentrations.  
Subsequently, the following protocol was used for periodate treatment of immunoblots: 
SDS-PAGE, electroblotting and blocking were performed as detailed in sections 2.2.6 
and 2.2.7.  Membrane strips were washed twice in 50mM sodium acetate, pH 4.5 for 20 
min, then incubated in 50mM sodium periodate/50mM sodium acetate in the dark for 1 h 
at room temperature.  The strips were re-washed twice in 50mM sodium acetate and then 
washed twice in TNTT, for 10 min per wash.  Blots were incubated in 50mM sodium 
borohydride/TNTT for 30 min at room temperature.  After three additional TNTT 
washes, the blots underwent a series of antibody incubations as required for the isotype 
under investigation (described in section 2.2.7). 
 
2.2.8 Detection of specific antibodies by ELISA 
For quantitative assessment of antigen-specific antibody responses, microtitre plates 
(Greiner Bio-one, flat-bottom high binding) were coated with 50 µl of 5µg/ml T. 
circumcincta extracts from L3, L4 and adult homogenates and L4 ES products, in 50mM 
sodium bicarbonate, pH 9.6, and incubated at 4°C overnight.  Plates were washed six 
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times with PBS containing 0.05% (v/v) Tween-20 (PBST) with an automated plate 
washer (BioTek ELX405).  Plates were incubated with blocking buffer (10% soya milk 
powder (Infasoy, Cow and Gate) in PBST) at 200µl per well for 2 h at room temperature 
to prevent non-specific binding.  After re-washing, plates were incubated with 50 µl of 
primary antibody (abomasal mucus or efferent gastric lymph, diluted at 1:5 and 1:20 in 
TNTT, respectively), and incubated for 2 h at room temperature.  After washing, 50 µl 
of secondary antibody (see Table 2.2 for antibody incubations) diluted in TNTT were 
added and incubated for 1 h at room temperature.  When a tertiary antibody was required 
to detect IgA binding, following washing, 50 µl of tertiary antibody, diluted to the 
appropriate concentration in TNTT, were added to each well and incubated for 1 h at 
room temperature.  After the final antibody incubation step, the plates were washed six 
times in PBST and then 50 µl O-phenylenediamine dihydrochloride (OPD) substrate 
(Sigma Fast™, Sigma-Aldrich, UK) were added.  Plates were incubated in darkness for 
20 min, the reaction was stopped by addition of 25 µl 2.5M H2SO4 per well and the 
optical density (OD) read at 492nm on a spectrometer.  All tests were conducted in 
triplicate on each plate and each plate was repeated on two independent occasions.  
Negative controls omitting the primary antibody incubation step were included on each 
plate.  A pool of efferent gastric lymph collected from VTRI ‘previously 
infected/challenged’ sheep at the time-point corresponding to the peak total IgA 
concentration, 6-10 dpc (Halliday et al., 2007), was used as a positive reference sample 
on all plates.  To control plate-to-plate variation, the absorbance value from the blank 
wells (wash buffer only) was subtracted from raw absorbance values before analysis.   
 
2.2.8.1 Periodate treatment of antigens for ELISA 
For optimization, L3 somatic extract was treated with a range (0-100mM) of sodium 
periodate concentrations in 50mM sodium acetate, pH 4.5.  Ten µg of L3 somatic extract 
were added to a 1.5 ml tube, with 50 µl of appropriate concentration of sodium periodate 
and incubated for 1 h in the dark at room temperature.  Solutions were centrifuged at 
10000 g for 10 min, and the supernatants from each preparation separated by 
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electrophoresis using a NuPAGE SDS gel (Section 2.2.6). The gel was stained with 
Simply Blue stain (Invitrogen Ltd, UK) and comparisons made across the range of 
sodium periodate concentrations with regards to the level of protein degradation. To 
investigate the contribution that carbohydrate moieties made towards generating local 
antibody responses, L3 and L4 antigen preparations were pre-treated with sodium 
periodate in solution before ELISA analysis.  Antigen-specific IgA and IgG antibody 
binding to L3 somatic, L4 somatic and L4 ES antigens were treated with sodium 
periodate was compared to binding to non-periodate-treated antigens.  ELISAs were 
carried out as described in section 2.2.8, but the following additional steps were included 
after sample addition.  Plates were washed six times with PBST, then incubated with 
10mM sodium periodate/50mM sodium acetate in a final volume of 100 µl/well.  Plates 
were incubated at 37°C for 1 h in the dark.  Plates were re-washed twice with 50mM 
sodium acetate and then twice with TNTT (200µl/well).  To stop the oxidative activity 
of sodium periodate, 50mM sodium borohydride/TNTT were added to each well 
(100µl/well) and incubated at 37°C for 30 min.  Following the sodium borohydride 
incubation, plates were re-washed six times with PBST, and were processed for antibody 
incubations as required for the isotype under investigation 
 
2.2.9 Local immune response to L3 antigens by antibodies in efferent gastric 
lymph 
To investigate antibody responses in efferent gastric lymph to L3 antigens over the 
duration of a 50,000 L3 bolus challenge infection (VTRI experimental trial -2 to 10 dpc), 
ELISAs were conducted using samples from two animals.  The animals selected (#A295 
and #A1008) were chosen as they demonstrated high total IgA concentrations (mg/ml) 
in efferent gastric lymph following challenge with L3; IgA titres were 52.9% and 33% 
above the average of 3.65mg/ml at 8 dpc, with readings of 4.92mg/ml and 4.29mg/ml, 
respectively.  IgA and IgG responses to L3 antigens were analysed from days -2 to 10 
post-challenge and ELISAs were conducted as detailed in Section 2.2.8.  To investigate 
the antibody response to L3 somatic antigens during the peak period of total IgA 
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concentration in efferent gastric lymph, 6-10 dpc, and immunoblots using samples 
collected from individual sheep in this time period were used.  Immunoblots were 
conducted as detailed in Section 2.2.7.  All samples were investigated for IgA and IgG 
reactivity against L3 somatic extracts.  Separate immunoblots were treated with sodium 
periodate (Section 2.2.7.1) to assess the contribution that carbohydrate moieties made 
towards generating the local antibody response against L3.  
 
2.2.10  Statistical analysis 
In the antigen-specific ELISAs (Section 2.3.1), the data from each ELISA set were 
tested for normality of data through a residual plot of the individual OD values.  The 
probability plot of the residuals showed normal probability.  The differences between the 
mean OD values were statistically evaluated by the parametric one-way ANOVA test 
adjusted for the post hoc analysis, Fisher’s least significant difference.  To allow 
comparisons to be made on the effect of sodium periodate treatment of antigens towards 
the level of local immunoreactivity in the periodate antigen-specific ELISAs (Section 
2.3.2), differences between the mean OD values obtained from periodate-treated and 
untreated antigen samples were statistically evaluated by the non-parametric Wilcoxon-
Mann-Whitney U test (SPSS version 19).  For all statistical analysis tests the statistical 
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2.3 Results 
2.3.1 Isotype-specific antibody responses to T. circumcincta larval antigens  
ELISAs were used to investigate antibody isotypes present in abomasal mucus and 
gastric lymph that bound T. circumcincta larval antigens.  Both L3-specific IgA and IgG 
were detected in abomasal mucus obtained from previously infected/challenged sheep 
(Figure 2.3).  Mucus IgA activity against L3 somatic antigens was significantly higher 
(p<0.001) in previously infected/challenged sheep compared to sheep given a single 
challenge, with the percentage positivity being 100% and 23%, respectively (Figure 2.3).  
Likewise, the level of IgG binding to L3 antigens was significantly higher in the 
abomasal mucus from previously infected/challenged sheep compared to sheep given a 
single challenge and helminth-naïve sheep (p=0.008).  IgG binding to L3 antigens was 
detected in the efferent gastric lymph sample from helminth-naïve sheep (Figure 2.3; 
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Figure 2.3 Mucus IgA and IgG responses in previously infected and primary infected sheep to 
L3 somatic antigens.   
‘OD’ represents optical density value at 490nm measured in an ELISA to determine mucus IgA and IgG 
activity to L3 somatic antigens.  Group “M-PI” represents abomasal mucus pooled from previously 
infected sheep and group “M-CO” represents abomasal mucus pooled from sheep given a single infection.  
In both groups the sheep were given a single bolus challenge of 50,000 T. circumcincta L3 and necropsied 
2 dpc to collect abomasal mucus.  Group “GL-HF” represents pooled efferent gastric lymph from 
helminth-naïve sheep and was used as a ‘negative control’.  The positive control was pooled efferent 
gastric lymph collected over 6-10 dpc from previously infected/challenged sheep. The mean OD (± 
standard error of mean (SEM)) results are expressed as a percentage of the positive control.  ‘**’ denotes 
statistically significant differences at p<0.01 between the mean OD values of the M-PI group and the 
groups M-CO and GL-HF.   
 
 
Abomasal mucus IgA and IgG activity against L4 somatic antigens was detected in 
samples collected from previously infected/challenged sheep (Figure 2.4).  Levels of 
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isotypes in the previously infected/challenged sheep (p<0.01) compared to the sheep 
given a single challenge and helminth-naïve sheep (Figure 2.4).     
 
Figure 2.4 Mucus IgA and IgG responses in previously infected and primary infected sheep to 
L4 somatic antigens.   
‘OD’ represents optical density value at 490nm measured in an ELISA to determine mucus IgA and IgG 
activity to L4 somatic antigens.  Group “M-PI” represents abomasal mucus pooled from previously 
infected sheep and group “M-CO” represents abomasal mucus pooled from sheep given a single infection.  
In both groups the sheep were given a single bolus challenge of 50,000 T. circumcincta L3 and necropsied 
2 dpc to collect abomasal mucus.  Group “GL-HF” represents pooled efferent gastric lymph from 
helminth-naïve sheep and was used as a ‘negative control’.  The positive control was pooled efferent 
gastric lymph collected over 6-10 dpc from previously infected/challenged sheep. The mean OD (± 
standard error of mean (SEM)) results are expressed as a percentage of the positive control.  ‘**’ denotes 
statistically significant differences at p<0.01 between the mean OD values of the M-PI group and the 
groups M-CO and GL-HF.   
 
L4 ES specific-IgA was detected in the abomasal mucus obtained from previously 
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Figure 2.5 Mucus IgA and IgG responses in previously infected and primary infected sheep to 
L4 ES antigens.   
‘OD’ represents optical density value at 490nm measured in an ELISA to determine mucus IgA and IgG 
activity to L4 ES antigens.  Group “M-PI” represents abomasal mucus pooled from previously infected 
sheep and group “M-CO” represents abomasal mucus pooled from sheep given a single infection.  In both 
groups the sheep were given a single bolus challenge of 50,000 T. circumcincta L3 and necropsied 2 dpc to 
collect abomasal mucus.  Group “GL-HF” represents pooled efferent gastric lymph from helminth-naïve 
sheep and was used as a ‘negative control’.  The positive control was pooled efferent gastric lymph 
collected over 6-10 dpc from previously infected/challenged sheep. The mean OD (± standard error of 
mean (SEM)) results are expressed as a percentage of the positive control.  ‘**’ denotes statistically 
significant differences at p<0.01 between the mean OD values of the M-PI group and the groups M-CO 
and GL-HF.   
 
The levels of IgA binding to L4 ES antigens was significantly higher (p<0.001) in 
previously infected sheep in comparison to sheep given a single challenge (Figure 2.5).  



















































































IgG * * 
* * 
 
Chapter 2: Immunoreactivity of Teladorsagia circumcincta larval antigens 69 
 
the previously infected sheep compared to the mucus from sheep given a single 
challenge (Figure 2.5).    
 
2.3.2 Contribution of glycan to the antigen-specific antibody response in gastric 
lymph 
To determine if glycans on larval antigens are important in immune responses to T. 
circumcincta, sodium periodate was used to disrupt the carbohydrate moieties.  Initial 
experiments determined the effects of increasing sodium periodate concentrations on the 
protein profile in the T. circumcinta preparations.  The optimal sodium periodate 
concentration for use in antigen-specific ELISAs was determined.  The protein profiles 
of L3 somatic extract after treatment in solution with a range of sodium periodate 
concentrations are shown in Figure 2.6.  Treatment of the native L3 antigen preparation 
with 10mM sodium periodate (Figure 2.6, Lane 2) did not affect the electrophoretic 
profile of the proteins in the extract, as the profile is the same as the extract incubated 
without sodium periodate (Figure 2.6, Lane 1).  Incubation with sodium periodate at 
concentrations of 20mM and above altered the protein profile indicating degradation of 
proteins in the extract (Figure 2.6, Lanes 3-5).  The optimal concentration for sodium 
periodate treatment of parasite antigens in the ELISA investigations was thus determined 
to be 10mM. 
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Figure 2.6 Protein profiles of T. circumcincta L3 somatic extract following incubation of native 
antigen preparation with a concentration range of sodium periodate in solution.   
Lane 1, No sodium periodate.  Lane 2, 10mM sodium periodate.  Lane 3, 20mM sodium periodate.  Lane 
4, 50mM sodium periodate.  Lane 5, 100mM sodium periodate.  All samples of L3 somatic extracts (5µg) 
were incubated in solution with sodium periodate, and the supernatant retained and subjected to 
electrophoresis under reducing conditions.  Protein was detected by Simply Blue stain.  Lane M denotes 
molecular weight standards given in kDa. 
 
To investigate the effect of pre-treatment with sodium periodate on  the binding of sheep 
IgA and IgG to larval antigens, antigen-coated ELISA plates were treated with 10mM 
sodium periodate then processed for antibody probing.  An equivalent number of antigen 
samples were not treated with sodium periodate prior to antibody probing to allow 
comparison.  The results from the L3 antigen-specific ELISA to assess the level of 
antibody binding with periodate-treated L3 antigens and untreated L3 antigens are 
presented as a percentage of the positive control (Figure 2.7). 
 







Chapter 2: Immunoreactivity of Teladorsagia circumcincta larval antigens 71 
 
 
Figure 2.7  Effect of sodium periodate treatment of L3 somatic extract on IgA and IgG antibody 
binding to L3 somatic antigens.  
The mean OD (± SEM) results are expressed as percentage of the positive control.  The positive control 
was efferent gastric lymph pooled from previously infected/challenged sheep over 6-10 dpc. Group “M-
PI”, abomasal mucus pooled from previously infected sheep.  Group “GL-PI”, efferent gastric lymph from 
previously infected sheep.  Group “GL-CO”, efferent gastric lymph sheep given a single infection.  In all 
groups the sheep were given a single bolus challenge of 50,000 T. circumcincta L3.  Group “M-HF”, 
abomasal mucus pooled from helminth-naïve sheep.  In the mucus groups, sheep were necropsied at 2 dpc 
to collect abomasal mucus.  The gastric lymph samples were collected at 8 dpc. ‘**’ and ‘*’ denotes 
statistical significance (p<0.01, p<0.05) following comparison of the mean OD values between treated and 
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The ELISA results indicated that sodium periodate treatment of antigens resulted in a 
reduction in antibody binding in some of the groups.  The reductions in the level of both 
IgA and IgG binding in the previously infected sheep were statistically significant 
(p=0.004) (Figure 2.7).  The level of IgA binding in sheep given a single infection was 
not significantly affected by sodium periodate treatment of L3 antigens.  In contrast, the 
level of IgG binding in gastric lymph from sheep given a single infection was 
significantly reduced (p=0.004) following periodate treatment of L3 antigens (Figure 2.7, 
IgG graph).   
Following sodium periodate treatment of L4 somatic antigens, the level of IgA 
binding in abomasal mucus and gastric lymph samples from previously infected sheep 
was significantly reduced (p=0.003) (Figure 2.8, IgA graph).  The level of IgA binding 
detected in gastric lymph samples from sheep given a single infection was not affected 
by sodium periodate treatment of L4 somatic antigens.  Periodate treatment of L4 
antigens resulted in a significant reduction in the level of IgG binding in abomasal 
mucus and gastric lymph samples from previously infected and sheep given a single 
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Figure 2.8 Effect of sodium periodate treatment of L4 somatic extract on IgA and IgG antibody 
binding to L4 somatic antigens.  
The mean OD (± SEM) results are expressed as percentage of the positive control.  The positive control 
was efferent gastric lymph pooled from previously infected/challenged sheep over 6-10 dpc. Group “M-
PI”, abomasal mucus pooled from previously infected sheep.  Group “GL-PI”, efferent gastric lymph from 
previously infected sheep.  Group “GL-CO”, efferent gastric lymph from sheep given a single infection.  
In all groups the sheep were given a single bolus challenge of 50,000 T. circumcincta L3.  Group “M-HF”, 
abomasal mucus pooled from helminth-naïve sheep.  In the mucus groups, sheep were necropsied at 2 dpc 
to collect abomasal mucus.  The gastric lymph samples were collected at 8 dpc. ‘**’ denotes statistical 
significance (p<0.01) following comparison of the mean OD values between treated and untreated 
samples. For all groups, n = 6. 
 
Periodate treatment of L4 ES antigens prior to antibody probing revealed a significant 
reduction (p=0.003) in the level of mucus IgA binding in previously infected sheep 
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Figure 2.9 Effect of sodium periodate treatment of L4 ES products on IgA and IgG antibody 
binding to L4 ES antigens.  
The mean OD (± SEM) results are expressed as percentage of the positive control.  The positive control 
was efferent gastric lymph pooled from previously infected/challenged sheep over 6-10 dpc. Group “M-
PI”, abomasal mucus pooled from previously infected sheep.  Group “GL-PI”, efferent gastric lymph from 
previously infected sheep.  Group “GL-CO”, efferent gastric lymph from sheep given a single infection.  
In all groups the sheep were given a single bolus challenge of 50,000 T. circumcincta L3.  Group “M-HF”, 
abomasal mucus pooled from helminth-naïve sheep.  In the mucus groups, sheep were necropsied at 2 dpc 
to collect abomasal mucus.  The gastric lymph samples were collected at 8 dpc.  ‘**’ and ‘*’ denotes 
statistical significance (p<0.01, p<0.05) following comparison of the mean OD values between individual 
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This reduction in antibody binding was observed in all the individual gastric lymph 
samples from the previously infected sheep.  Similar results were seen in the level of 
IgG binding in gastric lymph from previously infected sheep following periodate 
treatment of L4 ES antigens (p=0.004).  However, in the IgG ELISA, periodate treatment 
of L4 ES antigens also significantly reduced (p=0.02) the level of IgG binding to the 
antigens in samples from sheep given a single infection (Figure 2.9, IgG graph).   
 
2.3.3 Immunoreactivity of IgA and IgG in mucosal washings against T. 
circumcincta antigens  
Coomassie stained protein profiles of L3, L4, adult somatic extracts and L4 ES products 
were separated by electrophoresis (refer to Section 2.2.6) as shown in Figure 2.10.  
 
Figure 2.10 SDS-PAGE protein profiles of L3, L4 and adult T. circumcincta somatic extracts and 
L4 excretory/secretory (ES) products.  
Somatic extracts were separated by electrophoresis under reducing conditions on a 4-12% Bis-Tris 
NuPAGE gel and peptides visualised by Simply Blue stain.  For each track, 10µg of somatic extract or ES 
products were loaded.  Lane M: Molecular weight markers.  Lane 1: L3 somatic extract.  Lane 2: L4 
somatic extract.  Lane 3: Adult somatic extract.  Lane 4: L4 ES products.   
 
In the L3 somatic extract (Figure 2.10, Lane 1), around 15 distinct bands, ranging from 
20 to over 100 kDa were present.  In lanes containing somatic extracts from L3, L4 and 
adult (Figure 2.10, Lanes 1, 2 and 3 respectively), there were similarities in the banding 
patterns in the regions of 10-24 kDa and 40-80 kDa.  Comparison of the banding pattern 
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the first 24 h of in vitro maintenance a wide range of proteins are produced, of which 
some of which may be ES-specific.  
Immunoblots of somatic extracts prepared from L3, L4 and adult stages of the parasite 
were incubated with abomasal mucus from animals that were subjected to a trickle 
infection/bolus challenge of T. circumcincta L3 (Figures 2.11 and 2.12).  Binding of 
abomasal IgA antibody to antigens in all parasite stages examined was evident (Figure 
2.11).  The profile of antibody binding to L3 antigens showed immunoreactive bands at 
30 kDa, and 50–100 kDa.  In the L4 and adult somatic extracts, the profiles of abomasal 
IgA binding were similar and were against higher molecular weight antigens (90–200 
kDa).  Somatic extracts probed with pooled antibody from sheep given a single infection 
were not reactive to IgA (Figure 2.11, Lanes 4-6).   
 
Figure 2.11 Immunoblot of T. circumcincta L3, L4 and adult somatic extracts probed for 
reactivity to mucus IgA from previously infected and primary infected sheep. 
“M-PI” represents abomasal mucus from previously infected sheep (n=4).  “M-CO” represents abomasal 
mucus from sheep given a single infection (n=4).  In both groups sheep were given a single bolus 
challenge of 50,000 T. circumcincta L3 and necropsied two days later to collect abomasal mucus.  Lanes 1 
and 4, L3 somatic extract.  Lanes 2 and 5, L4 somatic extract.  Lanes 3 and 6, Adult somatic extract.  Lane 
M, molecular weight marker shown in kDa.  Following incubation in the samples of abomasal mucus, all 
lanes were incubated with monoclonal mouse anti-bovine/ovine IgA, then polyclonal anti-mouse 
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The pattern of IgG binding to somatic extracts of L3, L4 and adult parasites was 
investigated by western blotting (Figure 2.12).  IgG reactivity was detected in all 
extracts and there were differences in the staining patterns between the three somatic 
extract preparations.  Numerous IgG-reactive bands were detected across the range of 
30–200 kDa in the L3 somatic extract (Figure 2.12, Lane 1).  Abomasal mucus from 
trickle-infected/bolus-challenged sheep bound to L4 somatic antigens across the range of 
20–200 kDa, with strong reactivity at approximately 45 kDa and 50 kDa (highlighted by 
arrows in Figure 2.12, Lane 2).  Antigens (40–190 kDa) present in the adult somatic 
extract were also bound by IgG in the pool of abomasal mucus from trickle-
infected/bolus-challenged sheep.   Somatic extracts probed with mucus antibody from 
sheep given a single challenge did not show IgG reactivity (Figure 2.12, Lanes 4-6).   
 
Figure 2.12 Immunoblot of T. circumcincta L3, L4 and adult somatic extracts probed for 
reactivity to mucus IgG from previously infected and primary infected sheep.   
“M-PI” represents abomasal mucus from previously infected sheep (n=4).  “M-CO” represents abomasal 
mucus from sheep given a single infection (n=4).  In both groups the sheep were given a single bolus 
challenge of 50,000 T. circumcincta L3 and necropsied two days later to collect abomasal mucus.  Lanes 1 
and 4, L3 somatic extract.  Lanes 2 and 5, L4 somatic extract.  Lanes 3 and 6, Adult somatic extract.  Lane 
M, molecular weight marker shown in kDa.  Following incubation in the pooled samples of abomasal 
mucus, all lanes were incubated with monoclonal mouse anti-ovine IgG-HRP.  Strips were developed with 
SigmaFast™ DAB.  Blue arrows highlight strong IgG-reactivity to antigens present at approximately 45 
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IgA in abomasal mucus from previously infected/challenged sheep bound to antigens in 
L4 ES products across the range 14-100 kDa (Figure 2.13, Lane 1), which was not 
observed in the lane probed with abomasal mucus from sheep given a single infection 
(Figure 2.13, Lane 2).  In the lanes probed for IgG binding, individual immunoreactive 
bands at approximately 10-14 kDa, 28 kDa, and 45-65 kDa were detected in the lane 
probed with abomasal mucus from previously infected/challenged sheep (Figure 2.13, 
Lane 3).   
 
Figure 2.13 Immunoblots of T. circumcincta L4 ES products showing abomasal mucus IgA and 
IgG binding to L4 ES antigens.   
ES (5µg) products from L4 were subjected to electrophoresis under reducing conditions and transferred to 
a nitrocellulose membrane.  Lanes 1 and 3 were incubated with abomasal mucus from trickle-
infected/bolus-challenged sheep (n=4).  Lanes 2 and 4 were incubated with a pool of abomasal mucus 
from sheep given a single infection (n=4).  All sheep had been necropsied two days post-bolus challenge 
to collect abomasal mucus.  Following incubation in abomasal mucus, all lanes were incubated as in Fig 
2.11 for IgA and Fig 2.12 for IgG reactivity.  Lane M, standard molecular weight markers given in kDa. 
 
Mucus IgG activity against L4 ES antigens was detected in abomasal mucus from sheep 
given a single infection (Figure 2.13, Lane 4).  This pattern of immunoreactivity had a 
similar profile to the lane probed with mucus from previously infected sheep; however, 
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2.3.4 The location of glycan moieties on immunoreactive antigens  
Work presented in this chapter so far has highlighted that carbohydrate moieties on T. 
circumcincta larval antigens contribute to the level of antibody binding in abomasal 
mucus and gastric lymph (Section 2.3.2).  For further investigation of these carbohydrate 
moieties, immunoblots of larval antigens were treated with sodium periodate prior to 
antibody probing.  These immunoblots were compared to immunoblots not treated with 
sodium periodate to allow visualization of the effect of sodium periodate treatment on 
parasite antigens.  
The optimal concentration of sodium periodate used to treat larval antigens immobilised 
on membranes was determined by staining for proteins following sodium periodate 
treatment.  The protein profiles of L3 somatic extract following treatment with a 
concentration range of sodium periodate are shown in Figure 2.14.   
 
Figure 2.14 Detection of proteins in T. circumcincta L3 somatic extract following sodium 
periodate treatment of antigens fixed on nitrocellulose membrane.   
L3 somatic extracts (5µg) were subjected to electrophoresis under reducing conditions, transferred to 
nitrocellulose membrane and strips thereof incubated with a concentration range of sodium periodate.  
Lane 1, no sodium periodate.  Lane 2, 10mM sodium periodate. Lane 3, 20mM sodium periodate. Lane 4, 
50mM sodium periodate.  Protein was detected by Simply Blue stain (Invitrogen).  Lane M denotes 
molecular weight standards which are marked in kDa. 
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The first track contains L3 somatic extract (5µg) not exposed to sodium periodate (0mM) 
and was used as a reference lane for comparison with the treated extracts.  All 
concentrations tested (10-50mM) showed a similar profile to the untreated sample.  The 
optimal concentration for the sodium periodate treatment of immunoblots to disrupt 
carbohydrate moieties, but leave proteins intact, prior to antibody probing was 
determined to be 50mM.     
 
Treatment of immunoblots of L3 somatic extract with sodium periodate prior to probing 
with antibodies in abomasal mucus from previously infected sheep resulted in depletion 
of immunoreactive IgA bands observed in the range 50-200 kDa (Figure 2.15, IgA, 
Lanes 2 and 4).  In contrast, the IgA-reactivity of bands detected in the L3 extract at 
approximately 20-30 kDa (Figure 2.15, IgA, Lanes 2 and 4) were not affected by sodium 
periodate treatment.  Sodium periodate did not have an obvious effect on IgG reactivity 
to T. cirumcincta L3 somatic extract as there was no visual differences between sodium 
periodate-treated and untreated lanes following probing with mucus from previously 
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Figure 2.15 Immunoblots demonstrating the effect of sodium periodate treatment of T. 
circumcincta L3 somatic extract upon the immunoreactivity of L3 antigens to mucosal IgA and 
IgG. 
Lanes 1 and 2, no sodium periodate.  Lanes 3 and 4, antigens were treated with 50mM sodium periodate 
prior to antibody probing.  Lanes 1 and 3, probed with pool of abomasal mucus from sheep given a single 
infection (M-CO).  Lanes 2 and 4, probed with pool of abomasal mucus from given a trickle 
infection/bolus challenge (M-PI).  All lanes were incubated with the appropriate secondary and tertiary 
antibodies for the isotype under investigation, and developed with SigmaFast DAB. Lane M represents 
molecular weight markers given in kDa.   
 
Binding to L4 somatic antigens of abomasal mucus IgA and IgG in sheep previously 
infected/challenged or given a single infection is shown in Figure 2.16.  IgG 
immunoreactivity to the high molecular weight L4 antigens (approximately above 90 
kDa) (Figure 2.16, Lane 2) was depleted following preincubation of the blot with 
sodium periodate (Figure 2.16, Lane 4).  IgA binding to a range of L4 somatic antigens 
(20–150 kDa) was detected in abomasal mucus from previously infected sheep (Figure 
2.16, Lane 2).  Following periodate treatment, the IgA reactive bands across the range of 
40–60 kDa were retained; however, reactivity at 28 kDa and 100 kDa was depleted 
(Figure 2.16, Lane 4).  Mucus IgA and IgG activity against L4 somatic antigens was not 
detected in sheep given a single infection (Figure 2.16, Lanes 1 and 3). 
No periodate
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Figure 2.16 Immunoblots showing the effect of sodium periodate treatment of L4 somatic 
extract towards the immunoreactivity of L4 antigens to mucus IgA and IgG.   
Lanes 1 and 2, no sodium periodate.  Lanes 3 and 4, treated with 50mM sodium periodate prior to 
antibody probing.  Lanes 1 and 3, probed with pool of abomasal mucus from sheep given a single 
infection (M-CO).  Lanes 2 and 4, probed with abomasal mucus from trickled-infected/bolus-challenged 
sheep (M-PI).   After primary antibody incubations, all lanes were incubated with the appropriate 
secondary and tertiary antibodies for the isotype under investigation, and developed with SigmaFast DAB.  
Lane M, standard molecular weight markers given in kDa.  Area of L4-IgA reactivity affected by sodium 
periodate treatment highlighted by red boxes.  Area of L4-IgG reactivity affected by sodium periodate 
treatment highlighted by blue boxes.   
 
Antigens from L4 ES products were treated with sodium periodate prior to antibody 
probing for the detection of IgA and IgG binding (Figure 2.17).  Mucus IgG binding to 
L4 ES antigens (30-200 kDa) was detected in abomasal mucus from previously infected 
sheep (indicated in brackets on the blot), and following periodate treatment this 
immunoreactivity was reduced (Figure 2.17, Lane 3).  The lanes probed with abomasal 
mucus from sheep given a single infection showed no IgA and IgG binding to L4 ES 
antigens (Figure 2.17, Lanes 2 and 4).  A large area of IgA reactivity was detected 
against L4 ES antigens (range of 4–200 kDa) when probed with abomasal mucus from 
previously infected/challenged sheep (Figure 2.17, Lane 1).  Following periodate 
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treatment, IgA immunoreactivity >90 kDa (highlighted on Figure 2.17, Lane 1) was 
reduced (Figure 2.17, Lane 3).   
 
Figure 2.17 Immunoblot showing the the effect of sodium periodate treatment of L4 ES antigens 
on mucus IgA and IgG binding to L4 ES antigens.   
Lanes 1, 2 and 5, no sodium periodate treatment.  Lanes 3 and 4, treated with 50mM sodium periodate 
prior to antibody probing.  Lanes 1 and 3 were incubated with pooled abomasal mucus from previously 
infected/bolus-challenged sheep (M-PI).  Lanes 2 and 4 were incubated with pooled abomasal mucus from 
sheep infected with a single bolus infection of 50,000 L3.  Lanes 5, no primary antibody controls.  
Following incubation with the abomasal mucus samples, lanes were incubated with the correct 
combination of secondary and tertiary developing antibodies for the isotype under investigation, and 
developed with SigmaFast DAB™.  Lane M, standard molecular weight markers given in kDa.  Areas of 
IgA and IgG reactivity that were affected by treatment are highlighted by brackets.   
 
The patterns of IgG reactivity detected in the lanes probed with gastric lymph from 
previously infected/challenged sheep were similar to each other as binding >28 kDa was 
detected in all lanes (Figure 2.18, Panel A, Lanes 3–5).  IgG reactivity was affected by 
periodate treatment of L3 somatic antigens; there was a reduction in the intensity of the 
binding detected (Figure 2.18, Panel B, Lanes 3–5).    
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Figure 2.18 Immunoblots of T. circumcincta L3 somatic antigens probed with efferent gastric 
lymph samples showing the effect of sodium periodate treatment of L3 antigens on IgG binding.   
Panel A, not treated with sodium periodate.  Panel B, antigens treated with 50mM sodium periodate prior 
to antibody incubations.  Lane 1, probed with abomasal mucus from previously infected/challenged sheep 
(n=4).  Lane 2, probed with abomasal mucus from helminth-naive sheep (n=4).  Lanes 3–5, probed with 
efferent gastric lymph from previously infected/challenged sheep.  Lanes 6 and 7, probed with efferent 
gastric lymph from sheep given a single bolus infection.  Lane 8, no primary antibody control.  The gastric 
lymph samples were from a single time-point, 8dpc.  Following primary antibody incubations, lanes were 
incubated with monoclonal mouse anti-ovine IgG-HRP and developed with SigmaFast DAB™.  Lane M, 
molecular weight markers given in kDa.   
 
IgG present in gastric lymph from animals subjected to a single infection (Figure 2.18, 
Lanes 6–7) bound to L3 somatic antigens across the molecular weight range of 28 kDa 
and above; however, this binding was not as intensely stained as in the previously 
infected/challenged sheep.  Binding of IgG to L3 antigens was not evident in the no 
primary antibody control lane (Figure 2.18, Lane 8).  Abomasal mucus from previously 
infected/challenged sheep contained IgG that bound to L3 somatic antigens as indicated 
by reactive bands detected at 60–200 kDa (Figure 2.18, Panel A, Lane 1).  This 
reactivity did not appear to be affected by sodium periodate treatment (Figure 2.18, 
Panel B, Lane 1).  L3 somatic antigens were not bound by IgG in the abomasal mucus of 
helminth-naive sheep (Figure 2.18, Lanes 2).     
Areas of IgA reactivity against L3 somatic antigens were detected when the extract was 
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infected/challenged sheep (Figure 2.19, Panel A, Lanes 1, 3, 4 and 5).  Following 
sodium periodate treatment, IgA reactivity were affected as the intensity of binding was 
reduced (Figure 2.19, Panel B, Lanes 1, 3–5).  The profiles of IgA reactivity against L3 
somatic antigens were very similar amongst all the gastric lymph samples from 
individual sheep (Figure 2.19).  The lanes of L3 somatic extract probed with gastric 
lymph from sheep exposed to a primary bolus infection did not demonstrate IgA binding 
(Figure 2.19, Lanes 6 and 7).  
 
Figure 2.19 Immunoblots of L3 somatic antigens probed with efferent gastric lymph samples 
showing the effect of sodium periodate treatment of L3 antigens on IgA binding.   
  
Panel A, not treated with sodium periodate.  Panel B, antigens treated with 50mM sodium periodate prior 
to antibody incubations.  Lane 1, probed with a abomasal mucus from previously infected/challenged 
sheep (n=4).  Lane 2, probed with abomasal mucus from helminth-naive sheep (n=4).  Lanes 3–5, probed 
with efferent gastric lymph from previously infected/challenged sheep.  Lanes 6 and 7, probed with 
efferent gastric lymph from sheep given a single infection.  Lane 8, no primary antibody control.  The 
gastric lymph samples were from a single time-point, 8 dpc.  Following primary antibody incubations, 
lanes were incubated with monoclonal mouse anti-bovine/ovine IgA, polyclonal anti-mouse 
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2.3.5 Anamnestic response to L3 somatic antigens 
Antigen-specific ELISAs were used to investigate antibody responses to L3 somatic 
antigens across a time frame in previously infected sheep.  Periodate treatment of 
antigens was used to determine if carbohydrate moieties on larval antigens contributed 
to the immune response.  Efferent gastric lymph samples from sheep subjected to an 
experimental trickle infection/challenge protocol were used to investigate antibody 
responses to L3 somatic antigens before and up to 10 days after challenge with 50,000 T. 
circumcincta L3 (Figure 2.20).  For this part of the study efferent gastric lymph samples 
from two sheep which were classified as ‘high-responders, as they had previously been 
demonstrated to have high total IgA concentrations in their efferent gastric lymph at 5-
10 dpc (Halliday et al., 2007), were used.  In both sets of gastric lymph samples, the 
level of IgA binding to L3 antigens across -2 to 2 dpc remained at a similar level (Figure 
2.20, IgA).  At 3 dpc, the level of IgA binding began to increase, and in the samples 
from #A1008 IgA levels peaked at 6 dpc whereas in #A295 IgA levels increased until 
the final time-point of 10 dpc (Figure 2.20, IgA).  Due to the rapidity of the IgA 
response, this suggests that an anamnestic IgA response to L3 somatic antigens was 
evident.  The L3 specific-IgG levels in the efferent gastric lymph from both previously 
infected sheep showed little fluctuation (Figure 2.20, IgG).  
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Figure 2.20 Gastric lymph IgA and IgG activity to T. circumcincta L3 somatic antigens across 
the time period of -2 to 10 days post bolus L3 challenge in two previously infected sheep. 
Plates were coated with L3 somatic antigen (5µg/ml) and probed with efferent gastric lymph samples (-2 
dpc to 10 dpc) from two previously infected/challenged sheep.  The two individual sheep were selected as 
they had been identified as ‘high-responders’ in a previous study.  Orange line, #A1008.  Purple line, 
#A295.  Results are presented as mean OD ± SEM.   
 
Periodate treatment of L3 antigens prior to antibody probing was used to examine the 
contribution of carbohydrate moieties towards antibody binding across a time frame in 
previously infected sheep.  Efferent gastric lymph samples which had previously been 
collected from two trickle-infected/challenged sheep across the time period of -2 to 10 
dpc were used as the antibody probes.  Due to the limited availability of gastric lymph 
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be used which mean the power of any statistical test will be too weak to allow statistical 
analysis to indicate biological importance.  In sheep #A295, periodate treatment of L3 
somatic antigens reduced the level of IgA binding at the following time-points: -2, -1, 1, 
2 and 3 dpc (Figure 2.21, Panel A).   
 
 
Figure 2.21 Effect of sodium periodate treatment of L3 somatic extract on IgA antibody binding 
in gastric lymph samples from previously infected sheep. 
Plates were coated with L3 somatic antigen, and probed with gastric lymph from previously 
infected/challenged sheep.  Samples were across the time period of -2 to 10 dpc. Panel A, #A295 and 
panel B, #A1008.  Dark blue bars represent L3 somatic extract not treated with periodate.  Light blue bars 
represent L3 somatic extract treated with periodate prior to antibody probing.  Results are presented as 
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In contrast, periodate treatment of L3 antigens prior to antibody probing was seen to 
increase the level of IgA binding at 7, 8 and 10 dpc.  Using gastric lymph samples from 
sheep #A1008, the level of IgA binding to L3 somatic antigens following periodate 
treatment of L3 somatic extract was reduced at the following time-points: -2, -1, 0, 1, 3, 
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2.4 Discussion 
In this chapter, interactions between antigens in extracts of various developmental stages 
of T. circumcincta and local antibody in previously infected/challenged and sheep given 
a single infection were investigated in detail.  The antibody probes were generated from 
abomasal mucus and efferent gastric lymph, which had been collected in experimental 
trials in which sheep had been subjected to a T. circumcincta trickle infection and a 
single bolus challenge.  The investigations demonstrated that IgA and IgG were reactive 
with a range of T. circumcincta antigens in larval somatic extracts and L4 ES products.  
An anamnestic IgA response to L3 antigens was evident in gastric lymph from trickle-
infected/challenged sheep.  Removal of carbohydrate moieties on the larval and ES 
antigens, by treatment with sodium periodate, significantly reduced the level of binding 
of IgA in gastric lymph and/or abomasal mucus from trickle-infected/challenged sheep.  
Further investigations revealed that a proportion of the local IgA reactivity was directed 
against glycans found on high molecular weight immunogenic antigens.   
Numerous parasite antigens contain unique and immunogenic glycans, some of 
which may play a role in immune evasion (Hokke and Deelder, 2001; Nyame et al., 
2003).  Periodate treatment of immunoblots and ELISAs here indicates that 
carbohydrate moieties on antigens are involved in the reactivity of locally derived 
antibodies.  Using abomasal mucus from trickle-infected sheep responding to a 
challenge infection as a source of antibody, it was demonstrated that periodate treatment 
of larval somatic extracts depleted IgA reactivity detected in the high molecular weight 
ranges 50-100 kDa and above 80 kDa in L3 and L4 blots, respectively.  Carbohydrate 
moieties were also identified to be present in L4 ES antigen preparations, as periodate 
treatment of L4 ES depleted the high molecular weight IgA reactive regions (above 90 
kDa).  Carbohydrate epitopes and moieties have been found in a range of nematode 
parasite extracts, in particular larval and adult extracts from H. contortus (Schallig and 
Leeuwen, 1996; Van Stijn et al., 2010; Vervelde et al., 2003), adult ES products from D. 
viviparus (Kooyman et al., 2007) and L3 extracts of T. colubriformis (Harrison et al., 
2008).  In a study investigating the presence of the LDNF glycan on the antigenic profile 
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of H. contortus, immunbolotting and a monoclonal antibody were used to identify 
glycoproteins in L3 and adult extracts (Vervelde et al., 2003).  The range of H. contortus 
L3 antigens containing glycans were in the same molecular weight range to that reported 
here for T. circumcincta L3.  Earlier work in H. contortus revealed that sodium periodate 
treatment of antigens reduced the reactivity of larval and adult somatic extracts (Schallig 
and Leeuwen, 1996).  Similar to the work presented here for IgA reactivity following 
periodate treatment of larval antigens, Schallig and Leeuwen (1996) found that treatment 
of L3 somatic antigens with 20mM sodium periodate resulted in the removal of the high 
molecular weight regions of serum IgG reactivity.  Together, these reductions in 
antibody binding to L3 antigens following periodate treatment suggests that carbohydrate 
residues can play an important role in antibody binding.    
Periodate treatment of antigen-specific ELISAs showed that, for all the extracts 
tested, there was a significant reduction in the level of IgA binding in efferent gastric 
lymph compared to untreated samples using material from sheep subjected to a trickle 
infection/challenge regime.  A similar study using periodate treatment of antigens from 
larval and adult extracts of H. contortus indicated that removal of carbohydrate moieties 
led to a reduction in the level of binding of serum IgG1 from H. contortus-
hyperimmunised sheep (Schallig and Leeuwen, 1996).  The same concentration of 
sodium periodate (20mM) was used to treat antigens before antibody probing in the 
antigen-specific ELISAs in both Schallig and Leeuwen (1996) and the work presented 
here.  Following periodate treatment of antigens, the reductions in absorbance readings 
were of similar proportions, as in both studies the level of binding decreased by an OD 
reading of 0.1-0.2.  However, in Schallig and Leuwen (1996) these findings were 
focused on the serum IgG response, whereas the work here reports local IgA response to 
T. circumcincta antigens.  Glycoconjugates have been identified in L3 and adult extracts 
of H. contortus by using lectin panels to specifically identify and characterize the 
glycans present (Schallig and Leeuwen, 1996).  In particular, the study demonstrated 
through periodate treatment of antigen-specific ELISAs that a degree of the antibody 
response was directed against the carbohydrate epitopes on the H. contortus antigens 
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(Schallig and Leeuwen, 1996).  A vaccination trial in H. contortus with adult ES 
products revealed that a proportion of the ES-specific IgA and IgG antibodies were 
directed against glycan epitopes and were associated with protection against a challenge 
infection (Vervelde et al., 2003).  In these experiments, vaccination with the ES 
glycoproteins resulted in an 89% reduction in parasite egg output and a 54% reduction in 
worm burden compared with the adjuvant control group (Vervelde et al., 2003), 
highlighting the importance of glycans in immunity to nematodes.   
Glycan moieties have been suggested to be important in the immunity to the 
bovine lungworm D. viviparus through their identification in both L3 and adult ES 
products (Kooyman et al., 2007).  The latter study used a deglycosylation enzyme, 
PNGase F, to remove glycosylation sites on antigen preparations.  Following this, there 
were reductions in IgA, IgG and IgE reactivity to L3 and adult antigens in sera obtained 
from primary infected calves in response to challenge infection (Kooyman et al., 2007).  
Further investigations revealed that whilst the N-glycan moieties on D. viviparus L3 and 
adult ES products induced a strong antibody response, they failed to elicit a long-lasting 
antibody response to a challenge infection (Kooyman et al., 2007).  From the results 
presented here, it is unclear if glycan moieties on T. circumcincta antigens are involved 
in the maintenance of the local IgA response.  The results from Kooyman et al. (2007) 
raise the possibility that glycan moieties may be implicated in a strong host immune 
response and, through their influence on the conformation of antigenic proteins, could be 
important for the maintenance of a protective response. 
The results from immunoblots and ELISAs here suggest that carbohydrate 
moieties on T. circumcincta larval antigens may contribute to the protective immune 
response in previously infected sheep.  This potential role of glycans in immunity is 
supported by studies on schistosomiasis, as serum IgA, IgG and IgM antibodies in 
Schistosoma mansoni-infected humans have been shown to be specifically reactive 
against carbohydrate N-glycan antigens, LDN (GalNAcβ1-4GlcNAc-R) and LDNF 
(GalNAcβ1-4(Fucα1-3)GlcNAc-R) (Nyame et al., 2003; 2004).  Antibodies specific to 
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the LDN glycan in S. mansoni have a protective role against infection through direct 
lysis of the tegument of schistosomula in vitro (Nyame et al., 2003).   
Carbohydrate moieties in parasitic extracts potentially have the ability to 
modulate the type of immune response generated.  Glycan structures in the parasitic 
nematode, Brugia malayi, were found to play a role in the induction of a Th2-mediated 
immune response, as periodate-sensitive antigens were directly involved in the induction 
of IL-4 in the first 72 h following infection, highlighting a role in T-cell priming (Tawill 
et al., 2004).  Anti-glycan immune responses may be beneficial in different ways.  First, 
they could be beneficial to the parasite by the action of blocking binding of more 
protective anti-protein antibodies (Eberl et al., 2001).  These blocking properties of anti-
glycan antibodies have been shown in S. mansoni, with the eosinophil-mediated killing 
of the schistosomula, the infective stage of the parasite, being blocked by antibodies 
specific to a carbohydrate egg-antigen (Dunne et al., 1987).  Another theory is that they 
could act as a “decoy” for the host, by mimicking glycan structures present in the host to 
allow the parasite to evade the immune response (Van Die and Cummings, 2010).  
Glycan structures which are shared by both the parasite and hosts include the Lewis
x
, 
LDN and LDNF structures (Van Die and Cummings, 2010).  As discussed earlier in 
Section 2.1, the Lewis
x
 epitope and LDN-based glycans have been found in extracts of 
H. contortus (Van Stijn et al., 2010; Vervelde et al., 2003), and it is proposed that they 
may be involved in the modulation of the immune response.  Many helminths have the 
capacity to shift the host immune response to a CD4
+
 Th2 cell response, which is 
proposed to allow the parasite to establish a chronic infection; glycans have been 
implicated in the priming of this type of response (Tawill et al., 2004; Thomas and Harn, 
2004).   
Studies have shown that an important effector mechanism in sheep infected with 
T. circumcincta are local antibody responses, which been linked to inhibition of the 
development of larvae (Halliday et al., 2007; Stear et al., 1995; Strain and Stear, 1999) 
and immediate hypersentivity responses linked to the regulation of worm burdens (Stear 
et al., 1995).  Results here demonstrate that immunoblots of L3 antigens probed with 
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abomasal mucus from trickle-infected/challenged sheep identified regions of IgA 
reactivity around 30 kDa and 50-100 kDa, and IgG reactivity in the range 30-200 kDa.  
The profile of immunoreactivity detected against L3 antigens was similar to that 
identified previously when L3 antigen preparations were probed with antibody-secreting 
probes derived from abomasal lymph node cells (Balic et al., 2003).  The sheep in the 
latter experiments had been subjected to a trickle infection of 3,000 T. circumcincta L3 
weekly for a period of 9 weeks, and then, after a period of 12 weeks, they were  
administered an infection of 50,000 L3 (Balic et al., 2003).  In the current study, 
abomasal mucus IgA and IgG from trickle-infected/bolus-challenged sheep bound a 
wide range of antigens in L4 somatic extract and ES products.  The profile of IgA 
reactivity in the abomasal mucus to L4 somatic antigens was similar to that observed in 
efferent gastric lymph obtained from trickle-infected sheep at 8 days following a L3 
challenge infection (Halliday et al., 2007).  The L4 ES products used in this study were 
generated from an in vitro culture of T. circumcincta larvae collected from the 
abomasum at 7 dpi, and previous studies have looked at local IgA reactivity to L4 ES 
products collected at 1, 3 and 5 dpi (Smith et al., 2009).  The profiles of mucosal IgA 
reactivity to L4 ES antigens in the work presented in this thesis and reported in Smith et 
al. (2009) are similar.  More specifically, there are IgA-reactive bands at approximately 
26 kDa, 46 kDa and in the range >80 kDa in the 7 dpi ES products presented here and 
the 5 dpc ES products in Smith et al. (2009).  Using efferent gastric lymph from two 
individual trickle-infected/bolus-challenged sheep as local antibody probes, there was a 
clear anamnestic IgA response to nematode antigens after the administration of the L3 
challenge in trickle-infected sheep.  Previous studies have shown that a local anamnestic 
IgA response to L4 antigens was evident as early as 5 dpc in gastric lymph obtained from 
trickle-infected/bolus-challenged sheep (Halliday et al., 2007; Smith et al., 1983; Smith 
et al., 1984).  The results presented here using the same local antibody probes indicated 
that L3 antigen-specific IgA levels began to increase at an earlier time-point of 4 dpc.  
However, there are limitations to this result as gastric lymph samples across the time 
frame of -2 to 10 dpc were only available from two sheep from a trickle-infected/bolus-
challenged group.     
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Potential vaccine candidates have been found through targeting extracts of L3.  A 
carbohydrate larval antigen (CarLA) is an L3-specific surface antigen, which is present 
in a number of strongylid gastrointestinal nematodes and antibodies generated against it 
have been associated with a reduction in larval establishment (Harrison et al., 2003a; 
2003b; 2008).  Here, using abomasal mucus and efferent gastric lymph obtained from 
sheep subjected to a trickle infection, bolus challenge protocol, an IgA-reactive L3 
antigen of a similar size to CarLA, approximately 34-38 kDa (Figure 2.11, Lane 1; 
Figure 2.19, Lanes 1, 3-5) was detected.  Previously CarLA has been identified in T. 
circumcincta L3 antigens (Harrison et al., 2003a; 2003b).  This was discovered by 
probing an SDS-extract of T. circumcincta L3 with intestinal mucus from sheep 
subjected to a trickle infection of T. colubriformis (infected with 40,000 L3 on three 
separate occasions over 9-12 weeks) (Harrison et al., 2003a; 2003b).  The exact nature 
of the L3-specific CarLA antigen is yet to be elucidated.  However, biochemical analysis 
has revealed that it contains sugars, amino sugars and fatty acids (Maass et al., 2009).  
Treatment of CarLA with proteinase K, which would degrade proteins if present, did not 
affect the immunoreactivity of the antigen and in turn suggests that CarLA has a 
carbohydrate moiety (Harrison et al., 2003b).  Work presented in this chapter revealed 
that following sodium periodate treatment of T. circumcincta L3 somatic antigens there 
was a slight reduction in the L3-IgA reactive band (approximately 34-38 kDa) detected 
in abomasal mucus (Figure 2.19, Panel A, Lane 1) and gastric lymph (Figure 2.19 Panel 
A, Lanes 3-5) from sheep subjected to a trickle infection, bolus challenge protocol.  This 
finding specifically supports the work from Harrison et al. (2003b) and Maas et al. 
(2009), in which CarLA is shown to have a carbohydrate component, which is involved 
in antibody binding and epitope structure.  Antibodies specific to CarLA could be 
implicated in the protective mucosal antibody responses in sheep to trichostrongyloid 
infections (Harrison et al., 2003a; 2008; Maass et al., 2007).  However, a vaccination 
trial with purified CarLA, indicated that it did not induce a humoral response in the 
mucus and serum of sheep infected with T. colubriformis (personal communication).  
Research into how CarLA interacts with monocyte-derived dendritic cells (DCs), a type 
of antigen processing cell, concluded that both the purified and native forms of CarLA 
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are recognised and internalized by DCs (Pernthaner et al., 2012).  As a result of the 
interaction, the DCs were not able to mature but pro-inflammatory cytokines, IL-6 and 
TNF-α, were released (Pernthaner et al., 2012).  Collectively, these results highlight the 
importance of the L3-surface specific antigen CarLA in the immune response to 
trichostrongylid nematodes.             
Local antibody probes derived from sheep trickle-infected and bolus-challenged 
with T. circumcincta L3 were used in this study to look at isotype binding to larval 
antigens.  This was investigated by two routes: (1) antigen-specific ELISAs and (2) 
immunoblots.  Results from the two immunoassays were similar in terms of pattern of 
immunoreactivity.  Abomasal mucus and gastric lymph IgA and IgG gave the highest 
level and intensity of binding to all larval antigens when probed with antibody probes 
from trickle-infected/challenged sheep.  The probes derived from sheep receiving a 
single challenge infection and the helminth-naïve sheep showed little reactivity in both 
assays.  The immunoblots of L3 somatic extracts probed with the different antibody 
probes, abomasal mucus and gastric lymph showed differences in the level of binding.  
In particular, the IgG blots probed with efferent gastric lymph from sheep subjected to a 
trickle infection/challenge protocol showed stronger profiles of immunoreactivity 
compared to the blots probed with abomasal mucus.  There were no clear differences 
between the two trials in terms of their experimental trickle infection and bolus 
challenge protocol.  In the two separate experimental trials, the same dose of larvae was 
administered to the sheep over the same number of weeks and the sheep were killed at 
the same time-point of 2 days following the bolus challenge infection (Halliday et al., 
2007; Knight et al., 2011).  One possible explanation for the IgG reactivity demonstrated 
in the gastric lymph from the sheep subjected to a single bolus infection is that the 
cannulation method used to collect the efferent lymph from the common gastric lymph 
duct could have induced a local IgG response. 
 Abomasal mucus IgA from sheep subjected to a trickle infection have been used 
to select L4 antigens that are targets of early immune response in trickle-infected sheep 
responding to a bolus challenge infection (Nisbet et al., 2010a).  Proteomic approaches 
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were used to characterise components of L4 ES products and led to the identification of 
some of the most abundant proteins, such as cathepsin F-1 (Tci-CF-1) (Redmond et al., 
2006; Smith et al., 2009).  Tci-CF-1 is a potential protective candidate as it may have a 
role in the development of parasites and is a target of local IgA response in trickle-
infected sheep responding to a challenge infection (Redmond et al., 2006).  Another 
immunogenic molecule, Tci-ASP-1, found in L4 ES products is a member of a group of 
nematode-specific molecules referred to as ‘activation-associated secreted proteins’ 
(Nisbet et al., 2010a).  These molecules are thought to play a key role in the 
establishment of parasites in their hosts (Hawdon et al., 1996; 1999) and could be 
protective against challenge infection.  Work in subsequent chapters will focus on the 
identification of immunoreactive proteins from a somatic extract of T. circumcincta L3 
following an immunoaffinity purification process with local IgA from trickle-infected 
sheep in response to a challenge infection to select IgA-reactive antigens.   
In this Chapter, the immunoreactivity investigations demonstrated that larval 
antigens from T. circumcincta are bound by local antibodies generated in response to a 
challenge infection in trickle-infected sheep.  Further research revealed that glycan 
components are present in larval antigens and were bound by both IgA and IgG present 
in abomasal mucus and gastric lymph of trickle-infected/challenged sheep.  Work in the 
next chapter will focus on the interactions of L3 antigens with the host immune system 
through identification of the immunoreactive proteins.   
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Chapter 3 : Analysis of IgA-reactive Teladorsagia     
circumcincta larval proteins  
3.1 Introduction 
One traditional approach to identifying potential vaccine candidate molecules for the 
control of helminth infections is to perform systematic fractionation of parasite extracts 
to target molecules that may induce protective immune responses against challenge 
(Emery and Wagland, 1991; Emery et al., 1993).  As whole worm extracts are complex 
mixtures, several fractionation techniques have been employed to simplify the mixtures, 
or to select for a class (for example, cysteine proteases) of specific molecules.  Lectin 
affinity chromatography has used been to select glycosylated antigens from crude worm 
extracts (Smith et al., 1994), and affinity chromatography with thiol-sepharose has been 
used to purify thiol-binding molecules (Geldhof et al., 2002; Redmond and Knox, 2004).  
Another approach has been to use host antibodies to target protective antigens in parasite 
extracts or their excretory/secretory (ES) material (Murphy et al., 2010; Nisbet et al., 
2009; 2010a; Smith et al., 2009).  These methods often include protein denaturation or 
reduction steps in the sample preparation protocols, which may result in the loss or 
change of structural epitopes required for appropriate antibody binding (Pathak and 
Palan, 2005).  
Studies with Haemonchus contortus have revealed the importance of 
discontinuous or structural epitopes in immunity against nematodes (Munn et al., 1997; 
Smith and Smith 1996; Smith et al., 2000).  One prime example is with a microsomal 
aminopeptidase, termed H11, which was isolated from the interstinal microvilli of adult 
H. contortus (Smith and Smith, 1996).  In a vaccination trial, the levels of protection 
afforded by vaccination of sheep with two different forms of the antigen, (i) native and 
(ii) denatured by using sodium dodecyl sulphate (SDS) and dithiothreitol, were 
compared (Munn et al., 1997).  Following a challenge infection of 10,000 L3 there was a 
reduction in the levels of protection (reductions of 21% and 41% in faecal egg counts 
and adult nematode burdens, respectively) afforded by the H11 antigen when denatured 
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compared to the untreated antigen (Munn et al., 1997).  This demonstrates that structural 
epitopes were important for antibody binding and the protective immune response 
induced by vaccination with the native nematode antigen.  Further evidence for the 
importance of structural epitopes is provided by research into a lead vaccine candidate 
for H. contortus, termed Haemonchus galactose-containing glycoprotein complex (H-
gal-GP) (Smith et al., 2000).  Vaccination with native H-gal-GP antigens induced 90% 
and 70% reductions in faecal egg output and adult nematode burdens, respectively, 
following a challenge infection of yearling sheep with H. contortus L3, compared to 
unvaccinated sheep (Smith et al., 1994; 2000).  To identify components of the complex, 
native H-gal-G was dissociated and fractionated by gel filtration chromatography, 
revealing a high molecular weight fraction that contained four metalloendopeptidases 
(MEPs) (Smith et al., 2003a) and a low molecular weight fraction that contained pepsin-
like aspartyl proteases (Smith et al., 2003b).  The MEPs were fractionated further by 
non-reducing SDS-PAGE and vaccination with MEP-3 alone, or MEP-1, 2 and 4 in 
combination, resulted in a 33% mean reduction in faecal egg output after challenge, in 
comparison to challenged control sheep (Smith et al., 2003a).  These vaccination studies 
with the H-gal-GP complex emphasise that epitopes present on the native antigen can be 
discontinuous, i.e. on separate sections of the antigen complex.  In turn, these could be 
essential for antibody binding as fractionation/denaturation of the antigen complex was 
associated with a reduction in the antibody-based  immunity afforded by vaccination. 
A further approach used for identifying nematode vaccine candidates is based on 
the immunoscreening of protein extracts separated by SDS-PAGE (Schallig et al., 1997) 
or cDNA expression libraries (DeMaere et al., 2002; Newlands et al., 1999; Vercauteren 
et al., 2003) using polyclonal sera or local antibody probes derived from immune 
animals.  The vectors used for cDNA library preparation are often bacterial (Dale and 
Von Schantz, 2007) and proteins expressed by these systems do not facilitate the correct 
post-translational modifications (for example, glycosylation (Gelhof et al., 2007; Nyame 
et al., 2004)) which are critical.  This suggests that immunoscreening of bacterial cDNA 
libraries for protective antigens may miss glycosylated and other three dimensional 
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antigens due to differences in the linear structure compared to the native structure and 
components.  Bacterial expression systems often express the antigen as insoluble 
inactive intracellular inclusion bodies, which can be associated with the absence of 
structural epitopes (Dalton et al., 2003).   
The ability to identify protective antigens from complex organisms therefore 
requires a strategy that allows binding of antibodies to nematode components/molecules 
in their native conformation. In this chapter, an immunoaffinity chromatography method 
was used to target antigens separated under native conditions, in an attempt to target 
structural epitopes. Here, chromatography was used in combination with antibody 
binding experiments to target antigens/epitopes present in the L3 stage of T. 
circumcincta.  A similar strategy had been used previously in the development of a 
novel vaccine against the tick, Rhipicephalus (Boophilus) microplus (Opdebeeck et al., 
1989): purified serum IgG derived from an animal immunised with tick mid-gut extract 
(Opdebeeck et al., 1988) was used as an affinity ligand to purify sub-fractions, which 
were then administered to cattle (Opdebeeck et al., 1989).  Immunisation with these 
native antigen fractions elicited significant protection against challenge infection, with 
80% reduction in the weight of eggs laid by ticks in immunised animals compared to 
non-immunised controls (Opdebeeck et al., 1989).  Monoclonal antibodies, derived from 
mice immunised with gut microvilli surface antigens of H. contortus, were used to 
affinity-purify antigens from extracts of adult stages of this species (Jasmer et al., 1993).  
These affinity-purified antigens were shown to contain carbohydrate epitopes due to 
sensitivity to periodate oxidation (Jasmer et al., 1993).  Subsequent immunisation of 
goats with antigens isolated through affinity for the monoclonal antibodies induced a 
60% significant reduction in total worm counts following a H. contortus challenge 
infection in immunised goats compared with challenged control groups (Jasmer et al., 
1993).  To date, the immunoaffinity approach to purify antigens from extracts of T. 
circumcincta under native conditions, thereby retaining epitope structures, is an avenue 
which has not been explored in the development of a T. circumcincta vaccine.   
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Abomasal mucus IgA, which was generated from sheep administered a 50,000 
L3 challenge infection with T. circumcincta having previously been rendered immune by 
experimental trickle infection, has been positively correlated to the proportion of 
arrested larvae in the abomasum (Stear et al., 1995; 1999).  Using IgA from sheep 
experimentally-infected with a trickle infection of T. circumcincta L3 over 8 weeks, 
vaccine candidate antigens have been identified in T. circumcincta L4 ES products by 
immunoblotting with the abomasal mucus IgA (Nisbet et al., 2010a; Redmond et al., 
2006).  Here, the focus is the initial interaction between T. circumcincta and the sheep 
and so L3 antigens were subjected to analysis because these stages directly encounter the 
host’s response and physicochemical signals, which in turn can trigger processes to 
ensure the successful establishment of the parasite in its host niche (Kiel et al., 2007).  
Nematode proteomes are, to some degree, differentially regulated at different points in 
the life cycle.  The helminth proteome has been demonstrated to be dynamic in that the 
components present can change in response to specific alterations in environmental 
conditions and the immunological response by the host (Barrett, 2000; 2009).  Here, the 
proteome of T. circumcincta at the initial point of contact and establishment in the 
abomasum was investigated to provide information on potential vaccine candidates.   
The availability of helminth EST and genomic DNA databases, has led to the 
successful application of proteomics to target potential vaccine candidates (Wilson et al., 
2004; Smith et al., 2009).  Sequencing of the genome of T. circumcincta is still in 
progress (Accessed: February 2014, http://genome.wustl.edu/genomes/detail 
/teladorsagia-circumcincta/) and in February 2014 there were 6,061 T. circumcincta 
expressed sequence tags (ESTs) publically available (NCBI, 
http://www.ncbi.nlm.nih.gov).  The identification of proteins contained in T. 
circumcincta L4 ES products from parasites collected at 1, 3 and 5 dpi highlighted 
potential vaccine candidates; Tc-CF-1, astacin-like metalloprotease, activation-
associated secreted (ASP) proteins and an aspartyl proteinase enzyme (Smith et al., 
2009).  Tci-CF-1 is the most abundant component of L4 ES and is a target of local IgA 
responses in sheep rendered immune to infection (Redmond et al., 2006).  Homologues 
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of ASP proteins were found in L4 ES products and following recombinant expression of 
Tc-ASP-1 it was evident that the recombinant version is also bound by the IgA present 
in abomasal mucus from previously infected sheep (Nisbet et al., 2010a).  Following 
these approaches, a recombinant cocktail vaccine against T. circumcincta, containing 
eight antigens identified by the various means listed above is currently under 
development and is showing promise as a viable vaccine (Nisbet et al., 2012).  All of the 
previous work into vaccine development against T. circumcincta has focused on the 
identification of antigens present in L4 worms and/or their ES products and there has 
been little focus  towards the identification of the L3 antigens which are targets of the 
ovine immune response. 
Here, a multi-step immunoaffinity chromatography approach was used to 
identify IgA-reactive antigens present in somatic extracts of T. circumcincta L3.  A 
schematic illustration of the process is provided in Figure 3.1.  Following isolation of the 
IgA-reactive L3 fraction, liquid chromatography-electron spray ionisation-tandem mass 
spectrometry (LC-ESI-MS/MS; Ashton et al., 2001) was used to identify proteins eluted 
during the immunoaffinity purification step.  The peptide data generated by mass 
spectrometry were then analysed to provide information on protein structure, peptide 
mass and amino acid sequence (Graves and Haystead, 2002) using the MASCOT 
(MatrixScience™) software, which also provided a molecular weight search (MOWSE) 
score for protein identification of each peptide (Pappin et al., 1993). The relative 
immunogenicity of the selected antigens was then assessed by measuring specific 
abomasal and gastric lymph IgA responses in experimentally infected sheep 
demonstrated, by parasite burden analysis, to have varying degrees of immunity.  This 
was to confirm if components of purified L3 fraction could act as potential vaccine 























Figure 3.1 Schematic illustration of process for purification of IgA-reactive T. circumcincta L3 
antigens under native conditions. 
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3.2 Materials and Methods 
3.2.1 Purification of IgA and IgG from abomasal mucus 
A 5 ml pool of abomasal mucus obtained at post mortem from sheep previously infected 
then challenged with T. circumcincta L3 (see section 2.2.1) was created, diluted 1:3 in 
PBS, pH 7.4, and centrifuged at 700 g for 10 min to remove insoluble material.  The 
supernatant was loaded onto a 1 ml HiTrap Protein G column (GE Healthcare) pre-
equilibrated with PBS.  The column was attached to an FPLC chromatography machine 
(AKTA™ purifier UV-900/P-900) to allow monitoring of UV absorbance, pH, 
conductivity and sample collection time-points.  The column was washed with 10 
volumes of PBS and the unbound material collected (three x 10 ml fractions).  Unbound 
protein, containing IgA and depleted of IgG, was concentrated to 1 ml at 4°C using 
Amicon centrifugal Ultra-4 devices with a 10 kDa molecular weight cut-off (MWCO) 
membrane.  IgG bound to Protein G agarose beads on the column bed was eluted by the 
application of 2 ml of 0.5M NaCl in 0.1M citric acid, pH 2.5, and immediately 
neutralised with 150 µl of 1M Tris, pH 9.1, per ml of eluted fraction.  The column was 
re-washed with 10 ml PBS to re-equilibrate for future use.  Fractions containing purified 
IgG were aliquoted and stored at -20°C.  The presence of IgA and IgG in the unbound 
and eluted fractions, respectively, was investigated by immunoblotting as described in 
Section 2.2.4, with the appropriate secondary and tertiary anti-IgA and -IgG antibodies.  
For detection of IgA, a mouse monoclonal anti-bovine/ovine IgA (Serotec, MCA628) 
diluted at 1:250 in TNTT was used as a secondary antibody and a polyclonal rabbit anti-
mouse immunoglobulins-HRP (Dako, P0260), diluted at 1:1000 in TNTT, as a tertiary 
antibody.  For detection of IgG, monoclonal mouse anti-goat/sheep IgG-HRP (Sigma, 
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3.2.2 Size-exclusion chromatography purification of IgA 
To purify IgA in the unbound fraction further, the material was passed through a 
Superose 12 HR 10/30 column (GE Healthcare) coupled to FPLC apparatus at a flow 
rate of 0.3 ml/min.  Prior to loading onto the column, the concentrated unbound fraction 
was centrifuged at 16000 g for 5 min to pellet any insoluble material, then 200 µl loaded 
onto the Superose 12 column (pre-equilibrated with PBS, pH 7.4) at a flow rate of 0.3 
ml/min.  The initial flow-through from the column was discarded (classified as ‘void 
volume’; usually approximately 6ml).  The chromatograph trace tracked the absorbance 
in UV units, and when UV units began to rise, the FPLC was programmed to collect 26 
x 0.5 ml fractions, automatically.  The run was repeated until the entire unbound fraction 
was depleted.  Fractions containing IgA from across all the runs were pooled and stored 
at 4°C.  To identify which fractions from the size-exclusion purification of the unbound 
fraction contained IgA, NuPAGE SDS gel analysis was performed (see Section 2.2.4) 
with the following modifications: 10 µl of sample were separated by electrophoresis in a 
final volume of 20 µl in each well.  Two gels were run; one for protein staining, and the 
second for immunoblot detection of antibody isotypes IgA and IgG.  For detection of 
IgA and IgG, immunoblotting steps were performed as in section 3.2.1.   
 
3.2.3 Confirmation of immunoreactivity of purified IgA and IgG with T. 
circumcincta L3 somatic extracts 
Binding of purified IgA and IgG to antigens present in L3 somatic extracts was 
investigated by immunoblotting.  Briefly, 5 µg per lane of T. circumcincta L3 somatic 
extract (prepared as described in section 2.2.4) were run on 4-12% NuPAGE SDS gels 
under reducing conditions (see section 2.2.6).  Once run, one lane of the gel was stained 
using Simply Blue Stain and the remaining lanes were electro-blotted onto a 0.45 µmM 
nitrocellulose membrane (see section 2.2.7).  To block non-specific binding sites, 
nitrocellulose membranes were incubated in TNTT overnight at 4°C. The appropriate 
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lanes were then incubated in primary antibody; either purified IgA or purified IgG (see 
Table 3.1) for 2 h at room temperature.  Lanes were then washed in TNTT for 10 min, 
repeated 3 times.  Secondary and tertiary antibodies were then applied (detailed in Table 
3.1) for 1 h at room temperature, prior to 3 x 10 min TNTT washes.  Following the final 
wash after incubation with the HRP conjugated antibody, detection was carried out using 
DAB (3’, 3’ diaminobenzidine, Sigma). 
Primary 
antibody 
Secondary antibody Tertiary antibody 
 Dilution Description Manufacturer Dilution Description Manufacturer Dilution 
IgA
1







1 in 250 Polyclonal 













Sigma, A0452 1 in 
1000 
N/A N/A N/A 
 
Table 3.1 Antibodies used for the detection of ovine IgA and IgG on immunoblots
 
KEY:1 IgA from previously infected/challenged abomasal mucus purified by Protein G affinity 
chromatography and size-exclusion chromatography.  2 IgG from previously infected/challenged abomasal 
mucus purified by Protein G affinity chromatography 
 
3.2.4 Preparation of IgA custom NHS-sepharose immunoaffinity column 
For creation of an IgA affinity column, pooled fractions containing IgA (see Section 
3.2.2) were coupled to a HiTrap NHS-activated HP column, 1 ml capacity (GE 
Healthcare).  The NHS-activated HP column was pre-equilibrated by the following 
steps.  Isopropanol storage solution was washed out with 6 column volumes of 1 mM 
HCl, then 4 ml purified IgA, dissolved in coupling buffer (PBS, pH 7.4) at a 
concentration of 0.4 mg/ml (approximately 1.6 mg), were applied to the column through 
inlet tubing controlled by a peristaltic pump, and allowed to re-circulate for 45 min at 
room temperature at a flow rate of 0.5 ml/min.  The column was sealed to allow the IgA 
to cross-link to the activated sepharose beads for 30 min at room temperature.  
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Deactivation of excess amine groups and washing of non-specifically bound protein was 
achieved through a series of buffer exchange washes with blocking buffer (0.5M 
ethanoloamine, 0.5M NaCl, pH 8.3) and wash buffer (0.1M sodium acetate, 0.5M NaCl, 
pH 4.0).  The column was then re-equilibrated by washing with 12 column volumes of 
PBS, and stored at 4°C overnight. The coupling efficiency of protein ligand was 
measured by comparing the absorbance values, measured at 280nm (A280), of the IgA 
solution before and after coupling.   
 
3.2.5 IgA immmunoaffinity chromatography purification of antigens from 
somatic extracts of T. circumcincta L3 
The IgA-NHS affinity column was equilibrated prior to immunoaffinity purification by 
washing with 10 column volumes of PBS at a flow rate of 0.5 ml/min.  L3 somatic 
extracts were centrifuged at 14000 g for 10 min to pellet any insoluble material.  
Approximately 10 ml supernatants (protein concentration 0.7mg/ml) were recirculated 
through the column at a flow rate of 5 ml/min for 16 h at 4°C.  Following sample 
application, unbound material was washed from the column bed with 10 column volume 
washes of PBS at a flow rate of 0.5 ml/min, with the flow through retained.  Bound 
antigens were eluted with 2 column volumes of 0.1M glycine-HCl, 6M urea, pH 2.5, and 
10 x 1 ml fractions collected.  The column was then re-equilibrated with 10 column 
volumes of PBS, and stored in 20% (v/v) ethanol.  Eluted fractions (~10 ml) were 
pooled and concentrated to approximately 500 µl using Amicon Ultra-15 10kDa MWCO 
centrifugal devices at 3000 g for 20 min at 4°C.  These were then buffer exchanged with 
PBS over three washes, and the remaining 500 µl transferred to Microcon YM-10 10 
kDa NMWL centrifugal units.  The concentrator units were centrifuged at 10000 g at 




Chapter 3: Analysis of IgA-reactive T. circumcincta larval proteins 108 
3.2.6 Proteomic analysis of IgA affinity-purified L3 antigens 
For proteomic analysis, 10 µl of concentrated affinity-purified L3 extracts were 
fractionated by SDS-PAGE under reducing conditions.  Ten µl sample were mixed with 
5 µl SDS-PAGE sample buffer, 2 µl sample reducing agent (Invitrogen Lts, UK), boiled 
at 70°C for 10 min before loading onto 4-12% gradient gels.  After electrophoresis, 
resolved proteins were visualised with colloidal Coomassie Blue (Simply Blue Safe 
Stain, Invitrogen), and destained in water.  Gel tracks under investigation were sliced 
horizontally into 26 equal gel slices of 2.5 mm width.  Each of the slices were chopped 
finely, transferred to clean 0.5 ml Eppendorf  tubes and processed using standard in-gel 
reduction, alkylation and trypsinolysis steps (Shevchenko et al., 1996).  Samples were 
transferred to HPLC sample vials and stored at 4°C until LC-ESI-MS/MS analysis.  
Liquid chromatography was performed using an Ultimate 3000 nano-HPLC system 
(Dionex) comprising a WPS-3000 well-plate micro auto sampler, a FLM-3000 flow 
manager and column compartment, a UVD-3000 UV detector, an LPG-3600 dual-
gradient micropump and an SRD-3600 solvent rack controlled by Chromeleon 
chromatography software (Dionex).  A micro-pump flow rate of 246 µl/min
-1
 was used 
in combination with a cap-flow splitter cartridge, affording a 1/82 flow split and a final 
flow rate of 3 µl/min
-1
 through a 5 cm x 200 m ID monolithic reversed phase column 
(Dionex-LC Packings) maintained at 50°C.  Samples of 4 l were applied to the column 
by direct injection.  Peptides were eluted by the application of a 15 min linear gradient 
from 8-45% of solvent (80% acetonitrile, 0.1% (v/v) formic acid) and directed through a 
3 nl UV detector flow cell.  LC was interfaced directly with a 3-D high capacity ion trap 
mass spectrometer (Esquire HCTplus
TM
, Bruker Daltonics) via a low-volume (50 l/min
-
1
 maximum) stainless steel nebuliser (Agilent) and ESI.  Raw chromatography data were 
processed and Mascot compatible files created using DataAnalysis
TM
 3.2 software 
(Bruker Daltonics) with the following parameters: compounds (autoMS) threshold 1000, 
number of compounds 500, retention time windows were 2.0 min for C18 (30 min 
gradient) and 0.8 min for monolithic and C18 (9 min gradient).   
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Mascot-compatible files generated were inserted into ProteinScape, version 2.1.0.577 
(Bruker Daltonics), and were searched against five databases. First, Nembase Version 4 
(http://www.nematodes.org/nematodeESTs/nembase.html), last updated July 2011, 
which comprises the main depository for information generated from nematode EST 
databases.  The MS data were also searched against an annotated T. circumcincta EST 
database, generated in house at MRI.  This EST dataset was derived from two T. 
circumcincta cDNA libraries (one generated from T. circumcincta L3 exsheathed with 
sodium hypochlorite and one from L4 obtained at 7 dpi) generated by suppression 
subtractive hybridisation (SSH) (Nisbet et al., 2008).  Two of the other databases that 
were searched were generated by next generation sequencing using Roche-454 titanium 
technology and these were provided by Dr. Aileen Halliday (MRI) and Professor Steve 
Paterson (Department of Ecology, Evolution and Genomics of Infectious Diseases, 
University of Liverpool), respectively.  One database was created by 454 sequencing of 
cDNA derived from RNA obtained from L3 exposed to either an immune or naive ovine 
abomasal environment, obtained by the procedures outlined in Halliday et al. (2012).  
More specifically, 100,000 exsheathed T. circumcincta L3 were exposed in vitro to fluid 
collected from the culture of an abomasal fold in saline for 3 h.  There were two sources 
of abomasum; (i) a sheep trickle-infected and bolus-challenged with T. circumcincta or 
(ii) a helminth-naïve sheep (Halliday et al., 2012).  The other 454 database was created 
from cDNA generated from RNA from T. circumcincta L4 collected at 7 dpi from a 
previously uninfected sheep.  The final database was created from an EST dataset, this 
was derived from a T. circumcincta cDNA library generated from adult worms which 
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Database Reference Parasite stage Code 
EST data generated from SSH 
analysis of L3/L4  
Nisbet et al., 2008 L3/L4 L3/L4 SSH 
454 database from L3 exposed to 
immune or naïve abomasal 
environment 
Halliday et al., 2012 L3 L3 Immune - 
Naive 
454 database from L4 collected at 
7 dpi 
(Unpublished) L4 L4 454 
EST data generated from 
transcriptomic analysis of adults 
Menon et al., 2012 Adult Ad 
Table 3.2 Summary of databases for searching against mass spectrometry data. 
 
Interpretation and presentation of MS data were performed in accordance with published 
guidelines (Taylor and Goodlett, 2005). Fixed and variable modifications selected were 
carbamidomethyl and oxidation, respectively, and mass tolerance values were set at 1.5 
Da and 0.5 Da for MS and MS/MS, respectively. MOWSE scores obtained for 
individual protein identifications were inspected manually and considered significant 
only if a) two unique peptides were matched for each protein, and b) each peptide 
contained an unbroken “b” or “y” ion series of a minimum of four amino acid residues. 
Protein identifications were confirmed further with a MOWSE score of 42 or higher 
indicating that the match was statistically significant at the 95 % confidence level when 
searching against the four datasets.  Proteins identified in the proteomic analysis were 
analysed further by assessing if the protein was unique to a particular database for 
example, L3/L4 SSH, L3 Immune/Naive and L4 454 databases (Table 3.2).  All MS 
analysis was performed at the MRI Proteomics Facility.   
 
3.2.7 Confirmation of the ability of affinity-purified antigens to bind to antibodies 
in abomasal mucus  
To assess if antigens in the affinity-purified L3 extract bound antibodies from mucus and 
gastric lymph of previously infected/challenged sheep, 10µl of the affinity-purified L3 
extract were resolved by NuPAGE SDS-gel electrophoresis on a 4-12% gradient gel.  
The proteins were then transferred to nitrocellulose and the strips blocked as described 
in section 2.2.5.  Blot strips were probed with primary antibody (see Table 2.2 for 
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dilutions) for 2 h at room temperature.  Strips were washed in TNTT for 10 min, three 
times, and incubated in secondary antibody (Table 2.3) diluted at 1:250 in TNTT for 1 h 
at room temperature.  After re-washing in TNTT, strips were incubated in tertiary 
antibody (Table 2.3), diluted at 1:1000 in TNTT for 1 h at room temperature.  After a 
final wash in TNTT, strips were incubated in DAB for 6 min in the dark and reactions 
stopped with several washes in distilled water.  At the point between blocking and 
primary antibody incubation, one strip was treated with sodium periodate (detailed in 
Section 2.2.7) to disrupt carbohydrate moieties in an attempt to allow comparison 
between reactivity to protein and carbohydrate in the affinity-purified L3 extracts.   
 
3.2.8 Measurement of antigen-specific IgA levels in ovine efferent gastric lymph 
A direct ELISA was developed to analyse the relationship between binding of IgA 
present in ovine efferent gastric lymph to IgA-affinity purified L3 extracts and 
parameters known to be associated with protective immunity. Affinity-purified L3 
extracts were diluted in ELISA coating buffer (50mM sodium biocarbonate, pH 9.6) to 5 
µg/ml and 50 µl/well used to coat 96-well microtitre ELISA plates (Greiner Bio-one, flat 
bottomed, high-binding plates) overnight at 4°C.  Plates were washed six times with 
PBST (0.05% (v/v) Tween-20) with an automated plate washer (BioTek ELX405).  
Non-specific binding sites were blocked by incubation with 10% soya milk powder 
(Infasoy, Cow and Gate) in PBST at 200 µl/well for 2 h at room temperature.  After re-
washing, plates were incubated with 50 µl of primary antibody.  Here, individual 
efferent gastric lymph samples obtained from (i) trickle-infected/challenged sheep at 7 
dpc, (ii) single challenge infected sheep at 7 dpc or (iii) helminth-naïve sheep were used 
at the primary antibody step.  For details of these sample sources see section 2.2.1.2.  All 
gastric lymph samples diluted 1:20 in PBST were incubated for 2 h at 37°C.  After 
washing, 50 µl of secondary antibody (mouse monoclonal anti-bovine/ovine IgA), 
diluted at 1:250 in PBST, were added for 1 h at 37°C.  Plates were washed prior to the 
application of tertiary antibody (polyclonal anti-mouse immunoglobulins-HRP 
conjugated) at 50 µl per well, diluted 1:1000 in PBST, for 1 h at 37°C.  Plates were 
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washed, then 50 µl of OPD substrate added per well, and allowed to develop for 20 min 
at room temperature in the dark.  To stop reactions, 25 µl of 2.5M H2SO4 were added per 
well and absorbance read at 492nm.  Samples were conducted in triplicate on each plate, 
and all plates were run in duplicate. 
 
3.2.9 Statistical analysis  
Individual ELISA OD values from each infection group were plotted to assess the 
distribution of the data.  As ELISA OD values were not found to be normally 
distributed, differences between groups were then investigated statistically by a non-
parametric Kruskal Wallis test with the post hoc analysis Wilcoxon-Mann-Whitney test 
(SPSS version 19).  Relationships between three immunological parameters, (i) total IgA 
concentration in efferent gastric lymph at 7 dpc, (ii) total nematode burden and (iii) 
percentage of inhibited L4, and the level of IgA binding to the IgA-affinity purified 
antigens, were investigated by non-parametric correlation analysis using Spearman rank 
correlation coefficient (SPSS version 19).  For all statistical analysis, the level of 
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3.3 Results 
3.3.1 Purification of IgG from abomasal mucus 
Abomasal mucus derived from sheep previously infected with T. circumcincta on 
multiple occasions was used to supply IgA and IgG.   Affinity chromatography using 
Protein G HP agarose columns was used to separate ovine IgG from the samples.  A 
Coomassie stained gel of the unbound and eluted fractions from the chromatography 
process is shown in Figure 3.2.   
 
Figure 3.2 SDS-PAGE gel showing purification of IgG from abomasal mucus from previously 
infected/challenged sheep.   
Sheep experimentally previously infected with T. circumcincta L3 were then  subjected to a single bolus 
challenge infection of 50,000 T. circumcincta L3 and necropsied at 2 dpc to collect abomasal mucus.  
Protein G affinity chromatrography was used to purify ovine IgG.  Lane ‘UB’ contains a sub-sample of the 
unbound fraction from the Protein G column.  Lane ‘E’ is a sub-sample from the fraction eluted from the 
Protein G column using 0.1M glycine-HCl, pH 2.5.  The eluted fraction contains the heavy and light 
chains of ovine IgG (highlighted in red boxes). Lane M depicts standard molecular weight markers given 
in kDa.   
 
Large numbers of proteins were present in the unbound fraction (Figure 3.2, Lane UB).  
The band displaying the highest intensity of staining is likely to be serum albumin, as 
the estimated size of the band at approximately 60-62 kDa matches that known for 
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bands at 28 kDa and 50 kDa, which correspond with the known molecular weights of 
heavy and light chains of ovine IgG, respectively.   
An immunoblot (Figure 3.3) of the unbound eluate from the Protein G agarose column 
probed for IgA (Lane 1) and IgG (Lane 2) was conducted.  Gel electrophoresis was 
performed under non-reducing conditions to distinguish between IgA and IgG multimer 
units.   
 
Figure 3.3 Immunoblot of samples obtained by Protein G purification with abomasal mucus 
from previously infected/challenged sheep.    
Lane 1 is the unbound fraction probed for IgA reactivity.  An area of IgA binding in the unbound fraction 
was evident at 120 kDa and above 180 kDa (highlighted by red box).  Lane 2 is the unbound fraction 
probed for IgG reactivity.  All strips were incubated with SigmaFast DAB to detect binding of antibodies.  
Lane M is standard molecular weight markers given in kDa.  
 
The unbound fractions appeared to contain ovine IgA as indicated by binding to the anti-
IgA immunoglobulins in the range 120-200 kDa.  These sizes correspond with the 
known high molecular weight multimers of native ovine secretory IgA (Kerr, 1990).  
The Protein G column depleted, but did not remove all, IgG from the unbound fraction 
(Lane 2), as indicated by the detection of intense anti IgG-reactive bands at 150 kDa.  
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concentration of IgG in the pooled sample of abomasal mucus could have exceeded this 
and, as a result, the capacity of the column was saturated. 
 
3.3.2 Size-exclusion chromatographic purification of IgA 
The next step was to fractionate the ‘unbound’ fractions obtained in Section 3.3.1 further 
by size exclusion chromatography.  The chromatographic trace obtained during the size-
exclusion purification of IgA shows the absorbance (measured at 280nm) over the 
complete fractionation process (Figure 3.4).   
 
Figure 3.4 Chromatographic trace from the size-exclusion purification of IgA from abomasal 
mucus obtained from previously infected/challenged sheep.  
Samples (200 µl) obtained in Section 3.3.1 were injected at time 0, and the void volume was collected as 
waste.  The blue line is the absorbance at 280nm of the column flow through throughout the process.  
Fractions 1-5 were collected when the absorbance trace began to increase.  Fractions were collected 
automatically and matched the peaks outlined in the absorbance trace.   
 
The protein profiles of the chromatograph peaks from the fractions collected during size-
exclusion purification are shown in Figure 3.5.  In the starting material in Figure 3.5 
(Lane UB), there are a large number of protein bands present.  Secretory IgA is likely to 
be present in fractions 1 and 2 (Figure 3.5, Lanes 1 and 2), as there is a band at approx 
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200 kDa (highlighted by the red box).  Fractions 3-4 contained high molecular weight 
host proteins in the range 50-150 kDa.  Fraction 5 contained intensely stained protein 
bands at approximately 30-50 kDa.   
 
Figure 3.5 Protein profile of ovine IgA from IgG-depleted abomasal mucus by size-exclusion 
chromatography.  
Lane UB is a sub-sample of the starting material of the unbound Protein G fraction.  Lanes 1A, 2A and 3– 
5 are the subsequent fractions following size exclusion separation.  Lanes 1B and 2B represent sub-
samples from fractions 1 and 2, respectively, probed for IgA reactivity with anti-IgA antibody.  The red 
box surrounds the IgA complex.  Proteins are detected by Simply Blue stain.  Lane M is standard 
molecular weight markers given in kDa. 
 
For each of four independent runs, the chromatograph traces exhibited similarities in the 
absorbance traces, and the protein profiles of the all of the fractions were similar by gel 
electrophoresis (data not shown).  Fraction 1 across all four independent purification 
experiments contained purified IgA and no other major contaminant bands were detected 
(Figure 3.5, Lanes 1A and 1B).   
Following the two-step purification process, purified IgA was still able to bind to 
antigens present in T. circumcincta L3 somatic extract: numerous reactive bands were 
detected in the range of 20–200 kDa (Figure 3.6, Lane 1).  Purified IgG bound antigens 
across the same molecular weight range and showed a region of binding to antigens of 
high molecular weights (90–200 kDa, Figure 3.6, Lane 3).  These immunoblots 
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confirmed that, following the purification processes for ovine IgA and IgG, the 
paratopes present on the antibodies that are required for epitope binding appear to be 
retained.      
 
Figure 3.6 Immunoblot of T. circumcincta L3 somatic extract probed with IgA and IgG purified 
from the abomasal mucus obtained from previously infected/challenged sheep.  
L3 somatic extract (5 µg) was resolved by gel electrophoresis and transferred to nitrocellulose membrane.  
Lane 1: incubated with purified IgA (see Figure 3.5, lane 1).  Lane 2: no primary IgA control.  Lane 3: 
incubated with Protein G purified IgG (see Figure 3.2, lane E).  Lane 4: no primary antibody IgG. Lane 
MW are standard molecular weight markers given in kDa. 
 
3.3.3 Immunoaffinity purification of T. circumcincta L3 somatic antigens 
Abomasal mucus IgA from sheep subjected to a trickle infection/bolus challenge 
protocol purified as described above was used to create an immunoaffinity column for 
selecting L3 antigens.  Purified IgA was irreversibly chemically cross-linked to NHS-
activated sepharose through the antibody’s amine bonds.  T. circumcincta L3 somatic 
extract was passed through the custom IgA immunoaffinity column and bound antigens 
eluted by a gradient of buffers with reducing pH.  The protein profiles of the eluted 
fractions are shown in Figure 3.7.   
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Figure 3.7 SDS-PAGE gel of the fractions collected during immunoaffinity chromatography of 
T. circumcincta L3 somatic extract using ovine IgA as affinity ligand. 
A sub-sample of a L3 somatic extract (SM) was used for comparison of protein profiles. The unbound 
fraction (UB) is shown alongside the flow-through (FT) and eluted fractions (E1 and E2).  Eluted fractions 
were collected in 2 column volumes of 0.1M glycine-HCl, 6M urea, pH 2.4.  Proteins were stained with 
Simply Blue stain.  Lane M depicts standard molecular weight markers given in kDa.  Immunoaffinity 
chromatography appeared to enrich for proteins at 30 kDa and 100 kDa (highlighted by arrows).  
 
The eluate from the IgA column contained a number of enriched polypeptides over a 
broad molecular weight range.  Immunoaffinity chromatrography with ovine IgA 
appeared to enrich the T. circumcincta L3 extract for proteins at specific ranges, 
including 30 kDa and 100 kDa (Figure 3.7, lane E1, highlighted by arrows).  
Immunoblotting demonstrated that IgA in gastric lymph from sheep subjected to a 
trickle infection/bolus challenge protocol bound a range of antigens in the IgA-
immunoaffinity purified T. circumcincta L3 extract, with two intensely reactive regions 
at approximately 20-36 kDa and 60-80 kDa (Figure 3.8, Lane 1).  The intensity of IgA 
reactivity was diminished following periodate treatment of the antigens (Lane 4).  
Reactivity in the region 60-80 kDa was removed by periodate treatment, while reactivity 
to the lower molecular weight antigens of 20-40 kDa was retained to a degree (Lane 4).  
Antigen-specific IgA was not detected in samples obtained from the helminth-free sheep 
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(Lane 2) and no cross reactivity of the eluted fraction to the developing antibodies was 
detected (Lane 3).   
 
Figure 3.8 Immunoblot of purified IgA-binding antigens from a T. circumcincta L3 somatic 
extract probed for reactivity to IgA in efferent gastric lymph from previously infected/challenged 
sheep. 
Antigens in the purified IgA-binding fraction from L3 somatic extract were resolved by gel electrophoresis 
and transferred to a nitrocellulose membrane for antibody probing.  Lane 1, probed with efferent gastric 
lymph from previously infected/challenged sheep, pooled from samples over 6-10 dpc (n=4).  Lane 2, 
probed with efferent gastric lymph pooled from helminth naive sheep (n=4).  Lane 3, no primary IgA 
control.  Lanes 1–3 were not treated with sodium periodate prior to antibody probing.  Lane 4 was treated 
with 50mM sodium periodate prior to probing with efferent gastric lymph pooled from previously 
infected/challenged sheep (n=4).  All lanes were probed with appropriate secondary and tertiary antibodies 
for IgA detection.  Lane M depicts standard molecular weights markers given in kDa. 
 
3.3.4 Protein identification of IgA-immunoaffinity purified L3 somatic extract 
To identify which L3 somatic extract proteins bound IgA from infected sheep, the eluted 
fraction from the purification steps was analysed by LC-ESI-MS/MS.  The resultant MS 
data were searched against five databases as described in Section 3.2.6 and results are 
shown in Table 3.3.  
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Database Number of individual 
peptides identified by 
LC-MS/M S 
Number of proteins 
with significant 
matches in each 
dataset 
Nembase 4029 927 
L3/L4 98 69 
L4 454 2259 2123 
L3 Immune/Naïve  2100 1144 
Adult 2952 2570 
Table 3.3 Summary of number of peptides and proteins identified through Mascot searches of 
peptide data. 
 
A total of 374 (containing 155 unique proteins) proteins identified through the proteomic 
analysis were confirmed after further analysis to ensure that each protein contained two 
unique peptides with a consecutive sequence of 4 ‘b’ or ‘y’ ions and had a MOWSE 
score of >100.  Of the 374 proteins, 105 (28.1%) were either hypothetical proteins or 
their function has not yet been elucidated.  The remaining proteins were further 
classified according to their function.  The results are detailed in Appendix 2 and a 
subset of those proteins of particular interest, on the basis of homology to other parasite 
vaccine candidates or their putative function at the host/parasite interface, are 
summarised in Table 3.4.  The proteins identified have been divided into a number of 
functional classes which include: developmental, metabolic, transport, carbohydrate 
binding, cuticle synthesis, detoxification, lipid binding, heat shock, protein folding, 
cytoskeletal, actin binding, proteolytic enzymes, signalling and gut-associated 
(Appendix 2).  The number of unique peptides for each protein identified is shown, 
confirming that each met the minimum criterion of 2 unique peptides.  
 
Chapter 3: Analysis of IgA-reactive T. circumcincta larval proteins 121 




14-3-3 like C. elegans Q20655 372.9 7 56.9 
ASP-2 N. americanus AAP41952 166.1 13 26.8 
ASP-3 C-type single domain O. ostertagi CAO00416 100.0 2 79.1 
Beta-D-galactosidase B. malayi AAA27859 367.2 8 66.3 
Calponin C. elegans O01542 201.5 5 43.2 
CD109 A. suum ADY40184 162.6 3 74.6 
Cytochrome C H. contortus ACG69807 229.4 5 39.3 
DVA-1 polyprotein allergen D. viviparus Q24702 122.2 2 78.1 
Fatty acid/retinol binding protein H. contortus CDJ96356 272.8 4 49.8 
Ferritin C. elegans CE20622 285.4 5 76.5 
Fructose bisphosphate aldolase T. circumcincta CBO37380 190.5 3 57.1 
Galectin 5 A. cantonensis AEK98127 296.4 7 56.2 
Galectin 1 T. circumcincta AAD39095 533.1 9 91.4 
Glutathione-S-transferase H. contortus AAF81283 614.7 9 64.1 
Intermediate filament protein A. suum ADY43340 52.6 2 42.5 
L3B25 T. circumcincta AAM45145 371.7 7 68.6 
Myosin C. briggsae CAP36983 382.2 5 159.6 
Onchocerca related antigen C. elegans CBO38581 497.8 8 50.9 
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Paramyosin H. contortus CBO16022 365.4 6 113.1 
Peptidyl prolyl cis-trans isomerase O. ostertagi P52013 219.1 3 55 
Phosphatodylethanolamine binding H. contortus O16264 247.2 3 19.2 
Pterin-4-alpha carbinolamine C. elegans Q9TZH6 224.7 4 35.7 
Putative ES protein F7 O. ostertagi CAD20464 196.0 4 15.3 
Putative HEH-1 C. elegans O17271 238.7 4 61.4 
Saponin like C. elegans NP741465 71.3 2 37.3 
Superoxide dismutase extracellular H. contortus P51547 401.1 6 37.5 
Thrombospondin H. contortus AFO43121 468.2 9 171.8 
Transthyretin like C. brenneri EGT36246 209.5 4 56.4 
Venom-allergen like (VAL) protein C. brenneri EGT59294 441.1 9 66.6 
 
Table 3.4 A selection of the proteins identified from proteomic analysis of the IgA-immunoaffinity purified L3 fraction.   
 
All proteins have been identified by searching MS data against EST databases created from parasite material collected post-infection.  
Coverage of the full-length protein sequence by the assigned peptides is shown under the percentage of sequence coverage.  The protein 
MOWSE score is shown and all scores are above the threshold and are significant at the 95% confidence threshold.  Hits with trypsin and 
keratin were omitted. 
 
Chapter 3: Analysis of IgA-reactive T. circumcincta larval proteins 123 





























































































3.3.5 Measurement of IgA levels in ovine efferent gastric lymph to the affinity-
purified L3 extract  
To allow investigation of the immunoreactivity of the L3 antigens eluted from the IgA-
affinity column, antigen-specific IgA levels were assessed, in efferent gastric lymph 
obtained from sheep with varying levels of immunity, by antigen-specific ELISA 
(Figure 3.9).  Mean antigen-specific IgA levels in the gastric lymph of previously 
infected/challenged sheep, 7 dpc, were significantly higher (p=0.021) than those in 










Figure 3.9 Levels of binding of IgA from efferent gastric lymph to antigens present in the IgA-
immunoaffinity purified L3 fraction.  
ELISA plates were coated with the IgA-immunoaffinity purified L3 somatic extract (5µg/ml) and 
incubated with efferent gastric lymph from individual sheep of different infection status.  Group GL-PI: 
previously infected/bolus challenge (n=14).  Group GL-CO: single infection (n=11).  Group GL-HF: 
helminth-free (n=6).  Samples from Groups GL-PI and GL-CO were from a single time-point 7 dpc with 
50,000 T. circumcincta L3.  The level of IgA binding was detected by HRP-labelled developing 
antibodies.  Results are expressed as percentage of the positive control.  The positive control was efferent 
gastric lymph pooled from previously infected/challenged sheep over 6-10 dpc.  Samples were conducted 
in triplicate with two independent repetitions.  ‘*’ grouped median IgA concentrations of GL-PI sheep 
(Group 1) were significantly higher (p<0.05) than GL-CO or GL-HF median values. 
Relationships between the level of IgA binding and parasitological and immunological 
parameters were investigated and are summarised in Table 3.5.       
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Parameter  Rs value P-value Significance level 
Nematode burden  -0.565 0.004 ** 
% inhibited larvae  0.534 0.007 ** 
Total IgA in lymph  0.853 <0.001 *** 
Blast cell response  -0.058 0.979 NS 
 
Table 3.5  Relationships between antigen-specific IgA levels and parasitological and immune 
parameters. 
A significant negative correlation (p=0.004, rs = -0.565) was observed between antigen-
specific IgA levels in efferent gastric lymph and the total T. circumcincta burdens at 
necropsy (Figure 3.10; Table 3.5).  The total burdens were assessed by counting the 
number of adult males, females and inhibited L4 in a sub-sample of the digests of 
abomasal tissue and contents (Halliday et al., 2007).      
 
Figure 3.10 Relationship between the level of gastric lymph IgA binding to antigens in an IgA-
immunoaffinity purified T. circumcincta L3 somatic extract and the total nematode burden of 
sheep previously infected/challenged with T. circumcincta L3. 
Analysis of the association was conducted using Spearman correlation coefficients.  Data points represent 
absorbance (OD) values from individual gastric lymph samples (n=23).  Absorbance values were plotted 
against the total nematode burden for each individual.  The efferent gastric lymph was collected from 
sheep which had been previously infected with T. circumcincta L3 and subjected to a bolus challenge of 
50,000 T. circumcincta L3.  The gastric lymph samples used were all from a single time-point (7 dpc).  
The worm burden of the “GL-PI” sheep was assessed by counting the number of males, females and 
inhibited L4 in a sub-sample of the digests of the abomasal tissue and contents (Halliday et al., 2007).   
 
Chapter 3: Analysis of IgA-reactive T. circumcincta larval proteins 125 
In contrast, a significant positive correlation (p=0.007, rs = 0.534) was observed between 
the antigen-specific IgA levels in efferent gastric lymph and the percentage of inhibited 
L4 enumerated at necropsy (Figure 3.11; Table 3.5).  Some of the data points are stated 
as having 0% of inhibited L4; these are the samples from helminth-naïve and/or the 
sheep administered a bolus challenge of 50,000 T. circumcincta L3 only (Figure 3.11).    
 
 
Figure 3.11 Relationship between the level of gastric lymph IgA binding to antigens in an IgA-
immunoaffinity purified T. circumcincta L3 somatic extract and the percentage of inhibited T. 
circumcincta L4 in the abomasa of sheep previously infected/challenged with T. circumcincta L3.  
Analysis of the association was as in Fig 3.10.  Data points represent the absorbance values (OD) in 
individual gastric lymph samples (n=19).  The absorbance values were plotted against the percentage of 
inhibited T. circumcincta L4 in the abomasum at post mortem.  Efferent gastric lymph was collected from 
individual sheep as detailed in Fig. 3.10.   The percentages of inhibited T. circumcincta L4 present in the 
abomasum were estimated as detailed in Halliday et al. (2007).   
 
A strong positive correlation (p<0.001, rs = 0.853) was found between the level of L3-
antigen-specific IgA levels in efferent gastric lymph and the total IgA concentration in 
the efferent gastric lymph (Figure 3.12; Table 3.5).  The correlation analysis of this 
relationship found it to be tighter than the relationship between the level of L3 antigen-
specific IgA levels and the total nematode burden at necropsy (Figure 3.10).   
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Figure 3.12 Relationship between the level of gastric lymph IgA binding to antigens in an IgA-
immunoaffinity purified T. circumcincta L3 somatic extract and the total gastric lymph IgA 
concentration at 7 dpc of sheep previously infected/challenged with T. circumcincta L3.   
 
Analysis of the association was conducted as detailed in Figure 3.10.  Data points represent the absorbance 
values (OD) from individual gastric lymph samples (n=16).  The absorbance values were plotted against 
the total IgA concentrations for the individual samples. The efferent gastric lymph was collected from 
sheep which had been previously infected with T. circumcincta L3 and were subjected to a bolus challenge 
of 50,000 T. circumcincta L3 (“GL-PI”), as in Figure 3.10.  Total IgA concentrations were published 
previously in Halliday et al. (2007). 
 
No significant correlations (P=0.979, rs = 0.979) were observed when the antigen-
specific IgA levels were compared with the number of blast cells present in the lymph at 
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3.4 Discussion 
Here, for the first time with T. circumcincta, immunoaffinity chromatography was used 
to identify potentially protective antigens present in T. circumcincta L3 somatic extracts 
using abomasal mucus IgA.  Chromatography methods were used to purify IgA from 
abomasal mucus from previously infected sheep and the purified IgA was used, via 
immunoaffinity purification, to enrich a somatic extract of T. circumcincta L3 for a 
subset of IgA-reactive antigens.  The proteins in the subset of IgA-reactive antigens 
purified from T. circumcincta L3 somatic extract were then identified through proteomic 
analysis.  Proteomic analysis identified a range of possible vaccine candidates which had 
not previously been identified in L4 somatic extract and/or L4 ES products, including: 
fatty-acid/retinol binding protein (FAR), galectin, paramyosin and activation-associated 
protein (ASP-1).  Antigenic proteins identified from extracts of nematode parasites will 
not necessarily offer protection if they are used to immunise the host against challenge 
(Kiel et al., 2007).  The relative immunoreactivity of antigens in the purified L3 fraction 
was investigated by comparing antigen-specific IgA responses in sheep with varying 
levels of immunity to known parameters of the immune response.  Mean antigen-
specific IgA levels were significantly (p<0.05) higher in the trickle-infected/bolus-
challenged sheep compared to sheep subjected to a single bolus infection or sheep that 
had been reared in a helminth-free environment.  Positive associations existed between 
levels of affinity-purified L3 antigen-specific IgA and the total IgA concentration in 
efferent gastric lymph at 7 dpc (p<0.001) and the percentage of inhibited L4 calculated at 
necropsy 3 days after the lymph samples were collected (p<0.01).  In contrast, a negative 
correlation between levels of affinity-purified L3 antigen-specific IgA and nematode 
burden was demonstrated (p<0.01).  Proteomic analysis of the IgA-affinity-purified T. 
circumcincta L3 antigens was used to identify the proteins present and this yielded 
candidates of particular interest due to their selection as vaccines for other helminth 
species (for example paramyosin, ASPs, FARs, and galectin) and/or their putative role at 
the host/parasite interface (for example superoxide dismutase and glutathione-S-
transferase).  Immunoaffinity chromatography using abomasal mucus IgA to purify 
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antigens from T. circumcincta L3 somatic extract revealed a number of promising 
vaccine candidates which are potentially involved in the generation of a protective 
immune response. 
 ASP-like and venom allergen-like (VAL) proteins were detected in the IgA-
affinity-purified T. circumcincta L3 extract and these may represent key vaccine 
candidates against parasitic nematodes (Hawdon et al., 1996; Nisbet et al., 2010a).  
ASPs are nematode-specific members of a diverse protein family, called SCP/Tpx-
1/Ag5/PR-1/Sct (SCP/TAPS), present in eukaryotes and a range of parasites (Cantacessi 
et al., 2009; 2012).  The first report of their existence in parasites was in the ES products 
of serum-activated L3 of the canine hookworm, Ancylostoma caninum (Hawdon et al., 
1996; 1999).  They are key vaccine candidates against hookworm species and are 
thought to be important in the establishment of parasites in the host (Hawdon et al., 
1999; Tawe et al., 2000).   
Here we found for the first time that the affinity-purified T. circumcincta L3 
extract contained proteins that showed homology to two ASPs: an ASP-2 from A. 
caninum (Ac-ASP-2) and a C-type single domain ASP-3 from O. ostertagi (Oo-ASP-3).  
Phylogenetic analysis of Ac-ASP-2 and Oo-ASP-3 has shown that they are closely 
related homologues (Visser et al., 2008). A randomised, placebo-controlled, double-
blind vaccination trial with an ASP-2 homologue from the human hookworm Necator 
americanus (Na-ASP-2) indicated that immunisation of humans with recombinant Na-
ASP-2, injected intramuscularly with an alhydrogel adjuvant, induced antigen-specific 
serum IgG titres significantly higher than controls up to 8 months after the final 
vaccination (Bethony et al., 2008).  Serum antibodies from vaccinated humans were 
cross-reactive with native Na-ASP-2, prepared from an extract of N. americanus L3 
(Bethony et al., 2008), indicating that there were structural similarities between the 
recombinant and native proteins.  In a vaccine trial of A. caninum in dogs, vaccination 
with a recombinant version of Ac-ASP-2 was protective against a challenge infection, 
with 69% and 26% reductions in faecal egg counts and adult worm burdens, 
respectively, in vaccinated dogs compared to the control group (Bethony et al., 2005).  
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An investigation into the transcription of ASPs in O. ostertagi revealed that the 
transcript of Oo-ASP-3 is expressed in all larval and adult stages, and the protein was 
detected in the oesophagus and intestines of male and female worms (Visser et al., 
2008).  Oo-ASP was first identified in O. ostertagi adult ES products through affinity 
chromatography to enrich for proteins with affinity to thiol groups (Geldhof et al., 
2003).  It was later revealed to be involved in the protective immune response against 
infection of cattle with O. ostertagi, as vaccination of cattle with the native ASP antigen 
(purified through affinity for thiol) saw a significant reduction of 74% in cumulative egg 
output compared to the unvaccinated controls (Meyvis et al., 2007).  As O. ostertagi is a 
closely related parasite to T. circumcincta, this strongly suggested that ASP may also be 
involved in the protective immune response in T. circumcincta-infected sheep.  
Abomasal mucosal antibodies in T. circumcincta-infected sheep are specific to a number 
of ASPs in L4 ES products (Nisbet et al., 2010a; Smith et al., 2009).   In the current 
study we have shown for the first time that the affinity-purified T. circumcincta L3 
extract contained a homologue of Oo-ASP-3.  This Oo-ASP-3 homologue was different 
to the homologues previously identified in L4 ES products (Nisbet et al., 2010a; Smith et 
al., 2009). This novel identification of an ASP homologue in a T. circumcincta L3 
somatic extract supports the proposed role of ASPs in establishment of infection 
(Hawdon et al., 1996), as the parasite could be producing and sequestering ASP-3 
homologues in pre-parasitic larval stages for release upon ingestion to allow 
establishment and maintenance of the parasite in the host.  This is supported by studies 
with Ac-ASP-2, as transcript analysis revealed that its mRNA is present at all life-cycle 
stages but protein expression was only detected in L3 activated with host serum in vitro 
(Hawdon et al., 1999).   
The ASP-1 homologue found previously in T. circumcincta, using the local IgA 
response (Tci-ASP-1, Nisbet et al., 2010a), was not identified in the IgA-reactive L3 
antigens identified in this current study.  One of the reasons potentially behind this is 
that the L3 somatic extract used this study was prepared from free-living larvae, and the 
larvae had not been exposed to the host environment.  In contrast, in the previous study, 
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Tci-ASP-1 was identified in larvae which had already established in the host and had 
been exposed to the host environment, as it was identified in ES products of L4 collected 
at 5 dpi.  This indicates that there could be a mechanism, following ingestion, which 
triggers rapid synthesis and release of ASPs following infection, and is supported by 
studies with Ac-ASP-1 where the majority of the protein is released in the 4 h following 
stimulation with a low molecular weight ultrafiltrate of host serum and methylated 
glutathione analogues (Hawdon et al., 1996).   
The work here identified for the first time other members of the SCP/TAPS 
protein family, cysteine-rich secretory VAL proteins; these are closely related to ASPs 
(Mitreva et al., 2005).  Homologues of VAL proteins have been identified in the ES 
products of Heligmosomoides polygyrus adults (Hewitson et al., 2011) and Brugia 
malayi microfilaria and adults (Bennuru et al., 2009; Hewitson et al., 2008).  In B. 
malayi, VAL-1 is a target of the immune response with antigen-specific IgG3 and IgG4 
antibodies present in 95% of microfilaraemic patients with circulating parasites tested 
from a panel of human filariasis sera (Murray et al., 2001).  Vaccination with 
recombinant VAL-1 in jirds indicated there was a protective response as there was a 
64% decrease in the number of parasites recovered post-challenge in immunised jirds 
compared to the control group (Murray et al., 2001). 
Immunoreactivity of structural and muscle-derived proteins, including 
paramyosin, myosin and calponin, during natural exposure to pathogens has been 
observed previously in other proteomic studies on other helminth species (Bennuru et 
al., 2009; Curwen et al., 2004; Kiel et al., 2007, Murphy et al., 2010).  Paramyosin is an 
α-helical coiled protein and is a component of thick muscular filaments of invertebrate 
species (Epstein et al., 1985).  The first report of its immunoreactivity was in mice 
immunised with Schistosoma mansoni adult extracts (Lanar et al., 1986) and paramyosin 
was localised to the tegument muscle layers of adult S. mansoni.  Paramyosin is now a 
lead vaccine candidate against a range of parasites including Brugia malayi (Li et al., 
1999; 2004), Taenia solium (Vazquez-Talavera et al., 2001), Trichinella spiralis (Wei et 
al., 2011; Yang et al., 2010) and Schistosoma japonicum (McManus et al., 2001).  
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Studies in B. malayi have used a DNA vaccine encoding paramyosin to assess its 
potential as a vaccine candidate in mice (Li et al., 1999) and jirds (Li et al., 2004).  
Vaccination with plasmid DNA induced strong humoral responses, both IgG1 and IgG2a 
responses (Li et al., 1999; 2004), but was not protective against challenge infection and 
induced lower levels of antibody responses compared to vaccination with the native and 
recombinant versions of the protein (Li et al., 1993; 1999).  Vaccination against T. 
solium with a recombinant full-length version of paramyosin was protective against 
challenge infection, with a 52% reduction in the parasite burden of vaccinated mice 
compared to unvaccinated controls (Vazquez-Talavera et al., 2001).  This initial study 
into paramyosin led to further studies into identification of T-cell epitopes with an aim 
to develop a vaccine (Lopez-Moreno et al., 2003).  However this research has not to date 
translated into vaccine development. 
In T. spiralis vaccine studies, recombinant paramyosin induced significantly 
higher antigen-specific serum IgG titres in immunised mice compared to unvaccinated 
control mice and was protective against a challenge infection, with a 37% reduction in 
worm burdens in vaccinated mice compared to the unvaccinated controls (Yang et al., 
2010).  Recently, attempts were made to identify the epitope on paramyosin which is 
essential for antibody binding (Wei et al., 2011).  Also, paramyosin expression in both 
larval and adult T. spiralis was targeted by RNA interference and resulted in a reduction 
in viability of the parasites (Chen et al., 2012).  Collectively, the studies into the 
suitability of paramyosin as a protective antigen against a range of parasites strongly 
suggest that it is a possible vaccine candidate against T. circumcincta L3.    
 Recently paramyosin has also been identified in parasitic helminths, including T. 
colubriformis (Kiel et al., 2007), T. circumcincta (Murphy et al., 2010) and D. viviparus 
(Strube et al., 2009).  Using a 2-dimensional PAGE gel probed with serum from sheep 
with a high immunological responsiveness to T. Colubriformis, it was shown to be 
highly immunoreactive with serum IgG (Kiel et al., 2007).  Murphy et al. (2010) 
identified paramyosin in a T. circumcincta L3 somatic extract using a proteomic analysis 
of a 2-dimensional PAGE gel.  Immunoblotting of the 2-dimensional gel with serum 
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from lambs naturally infected with T. circumcincta revealed that serum IgE recognised 
the antigen (Murphy et al., 2010).  However, none of the studies detailed above 
conducted any protection experiments to investigate the potential of paramyosin to 
protect against parasite infection.  In this thesis, paramyosin was detected in the 
immuno-purified fraction and, as it was purified through affinity for IgA, this further 
supports its role as a target of the ovine immune system during infection with T. 
circumcincta.  Paramyosin from a range of parasitic nematode species is bound by 
various antibody isotypes: IgG (Loukas et al., 2001; Strube et al., 2009), IgE (Murphy et 
al., 2010) and IgA (Hernandez et al., 1999; Nara et al., 2007).  As paramyosin is bound 
by different antibody isotypes, this could be a result of repeated regions of hydrophobic 
and charged amino acids conferring strong binding affinity for different isotypes (Gobert 
and McManus, 2005).  Here, we identified paramyosin in a subset of IgA-reactive 
antigens from T. circumcincta L3.  
A homologue of a fatty-acid/retinol binding protein (FAR) was also for the first 
time found to be present in the IgA-affinity-purified T. circumcincta L3 extract (Table 
3.3).  FARs are a nematode-specific class of molecules that have selective binding 
affinity for lipids and have been described from Onchocerca volvulus (Kennedy et al., 
1997), B. malayi (Garofalo et al., 2002), H. polygrus (Hewitson et al., 2011), N. 
americanus (Daub et al., 2000) and A. caninum (Basavaraju et al., 2003).  Fatty acids 
and retinol (vitamin A) are essential for parasite development (Kennedy et al., 1997; 
Wolff and Scott, 1995); however, as parasites do not possess pathways for synthesis of 
these molecules (Behm, 2002), they must be able to acquire them from the host.  The 
function of FARs in nematodes is not yet clear but they have been proposed to play a 
role in host-parasite interactions.  The potential role could involve scavenging retinol 
produced by the host, which in turn may promote or favour parasite survival in the 
abomasum as this depletion of retinol can then impair the level of efficacy of the host’s 
Th2 immune response (Basavaraju et al., 2003).  Retinol is thought to have a key role in 
the hosts’ immune response in the local environment infected by the parasite as it has 
been shown to be involved in the repair of gut tissue damage (Bulger and Helton, 1998) 
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and in the prevention of the decline of secretory IgA in the small intestine of mice 
(Nikawa et al., 1999).  So, therefore, a mechanism by which the parasite can bind retinol 
may be an immune evasion strategy as it reduces the level of protective IgA in the 
mucosa.  Two types of FAR were identified in A. caninum through immunoscreening of 
a cDNA library with antibodies against A. caninum adult ES products (Basavaraju et al., 
2003).  However, despite mRNA encoding these molecules being present in L3 A. 
caninum, there were no detectable corresponding proteins expressed in L3 stages, in 
contrast to the results from T. circumcincta L3 here.  In O. ostertagi a FAR homologue 
was only detected, by immunoscreening, in the ES released from L4 and adult but not L3 
stages (Vercauteren et al., 2003).  The immunoaffinity screening approach used in this 
thesis may have enriched the FAR to such an extent that it was detectable in L3 stages 
whereas previous studies may have been insufficiently sensitive to detect the protein.   
Two antioxidants were identified in the IgA-affinity-purified T. circumcincta L3 
extract; extracellular superoxide dismutase and glutathione-S-transferase.  Antioxidants 
scavenge free radicals produced during oxidative stress and, in turn, could have a key 
role in parasite survival.  Proteomic analysis of ES products from adult H. contortus 
identified both extracellular superoxide dismutase and glutathione-S-transferase; 
however, these molecules were not found to be immunoreactive with sera from 
hyperimmune sheep (Yatsuda et al., 2003).  The antioxidant activity of superoxide 
dismutase has been noted as higher in L3 than in adult stages of a number of 
gastrointestinal parasitic nematode species, including T. circumcincta (Hadas and 
Stankiewicz, 1998; Knox and Jones, 1992).  As these were pre-parasitic stages this 
suggests that the antioxidant capacity of superoxide dismutase is required during 
interactions with the host, to counteract the oxidative stress associated with the mucosal 
inflammatory response during parasite invasion and to allow development through its 
life cycle stages (Knox and Jones, 1992).  High levels of superoxide dismutase activity 
were seen in soluble antigen extracts of both D. viviparus L3 and adults, as well as adult 
ES products (Britton, Knox and Kennedy, 1994).  Incubation of these extracts with 
serum IgG (purified from calves either naturally infected with the parasite through a 
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field challenge or from calves vaccinated with 20,000 irradiated L3) showed that 
superoxide dismutase activity was inhibited by the antibodies (Britton, Knox and 
Kennedy, 1994).  The identification of superoxide dismutase in the IgA-immunoaffinity 
purified T. circumcincta L3 fraction supports its possible roles in establishment in the 
host.  Immunoreactivity of helminth glutathione-S-transferases has been shown, using a 
2-dimensional gel electrophoresis and western blotting approach, in which extracts of 
both adult F. hepatica and S. mansoni were probed for serum IgG reactivity using a pool 
of serum samples which were seropositive for schistosomiasis and fascioliasis (Boukil et 
al., 2011).  Here, the proteomic identification of glutathione-S-transferase and 
superoxide dismutase in the IgA-reactive T. circumcincta L3 antigens suggests that these 
antigens are targets of the immune response  and could confer protection against 
infection in a novel vaccine directed towards incoming L3. 
The theory behind the immunoaffinity purification process used in this Chapter 
was to allow identification of IgA reactive antigens under native conditions.  Following 
periodate treatment of the IgA-immunoaffinity purified T. circumcincta L3 extract (see 
Figure 3.8) the reactivity of the antigenic bands at approximately 60 kDa was depleted, 
suggesting that these molecules may contain carbohydrate domains.  The protein 
identified in the IgA-immunoaffinity purified T. circumcincta L3 extract with the highest 
MOWSE score was the glycoprotein thrombospondin.  This is a component of the lead 
vaccine candidate complex from H. contortus, H-gal-GP from adult worms, but its 
transcript was not detected in sheathed or exsheathed H. contortus L3 stages (Skuce et 
al., 2001).  Thrombospondin contains numerous potential glycosylation sites; evidence 
shows that the backbone of a thrombospondin-like immunodominant antigen from D. 
viviparus is attached to N-linked glycans and is highly immunogenic (Kooyman et al., 
2009).    
Galectins are a lectin family with high affinity for β-galactosides and have been 
identified in a number of helminth parasites; H. contortus (Greenhalgh et al., 2000; 
Newlands et al., 1999), O. volvulus (Klion et al., 1994), T. circumcincta (Greenhalgh et 
al., 1999) and T. colubriformis (Greenhalgh et al., 1999).  The identification of a 
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galectin in extracts of T. circumcincta L3 is consistent with findings reported by Newton 
et al. (1997).  In immunoproteomic studies of T. colubriformis, two galectin homologues 
were identified in L3 extracts and these were reactive against serum IgG from sheep with 
high immunological responsiveness to T. colubriformis (Kiel et al., 2007).  The 
developmental regulation of three galectins in the parasitic nematode, H. contortus, 
indicated differences in the levels of expression across all life cycle stages (Greenhalgh 
et al., 2000).  Differences in the patterns of galectin expression in H. contortus L3 were 
evident; galectin-1 and galectin-4 showed increased expression in sheathed L3 compared 
to the other stages (Greenhalgh et al., 2000).  L3 used to prepare the somatic extract used 
in the immunoaffinity purification in the current study were also sheathed.  The roles of 
galectins in parasitic nematodes are not fully understood, but there are suggestions that 
they modulate the host’s immune response through mimicking host galectins to allow 
the parasite to evade the immune response (Vasta, 2009; Young and Meeusen, 2004).    
Transthyretin-like proteins (TTLs) were also identified in the IgA-affinity-
purified T. circumcincta L3 extract.  TTLs have an affinity for small hydrophobic 
ligands, and have been identified in ES products from adult extracts of B. malayi 
(Hewitson et al., 2008), H. polygyrus (Hewitson et al., 2011), H. contortus (Cantacessi 
et al., 2011; Yatsuda et al., 2003) and O. ostertagi (Saverwyns et al., 2008).  They were 
identified as highly immunoreactive against serum IgG obtained from sheep rendered 
hyperimmune to H. contortus infection by an experimental infection model (Yatsuda et 
al., 2003).  A recombinant TTL was used in a vaccination trial in dogs against A. 
caninum and significant negative correlations were found between antigen-specific 
serum IgE levels and worm burdens (Hotez et al., 2003).  It is suggested that TTLs could 
bind the hosts’ version of retinoic acid (Hewitson et al., 2008; 2009).  As retinoids (for 
example vitamin A) have been implicated in the co-induction of regulatory T-cells 
alongside transforming growth factor (TGF-β) (Mucida et al., 2007), the TTLs could 
enhance the sequestration of vitamin A by the parasite and allow the parasite to evade 
the host’s immune response.   
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An immunophilin, peptidyl-pro-cis-trans isomerase, was also identified in the T. 
circumcincta L3 extract.  Homologues have been previously identified in B. malayi ES 
products from moulting L3 (Bennuru et al., 2009) and B. malayi adult extracts (Hewitson 
et al., 2008). This protein is involved in protein folding and cuticle synthesis (Fischer 
and Aumuller, 2003).  Phosphatidylethanolamine binding protein is potentially involved 
in the cuticle moulting step, as its expression was upregulated in moulting L3 of B. 
malayi (Bennuru et al., 2009).  The glycolytic enzyme identified here in IgA-
immunoaffinity purified T. circumcincta L3 extract, fructose bisphosphate-1,6-aldolase, 
has previously been found in O. volvulus L3 (McCarthy et al., 2002) and extracts of 
adult S. mansoni (El-Dabaa et al., 1998).  Immunolocalisation experiments revealed that 
antibodies generated against the enzyme bound to the region where the cuticle separates 
during the moulting process in O. volvulus (McCarthy et al., 2002), and highlights the 
potential for this as a novel vaccine candidate directed at incoming T. circumcincta L3. 
Although 353 proteins were identified from the proteomic analysis of the IgA-
affinity-purified T. circumcincta L3 extract, there were a considerable number of 
peptides which were not assigned identities or proteins with unknown functions.  The 
genome sequencing project for T. circumcincta is not yet complete (as of September 
2012;http://www.sanger.ac.uk/resources/downloads/helminths/teladorsagiacircumcincta.
html) and it is likely that sequence coverage of the selected proteins will be improved on 
completion of the genome initiative.   
Antibodies generated against the L3 stage of T. circumcincta are thought to be 
associated with the protective immune response against challenge (Stear et al., 1995), 
with reports of reductions in worm length in the trickle-infected/bolus-challenged group 
compared to the group infected with a single bolus challenge (Halliday et al., 2007; 
Sutherland et al., 1999).   The potential role of IgA-affinity-purified T. circumcincta L3 
extract in protection against infection with T. circumcincta was assessed here by 
comparing antigen-specific IgA responses present in efferent gastric lymph from 
individual sheep with the following parameters; total T. circumcincta burden, total 
number of inhibited L4, total IgA concentration in efferent gastric lymph and the local 
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specific lymphoblast response (Halliday et al., 2007).  This investigation revealed that 
antigen-specific IgA levels were significantly higher in gastric lymph from sheep 
rendered experimentally immune via a trickle infection/bolus challenge compared to 
those infected with a single bolus challenge or helminth-naive sheep.  This was also 
reflected in the IgA levels of these samples, directed against L4 antigens (Halliday et al., 
2007).  The efferent gastric lymph samples used here were from 7 dpc.  This time-point 
corresponded to the peak of total IgA concentration measured in these efferent gastric 
lymph samples (Halliday et al., 2007).  A strong positive correlation between the total 
IgA concentration in gastric lymph at 7 dpc and binding of IgA to the purified L3 
antigens was found here.  This strongly suggests that the antigens present in the IgA-
reactive L3 fraction could be ideal candidates for the development of a vaccine targeted 
towards incoming L3 into the abomausm.  The correlation between the level of IgA 
binding to the antigens and nematode burden also suggests that they could be protective 
against infection.   
Both L3 and L4 somatic antigen-specific IgA levels in abomasal mucosa have 
been found to have an inverse relationship with the length of T. circumcincta L4 
recovered from the abomasum (Stear et al., 1995; 1999; 2004; Strain and Stear, 1999).  
In the study from which the gastric lymph samples used in this Chapter were obtained 
(Halliday et al., 2007), the authors concluded that the peak in IgA concentration in the 
lymph occurred too late to be associated with the parasite loss and arrested development 
that was seen by 5 dpc.  Here, we report a strong positive association between IgA levels 
against affinity-purified T. circumcincta L3 extract and the percentage of inhibited L4 
found post mortem in the gastric lymph samples used in that study (Halliday et al., 
2007).  This is consistent with findings from an experimental infection study, where a 
positive correlation was found between levels of anti-T. circumcincta L3 circulating 
serum IgA and an increase in the frequency of inhibited L4 (Beraldi et al., 2008). In 
addition, the levels of circulating serum IgA generated against T. circumcincta L3 whole 
worm extracts were correlated with a reduction in total adult worms at necropsy (Beraldi 
et al., 2008).  Results from Chapter 2 indicated an anamnestic IgA response in efferent 
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gastric lymph from sheep subjected to a trickle infection/bolus challenge model, which 
was directed against L3 somatic antigens, with a peak in antigen-specific IgA levels 
between 4-7 dpc.  Taken together, these findings suggest that local IgA directed against 
L3 antigens could be implicated in control of T. circumcincta in addition to the 
immediate hypersensitivity response proposed to mediate exclusion/expulsion of L3 
from the abomasum (Seaton et al., 1989; Smith et al., 1984).  
The large number of proteins identified here highlights the complexity of the B-
cell response against complex metazoan parasites and raises the possibility that immune 
responses directed against multiple antigens may be the most successful approach to 
vaccination.  Further work will be necessary to distil any protective antigens from the 
suite of L3 immunogenic antigens identified here.  Here, the antigens were identified 
under native affinity purification conditions to retain post-translational modifications.  
Previous studies in O. ostertagi have reported difficulties in stimulating the same levels 
of protective immunity with the recombinant version compared to the native version of 
the protein (Geldhof et al., 2008; Meyvis et al., 2008), and have linked this failure to the 
expression systems used to generate the protein.  If any of the antigens identified here 
are to be expressed in recombinant form, the C. elegans expression system might be the 
most appropriate to produce recombinant proteins with appropriate postr-translation 
modifications; for example, glycosylation (Murray et al., 2007).  Here, we have 
identified a number of IgA-reactive L3 antigens from a T. circumcincta L3 somatic 
extract.  The relative immunoreactivity of antigens in the purified L3 fraction was 
investigated by comparing antigen-specific IgA responses in sheep with varying levels 
of immunity to known parameters of the immune response and revealed that these 
antigens could be implicated in the generation of a protective immune response 
mediated by abomasal mucus IgA and directed at regulation of total nematode burden, 
either through inhibition of development or prevention of establishment. 
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Chapter 4 : Structural epitopes of Teladorsagia circumcincta L3    
somatic antigens 
4.1 Introduction 
A favoured approach in the development of vaccines against gastrointestinal parasitic 
nematodes has been the production of recombinant sub-unit protein-based vaccines 
(Emery et al., 1993; Geldhof et al., 2008; Munn, 1997).  Recombinant sub-unit vaccine 
candidate molecules represent native antigens that have been selected on the basis of 
either presumed functional importance to parasite survival (for example, enzymes for 
digestion), or on the basis of immunogenic properties, including the induction of host 
protective immune responses against parasite challenge (Emery et al., 1993).  However, 
despite years of research into the development of recombinant subunit vaccines against 
gastrointestinal parasites, there have been few successes (Geldhof et al., 2008; Knox, 
2000).  Formation of the correct structural epitopes in vaccine candidate molecules has 
been demonstrated to be crucial (Munn et al., 1997; Smith and Smith, 1996; Smith et al., 
2000).  The main hurdle restricting development of recombinant vaccines is thought to 
be the expression systems used for antigen production (as reviewed in Geldhof et al., 
2007).  These can lead to inadequate or inappropriate post-translational modifications 
(PTMs) (for example, tertiary protein folding) and consequently can result in the 
incorrect presentation of structural epitopes required for antibody binding (Geldhof et 
al., 2007).  Inappropriate or absent protein glycosylation represents a further important 
and potentially limiting PTM of recombinant proteins.  Novel glycosylation profiles 
have been identified in one of the lead vaccine candidates against the abomasal parasite, 
Haemonchus contortus (Haslam et al., 1996).  The glycoprotein vaccine candidate, H11, 
was isolated from the intestinal brush border of adult parasites and was found to have 
unusual highly fucosylated N-linked glycans – a profile which has not been described in 
any other eukaryotic system (Haslam et al., 1996).  The bacterial expression systems 
currently used for the production of many recombinant proteins do not facilitate 
glycosylation of proteins and insect and yeast systems are not able to introduce post-
translational modification of the glycans appropriately (Knox and Redmond, 2006; 
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Nyame et al., 2004).  Vaccination trials with H. contortus compared the protective 
capacity of both native and bacterial-expressed recombinant forms of cysteine proteases 
(Redmond and Knox, 2004; 2006), which had been previously targeted by thiol 
sepharose affinity chromatography of H. contortus adult extracts (Knox et al., 1995; 
Knox, Smith and Smith, 1999).   Sheep immunized with native cysteine proteases had 
reductions in faecal egg output and worm burdens of 48% and 46%, respectively, 
compared to unvaccinated controls (Redmond and Knox, 2004).  In contrast, the 
bacterial-expressed versions gave 38% and 27% reductions in worm burden and faecal 
egg output, respectively (Redmond and Knox, 2004; 2006).  The suggested reason 
behind the failure of the recombinant to reproduce the same level of protection as the 
native antigen, was that some of the recombinant proteins expressed by bacterial systems 
are insoluble and/or lack appropriate glycosylation.  Furthermore, re-solubilisation of the 
antigen can result in problems with incorrect epitope structures.  Yeast and eukaryotic 
expression systems may have the capability to glycosylate the recombinant protein but 
these can differ from the parasite glycans.  A prime example of this is from a vaccination 
trial against Fasciola hepatica.  Two different recombinant systems were used to 
produce versions of a cathepsin L protease, the yeast-expressed version was found to be 
hyperglycosylated, potentially masking epitopes, whereas the bacuolvirus-produced 
version was glycosylated and gave a reduction of 52% in fluke burden (Reszka et al., 
2005).    
An alternative, emerging approach is the production of synthetic peptide vaccines 
based on relevant immunogenic epitopes of protective antigens (Arnon et al., 1991; 
2000).  Synthetic peptide vaccines can be used to prime the host immune response in the 
appropriate direction, for example, cellular or humoral response, depending on the 
selection of specific T-cell and B-cell epitopes (Arnon et al., 2000).  Often, synthetic 
peptide vaccines are based on epitope mapping of larger immunogenic antigens, to 
generate small linear amino acid sequences to induce a protective immune response 
(Arnon et al., 1991; 1996).  However, as discussed in Chapter 3, discontinuous or 
structural epitopes have an important role in protective immunity against nematodes.  
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The identification and synthesis of peptides representing discontinuous epitopes is not 
straightforward due to the principle that structural epitopes are formed by amino acid 
residues on separate areas of the antigen which, when brought into close proximity 
during tertiary protein folding, form a three-dimensional epitope (Goldsby et al., 2003).  
One approach used in an attempt to identify the structure of discontinuous epitopes 
involves panning of combinatorial random peptide phage display libraries (Coley et al., 
2001; Fu et al., 1997; Gazarian et al., 2003; Theisen et al., 2000).  Peptide sequences 
identified from such libraries do not necessarily share sequence homology with the 
primary amino acid sequence of the original antigens; however, they may contain 
structures that mimic those of structural native epitopes (Arnon, 2000; Smith and Scott, 
1993).  Phage display could therefore provide a useful tool to identify peptide sequences 
that mimic the structure of antigenic epitopes, allowing the production of a novel 
vaccine that can be produced cheaply in sufficient quantities for commercial exploitation 
(Devlin et al., 1990; Sidhu and Koide, 2007).    
Phage display libraries contain filamentous bacteriophage, which are viruses that 
use bacteria as replication vectors; these have been manipulated through cloning of 
specific DNA sequences into the DNA- or RNA-based genomes (Parmley and Smith, 
1988).  The inserted DNA sequence is incorporated into a gene encoding one of the 
bacteriophage minor coat proteins, and the peptide sequence encoding the inserted DNA 
sequence is therefore displayed on the surface of the bacteriophage (Gao et al., 2010).  
Phage display libraries of random peptides are available commercially to study protein 
interactions, for example antibody-antigen, and are available with different lengths of 
displayed peptide sequences, for example 7-mer or 12-mer peptides.  The ‘biopanning’ 
procedure illustrated in Figure 4.1 involves the co-incubation of an immobilised 
antibody ‘target’ with the phage display library.  Following several rounds of 
biopanning, peptides that bind to the antibody with the highest affinity and specificity 
are identified by sequencing the DNA inserts of the selected clones (Jefferies, 1998).  
This provides a link between the phenotype of the peptide sequence with the genotype of 
the inserted DNA sequence. 
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Figure 4.1 Schematic illustration of process of biopanning an antibody target against a random 
peptide phage display library. 
 
In parasite vaccine development, examples of the use of phage display libraries include 
schistosomiasis (Adda et al., 1999; Wu et al., 2006), Trichinella spiralis (Gu et al., 
2008) and Fasciola hepatica (Villa-Mancera et al., 2008).  One of the studies into 
vaccine production against T. spiralis involved biopanning of a 12-mer phage display 
library with a monoclonal antibody specifically raised in mice against a 38 kDa antigen 
found in adult ES products (Gu et al., 2008).  Four phage clones selected through 
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panning were used in immunisation trials in pathogen-free mice (Gu et al., 2008).  The 
mice were immunised with individual phage clones or a combination of clones and two 
of the clones induced antibodies which cross-reacted with a recombinant version of the 
38 kDa antigen.  Immunisation of mice with these two phage clones, followed by an oral 
challenge with 400 T. spiralis larvae 2 weeks after the final immunisation, induced a 
reduction of 29% in worm burden compared to unvaccinated animals (Gu et al., 2008).  
Research into the use of phage display libraries in the production of a vaccine against F. 
hepatica used polyclonal antibodies raised in sheep that had previously been immunised 
with a lead vaccine candidate, cathepsin-L-like cysteine protease (Villa-Mancera et al., 
2008).  Seven 12-mer phage clones derived from panning these libraries with these sera 
were administered as a multivalent vaccine to yearling sheep, which were then 
challenged with F. hepatica metacercariae. The results showed higher ES-specific serum 
IgG levels and 34% reduction in fluke burdens in vaccinated animals compared to 
unvaccinated controls (Villa-Mancera et al., 2008).   
In this Chapter, the aim was to use phage display libraries to identify peptide 
sequences that mimic structural epitopes of Teladorsagia circumcincta L3 antigens.  To 
achieve this, abomasal mucus from sheep, which had previously been exposed to the 
parasite, was enriched for IgA antibodies that bound T. circumcincta L3 somatic 
antigens. This was achieved via a two-step immunoaffinity process.  The purified 
antibodies were then incubated with a 7-mer random peptide phage display library to 
enrich the phage pool for clones with high affinity and specificity for the ovine IgA 
target.  The relative immuno-reactivity of the selected peptide sequences from the phage 
clones was then assessed by examining antibody reactivity to them using samples from 
sheep that had acquired immunity to T. circumcincta infection through an experimental 
infection programme.   
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4.2 Materials and methods 
4.2.1 Affinity purification of ovine abomasal antibodies against T. circumcincta 
L3 somatic antigens 
An affinity purification procedure was conducted to purify ovine abomasal mucosal 
antibodies that bound T. circumcincta L3 somatic antigens.  Approximately 450µg of T. 
circumcincta L3 somatic extract were separated on an SDS-PAGE 4-12% NuPAGE  
Bis-Tris Mini gel and transferred to a PVDF membrane (Immobilon, Millipore) as 
described in section 2.2.7.  The membrane was then incubated for 2 h at room 
temperature in blocking buffer (TNTT , pH 7.4) to block non-specific binding of 
proteins before washing (x3) in fresh TNTT, 10 min per wash.  After washing, the 
membrane was incubated with a 10 ml pool of abomasal mucus from “Previously 
infected/challenged” sheep (they had been trickle-infected with 2,000 L3 three times per 
week for 8 weeks, then subjected to a bolus challenge of 50,000 L3; termed ‘M-PI”, see 
Table 4.1 for further details) diluted 1:5 in TNTT (Appendix 1) and incubated overnight 
at 4°C.  The membrane was re-washed (x3) in TNTT.  To elute bound antibodies, the 
membrane was incubated with 10 ml of elution buffer (5 mM glycine, 0.5M NaCl, pH 
2.5) for 5 min.  The eluate was removed from the membrane, neutralised immediately 
with 500 µl of 1M Tris (pH 8.5) and stored at -20°C.  Ovine antibody probes used in this 
Chapter were the same as described in sections 2.2.1.1 and 2.2.1.2.  The abomasal 
mucus and efferent gastric lymph probes and the associated infection status of the sheep 
used to generate the antibody probes are detailed in Table 4.1. 
Sample  Infection status Abbreviation 
Abomasal mucus Trickle infection/challenge 
Primary infection (challenge only) 
M-PI 
M-CO 
Efferent gastric lymph Trickle infection/challenge 





Table 4.1  Summary and abbreviations for samples used in immunoreactivity investigations 
Key: M = Abomasal mucus; GL = Efferent gastric lymph; PI = Previously infected by a trickle 
infection/challenge; CO = Primary infection with a single bolus challenge; N = Helminth-free naive sheep 
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The antibody-containing fraction eluted from the L3 immunoblot was concentrated to 1 
ml at 4°C using an Amicon centrifugal device Ultra-15 with a 10 kDa molecular weight 
cut-off (MWCO) membrane.  The protein concentration of the eluate was determined 
using a BCA protein assay kit (Pierce, Thermo Scientific Ltd; section 2.2.4).  To purify 
antibodies which bound glycans on T. circumcincta L3 antigens, this eluted fraction was 
then incubated with a periodate-treated immunoblot of T. circumcincta L3 somatic 
extract (sections 2.2.7 and 2.2.7.1).  The unbound fractions in this step are likely to 
contain antibodies which would normally bind glycans, as the structures of their 
corresponding antigenic epitopes will have been distorted by sodium periodate 
treatment, preventing binding (Figure 4.2).   
 
Figure 4.2 Schematic illustration of process for purification of abomasal mucus antibodies 
against glycans on T. circumcincta L3 somatic antigens. 
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The unbound fraction was collected.  IgA reactivity of antibodies in this unbound 
fraction to glycans present on T. circumcincta L3 somatic antigens was confirmed by 
immunoblotting of T. circumcincta L3 somatic extract, using anti-ovine IgA conjugate as 
a secondary antibody (section 2.2.7). 
 
4.2.2 Biopanning of purified abomasal mucosal antibodies against a 7-mer 
phage display library 
Abomasal mucosal antibodies purified against glycans on T. circumcincta L3 somatic 
antigens were used for screening commercially available heptapeptide (PhD-7™) M13 
pIII libraries (New England Biolabs Inc, USA).  The phage display kit was used 
according to the manufacturer’s instructions.  Briefly, purified abomasal mucus 
antibodies (see section 4.2.1) were diluted in coating buffer (0.1M Na2CO3, NaHCO3; 
pH 9.6) to 10µg/ml, and used to coat a 90 mm Petri dish overnight at 4°C.  The dish was 
washed six times with TBST [50mM Tris-HCl (pH 7.5), 150mM sodium chloride, 0.1% 
(v/v) Tween-20].  Following washing, plates were incubated with a blocking buffer 
[0.1M sodium carbonate, 5 mg/ml bovine-serum albumin (BSA), pH 8.6] for 2 h at 4°C 
to prevent non-specific binding.  Plates were incubated with a 1:100 dilution (in TBST) 
of the 1 x 10
11
 phage library for 1 h at room temperature.  Unbound phage were removed 
by washing with TBST; high-affinity bound phage were eluted with 1 ml of the elution 
buffer (0.2M glycine-HCl, 1mg/ml BSA, pH 2.2) and neutralised with 150 µl/ml of 1M 
Tris-HCl (pH 9.1).  This eluted phage was amplified, as described below, prior to use as 
the input phage for the subsequent rounds of panning with three complete rounds of 
panning conducted in total.   
 
4.2.2.1 Amplification and titration of phage clones selected through biopanning with 
purified abomasal mucosal antibodies 





 rounds of biopanning against purified antibodies.  Phage eluted from the 
biopanning round were added to a 20 ml K12 ER2738 Luria-Bertani (LB) broth 
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(Appendix 1) culture in early log-phase of growth and were incubated for 4.5 h at 37°C 
with shaking at 200 rpm.  The culture was centrifuged for 10 min at 12000 g at 4°C to 
pellet E. coli cells.  The supernatant was transferred to a 50 ml tube, and 1/6
th
 of the 
volume of 20% polyethylene glycol-8000 (PEG-8000)/2.5M NaCl added to aid 
precipitation of phage from cell supernatants.  Phage were precipitated overnight at 4°C.  
The PEG/phage precipitation was centrifuged at 12000 g for 15 min at 4°C and the 
supernatant discarded.  Phage formed a white fingerprint-sized smear on the side of the 
tube and were resuspended in 1 ml of TBS.  The suspension was transferred to a 1.5 ml 
tube and centrifuged at 9000 g for 5 min at 4°C to pellet residual cells.  The supernatant 
was transferred to a fresh 1.5 ml tube, re-precipitated by the addition of 1/6
th
 volume of 
20% PEG-8000/2.5M NaCl and incubated on ice for 1 h.  The phage/PEG suspension 
was centrifuged again at 9000 g for 10 min at 4°C, the supernatant discarded and the 
phage pellet resuspended in 200 µl of TBS.  This was termed ‘the amplified eluate’ and 
was stored at 4°C until required for the input phage step in the subsequent panning 
round.  The ‘plaque-forming units’ (PFU) per ml of the amplified phage eluates were 
estimated through titration as follows.  For titration of unamplified panning eluates and 
amplified phage culture supernatants, 10 ml of LB broth with ER2738 were inoculated 
with a loopful of ER2738 from the LB agar/Tet (Tetracycline, 20 mg/ml) stock plate and 
then incubated at 37°C for 3.5 h with shaking at 200 rpm.  Whilst the cells were growing, 
Top Agar (see Appendix 1 for recipe) was melted and 3 ml dispensed into sterile culture 
tubes, one per phage dilution and kept at 45°C until required.  One LB/IPTG (isopropyl-
β-D-thiogalactoside; Promega)/X-gal(5-Bromo-4-chloro-3-indolyl-β-D-galactoside; 
Promega) plate per dilution (see Appendix 1 for recipe) was pre-warmed for 2 h at 37°C 
until required.  Phage eluates were serially diluted 10-fold in LB broth, in the following 









.  To carry out the infection of E. coli with phage, 200 µl of mid-
log phase ER2738 were dispensed into 1.5 ml tubes, 10 µl of the appropriate phage 
dilution were added, vortexed and incubated at room temperature for 5 min.  The 
infected cells were transferred, one infection at a time, to culture tubes containing 45°C 
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Top Agar, vortexed briefly and the culture immediately poured onto a pre-warmed 
LB/ITPG/Xgal plate.  The plates were allowed to cool for 5 min, inverted and incubated 
overnight at 37°C.  After 16 h, blue plaques were counted on those plates that had 
approximately 100 plaques and multiplied by the dilution factor to give the phage titre in 
plaque-forming units (pfu) per 10 µl.  The cloning vector used in the generation of the 
phage display library is derived from the common cloning vector, M13mp19, which 
contains the lacZα gene and the M13 phage plaques appear blue when plated on LB 
media containing X-gal and IPTG.  Environmental filamentous phage appeared as white 
plaques on the media and were not selected.  Phage clones selected in this way were then 
used for DNA sequencing and target specificity confirmation by phage ELISA. Fifty 
clones were selected and isolated for initial DNA sequencing.  Subsequently, 20 of the 
sequenced clones also had a phage stock prepared for the assessment of target specificity 
by ELISA.  In both cases it was necessary to re-amplify phage from individual plaques 
to obtain sufficient quantities to work with.  For this, an overnight culture of ER2738 
was diluted 1:100 in LB, then 1 ml was dispensed into sterile culture tubes, one for each 
clone to be characterised.  A sterile pipette tip was used to stab a suitably discrete blue 
plaque from the round three titration plates and transferred to a tube containing the 
diluted bacterial culture.  Transfected cultures were incubated at 37°C for 5 h, shaking at 
200 rpm.  Cultures were centrifuged at 9000 g for 1 min to pellet bacterial cells, the 
supernatant was retained and was classified as the “amplified phage stock” and was 
stored at -20°C diluted 1:1 with sterile glycerol.   
 
4.2.2.2 Biopanning with “control” antibodies from sheep abomasal mucus  
A control experiment was performed to address the potential issue of isolating phage 
clones that had been selected through non-specific interactions with antibodies or host 
proteins present in the abomasal mucus antibody preparations. Biopanning experiments 
were conducted with purified antibodies from abomasal mucus collected from sheep 
given a single infection (termed “M-CO”, see Table 4.1).  The protocol followed for 
biopanning was the same as detailed in Section 4.2.2 with the following modification:  
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in the coating steps, Petri dishes were coated with 10 µg/ml of abomasal mucus 
antibodies collected from sheep infected with a single bolus challenge infection of 
50,000 T. circumcincta L3 (termed ‘M-CO’ and detailed in section 2.2.1.1).  
 
4.2.2.3 Preparation of phage DNA sequencing templates 
For preparation of phage DNA sequencing templates, 500 µl of phage-containing 
supernatant generated as described in sections 4.2.2.1 and 4.2.2.2 were added to 200 µl 
of 20% PEG-8000/2.5M NaCl for 20 min at room temperature to precipitate phage.  The 
tubes were centrifuged at 9000 g for 10 min at 4°C and the supernatant discarded.  Phage 
pellets were resuspended in 100 µl of iodide buffer (Appendix 1).  Single-stranded 
phage DNA was then precipitated by the addition of 250 µl of 100% ethanol to the 
samples and incubation for 20 min at room temperature.  The phage DNA preparations 
were centrifuged at 9000 g for 10 min at 4°C and the supernatant discarded.  Phage DNA 
pellets were washed with 500 µl of 70% ethanol (at -20°C), re-centrifuged at 9000 g for 
10 min at 4°C and the pellet air-dried.  Phage DNA pellets were resuspended in 30 µl of 
molecular biology grade water and stored at -20°C.  Phage DNA was quantified by 
spectrophotometry (Nanodrop ND-1000 UV-Vis Spectrophotomer) and 20 µl of each 
phage clone were sent for DNA sequencing at Eurofins MWG with the 96gIII primer (5’ 
CAACAAATCGTTTTAGGGTATG 3’).   
 
4.2.3 Sequence analysis of immunoreactive heptapeptides from a phage-
display library 
Sequences were assembled and the specific locations of sections of the M13KE vector 
were located prior to isolation of the insert sequence representing the heptamer.  Briefly, 
as sequencing was on the anti-sense strand of the M13KE vector, the reverse 
complement sequence was derived from the raw data.  Specific sections of the M13KE 
vector sequence were searched for (Figure 4.3).  This was to ensure that the DNA 
sequence obtained matched that of the M13KE vector and the randomized region 
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contained a single sequenced insert.  Also, the third nucleotide of each codon within the 
heptamer in the randomized region was confirmed to be either G or T and the Gly-Gly-
Gly leader sequence located (Figure 4.3).  These sequence checks facilitated 
identification of the location of the insert sequence.  The insert sequences were 








Figure 4.3 Example of a section of the M13KE vector DNA sequence obtained through 
sequencing of  phage clones isolated by biopanning purified ovine abomasal mucosal antibodies 
against a 7-mer phage display library.   
The sequence obtained corresponds to the anti-sense strand (5’ to 3’) of the M13KE vector, and the 
following areas of the vector sequence were located prior to isolation of the randomised region: 
(i) Hybridisation site of -28gIII primer (highlighted in grey) 
(ii) Flanking region of the library insert incorporating Acc651 restriction site (highlighted in 
pink) indicates start of insert sequence 
(iii) Flanking end region of the library insert incorporating EagI restriction site (highlighted in 
green) indicates end of insert sequence 
(iv) Randomised region (highlighted in yellow) 
(v) Gly-Gly-Gly leader sequence of DNA insert (underlined in yellow region) 
 
4.2.4 Bioinformatic analysis of peptide sequences 
Peptide sequences obtained through DNA sequencing of isolated phage clones were 
analysed to assess if any of the identified sequences were classified as propagation target 
unrelated peptides (TUPs) through the depository database MimoDB version 3 
(http://www.immunet.cn/mimodb).  Propagation TUPs are phage clones that have a 
distinct growth advantage over other phage clones in the library, often due to a mutation.  
As a result they are enriched during the amplification and propagation steps following 
phage selection (Thomas, 2010; Vodnik, 2011).  To identify if any peptide sequences 
shared or matched linear peptide sequences already associated with previously identified 
parasite proteins, the peptide sequences were also BLAST (Basic Local Alignment 
Search Tool, Altschul et al., 1990) searched against the publically available databases, 
 
Chapter 4: Structural epitope mimics of T. circumcincta L3 somatic antigens               151 
National Centre for Biotechnology Information (NCBI) (http://blast.ncbi.nlm.nih.gov) 
and WormBase 2 WS234 (http//www.wormbase.org/#012-3-6).   
 
4.2.5 Assessment of specificity of phage clones for target antibodies by ELISA 
Target specificities of selected phage clones were assessed by distinguishing true target 
binding from background binding to both the plastic support and the BSA blocking 
agent.  This was achieved through comparison of the level of binding in uncoated wells 
of the 96-well plate to levels in wells coated with the target IgA (as illustrated in Figure 
4.4).  To prepare phage clones for assessment by ELISA, amplified phage stocks of 20 
clones (see section 4.2.2.1) were re-amplified to obtain sufficient quantities for the 
assays.  Briefly, overnight cultures of ER2738 in LB were diluted 1:100 in 20 ml of 
fresh LB, with one new culture for each clone to be characterized.  Phage glycerol stocks 
(5 µl each) were added to a 20 ml culture and incubated at 200 rpm, 37°C for 5 h.  The 
culture was centrifuged at 12000 g for 10 min at 4°C and the supernatant transferred to a 
50 ml tube.  To the phage containing supernatant, 1/6
th
 of the volume of 20% PEG-
800/2.5M NaCl was added and the phage were precipitated at 4°C overnight.  The PEG 
precipitations were centrifuged at 12000 g for 15 min at 4°C and the supernatant 
discarded.  The phage pellet was resuspended in 1 ml of TBS, transferred to a 1.5 ml 
tube and centrifuged at 9000 g for 5 min at 4°C to pellet residual cells.  The supernatant 
was transferred to a fresh 1.5 ml tube, re-precipitated with 1/6
th
 volume of 20% PEG-
800/2.5M NaCl and incubated for 1 h on ice.  The phage precipitation solutions were 
centrifuged at 9000 g for 10 min at 4°C and the supernatant discarded.  The amplified 
phage clone pellet was resuspended in 50 µl of TBS and stored with an equal volume of 
sterile glycerol at -20°C.  For each phage clone, three wells of a 96-well plate were 
coated with 100 µl of L3-purified antibody (section 4.2.1) at 100 µg/ml in 0.1M sodium 
carbonate, pH 8.6.  Three wells of the 96-well plate were left uncoated for each clone 
(Figure 4.4) and the plates incubated overnight at 4°C.  Excess target (antibody) solution 
was removed and the plates washed six times with TBST.  Plates were blocked for non-
specific interactions with blocking buffer [TBST + 5% (w/v) BSA] at 200µl/well for 2 h 
 
Chapter 4: Structural epitope mimics of T. circumcincta L3 somatic antigens               152 
at 4°C.  The uncoated wells were also blocked to test for binding of each selected peptide 
sequence to BSA-coated plastic.  Blocking buffer was aspirated and the plates washed 
six times with TBST.  Phage clones were diluted 1:100 from the stock (10
14 
pfu/ml) and 
100 µl of this preparation added to each well of the assay plate followed by incubation at 
room temperature for 2 h on an orbital shaker.  After six washes with TBST, an anti-
M13 mouse monoclonal HRP-conjugated antibody (GE Healthcare, #27-9421-01) was 
diluted 1:1000 in TBST and 100 µl of this added to each well, and incubated at room 
temperature for 1 h.   
 
Figure 4.4 Schematic illustration of the plate template for the ELISAs used to assess and 
compare the background binding of the phage clones under investigation to the specificity for 
the target antibodies. 
One row of the plate was used for each phage clone.  For each phage clone under investigation, three wells 
were coated with the target antibody used in the biopanning, L3-purified IgA (100µl/well) (blue wells).  
Three wells were uncoated and only received the BSA-blocking buffer (clear wells).    
 
 
After final washes in TBST, OPD (50 µl/well) was applied and the plates incubated at 
room temperature in the dark for 20 min.  The reaction was stopped by the addition of 
25 µl 2.5M H2SO4 and the absorbance measured at 490nm.  For each phage clone, the 
OD values obtained from the wells coated and uncoated with the target were compared.   
 
Coated Coated Uncoated Uncoated 
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4.2.6 Immunoblot of phage clones to detect the binding of abomasal mucosal 
IgA 
Five microlitres of the phage supernatant (as prepared in Section 4.2.2.1) of four phage 
clones (Clone 2: LPLTPLP, Clone 6: HAIYPRH, Clone 8: WPTLQWA, Clone 20: 
YGFVPSW) were pipetted onto an 8cm x 8cm square of 0.45 µm pore-size 
nitrocellulose membrane (cut into 5 strips) and left to air dry at room temperature for 2 
h.  As a positive control, 2 µg T. circumcincta L3 somatic extract (section 2.2.4) were 
also applied to the membrane.  Five microlitres of an overnight culture of ER2738 were 
also added to assess the presence of any background reactivity of ovine antibodies to the 
bacterial strain used for the propagation of phage.  Once dry, the strips were blocked 
against non-specific interactions by incubation in TNTT overnight at 4°C.  Strips were 
incubated with primary antibody (abomasal mucus from M-PI or M-HF [helminth-free], 
Table 4.1), diluted 1:5 in 5 ml of TNTT, and were incubated for 2 h at room temperature 
as follows: three strips were probed with abomasal mucus from individual M-PI sheep, 
one strip was incubated with TNTT as the “no primary antibody” control and one strip 
was incubated with a pool of abomasal mucus from M-HF sheep.  After the primary 
antibody incubations, strips were washed three times in TNTT (10 min/wash) and 
incubated in mouse monoclonal anti-ovine/bovine IgA (Serotec, MCA628) (diluted at 
1:250 in 5 ml of TNTT) for 1 h at room temperature.  Following re-washing in TNTT, 
strips were incubated in polyclonal rabbit anti-mouse immunoglobulins-HRP conjugate 
(Dako, P0260) (diluted at 1:1000 in 5 ml of TNTT) for 1 h at room temperature.  
Following the final washes, detection was carried out using DAB (3,3– 
Diaminobenzidine) and stopped after 6 min with a rinse in distilled water.   
 
4.2.7 Optimisation of ELISA to assess immunoreactivity of selected peptides 
Several ELISA methods were used to detect and quantify the level of ovine IgA in 
abomasal mucus and efferent gastric lymph from M-PI and G-PI sheep (section 2.2.1.1) 
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that bound to the selected phage clones. Due to time and material constraints only two 
clones (8 and 10) were tested in the immunoreactivity investigations.   
a) Direct phage ELISA 
Phage clones, diluted in coating buffer, were coated directly onto the surface of the 





 pfu/ml), primary antibody dilution (1:20–1:500) and conjugated secondary 
antibodies (1:250–1:4000) were investigated. Following this optimisation, the phage 
clones, at a concentration of 10
12
 pfu/ml (50µl/well) in phage coating buffer (0.1M 
NaHCO3, pH 8.6), were coated to the surface of the plates and incubated overnight at 
4°C.  Plates were then washed six times with PBST and non-specific binding blocked as 
described in Section 4.2.7 (a).  After re-washing, plates were incubated with 50 µl of 
primary antibody (the samples were the same as used in section 4.2.7 (a) and were 
diluted 1:20 in PBST) and incubated for 2 h at 37°C.  Plates were re-washed in PBST 
and the subsequent secondary antibody incubation and detection of binding performed as 
detailed in section 4.2.7 (a).  All primary antibody samples were in duplicate on each 
plate and each plate was repeated in triplicate.  The absorbance values were collated 
from the six independent readings across the three plates and presented as the mean with 
the standard deviation. 
b) Synthetic peptide ELISA: 
Two biotinylated peptides, representing the heptamer sequences of two immunoreactive 
phage clones from the library screen, (HAIYPRH = equivalent to clone 2 and 
WPTLQWA = equivalent to clone 8) were synthesized by Mimotopes Pty Ltd, UK (see 
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N-terminus          C-terminus 
Biotin-S-G-S-G-peptide sequence of interest -G-G-G-S-NH2 
 
                                                                                                                                                                   
Figure 4.5 Schematic illustration of the modifications to the design of the synthetic peptides, 
which were based on the 7-mer peptide sequences, identified through biopanning purified 
abomasal mucosal antibodies with a phage display library.   
 
The modifications in the design of the synthetic peptides were as follows: 
(i) Amidation of C-terminal carboxylate to block the negative charge of the free carboxyl group.   
During panning the C-terminus of the inserted sequence is fused to phage so does not have a 
free negatively charged carboxylate and if left unmodified it would abolish binding. 
(ii) A Ser-Gly-Gly-Gly peptide spacer inserted between the random sequence and biotin tag . 
(iii) A Gly-Gly-Gly-Ser peptide space between the C-terminus end of the random sequence and 
pIII sequence. 
 
To provide a positive control, T. circumcincta L4 ES products (prepared as described in 
Section 2.2.3) were biotinylated with a commercially available Biotin labeling kit 
(Abnova, US, KA0003), according to the manufacturer’s instructions.  T. circumcincta 
L4 ES products were used because of the limited availability of T. circumcincta L3 
somatic extract at the time the assay was conducted.  Pre-BSA blocked streptavidin-
coated clear 96-well plates (Thermo Scientific, 15500) were washed four times with 
PBST.  The stock solution of each synthetic peptide [1 mg/ml in DMSO (dimethyl 
sulphoxide; Sigma-Aldrich)] was diluted 1:1000 in PBST and 100 µl were applied into 
the corresponding well positions (in triplicate).  Plates were incubated for 1 h at room 
temperature.  Plates were re-washed in PBST before primary antibody incubations.  
Plates incubated with 100 µl of primary antibody (the samples were the same as used in 
section 4.2.7 (a) and were diluted 1:500 in PBST) and incubated for 1 h at room 
temperature.  Plates were re-washed in PBST and the subsequent secondary antibody 
incubation and detection of binding was as detailed in section 4.2.7 (a).   
 
 
Spacer for addition of biotin Spacer as present in library 
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4.2.8 Definitive phage ELISAs probed with efferent gastric lymph IgA from 
sheep with differing levels of acquired immunity to T. circumcincta 
Four phage clones (Clone 2, LPLTPLP; Clone 6, HAIYPRH; Clone 8, WPTLQWA; 
Clone 10, YGFVPSW) were investigated to quantify binding of IgA in efferent gastric 
lymph from previously infected/challenged sheep to the structures presented by the 
peptide sequences.  Further analysis was conducted to identify if binding to the peptide 
clones was related to known correlates of immunity in these animals: worm burden, 
percentage of inhibited T. circumcincta L4 and total concentration of IgA in efferent 
gastric lymph at 7 dpc. Following optimisation (section 4.2.7), the “direct phage ELISA” 
was employed: microtitre plates were coated with an individual phage clone diluted to 
10
12 
pfu/ml in coating buffer (50µl/well) overnight at 4°C. Following washes in PBST, 
primary antibody incubations were conducted at room temperature for 1 h.  The source 
of primary antibodies was individual efferent gastric lymph samples collected at a single 
time-point during the experimental infection: “G-PI” at 7 dpc, “GL-CO” at 7 dpc and 
“GL-HF” at 0 dpc (see Table 4.1).  All remaining procedures were as documented in 
Section 4.2.7 (b). 
 
4.2.9 Statistical analysis  
Data obtained from both assays investigating the level of ovine IgA binding to the two 
phage clones/peptide structures and the relationships between the level of IgA binding 
and immune parameters differed significantly from a normal distribution (Anderson 
Darling Test, p<0.05).  The median values obtained in the ELISAs investigating the 
level of ovine IgA binding to the two phage clones/peptide structures from the different 
infection groups were statistically evaluated by the non-parametric Friedman two-way 
ANOVA test.  An interactions analysis was used to analyse interactions between parasite 
challenge status, clone identity and inter-plate variability between plates.   
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This was conducted through a univariate Generalised Linear Model (GLM), with the 
following formula: 
OD ~ (Plate) + Challenge + Clone + Challenge*Clone 
 
The formula was adjusted to take into account plate-to-plate variance, represented by 
‘(Plate)’.  It also took into account the effect of two independent variables on the OD 
value obtained from the ELISA.  This was shown by ‘Challenge’ representing the 
infection status (previously infected/challenged or helminth-naïve) and ‘Clone’ which 
represented the phage clone under investigation.  The benefit of a GLM is that it also 
investigates the interactions between mutilple factors/variable and their impact upon the 
OD, this was incorporated into the formula as indicated by ‘Challenge*Clone’.   
The relationships between the levels of IgA binding to the selected peptide sequences 
and the immune parameters were summarised by non-parametric correlation analysis 
using Spearman rank correlation coefficient (SPSS version 19).  For all statistical 










Chapter 4: Structural epitope mimics of T. circumcincta L3 somatic antigens               158 
4.3 Results 
4.3.1 Affinity purification of ovine antibodies which bind glycans on T. 
circumcincta L3 somatic antigens 
Following the double immunoblot purification procedure (Figure 4.2) for purifying 
antibodies that bound structural glycans, the unbound fraction (containing the purified 
antibodies) was retained.  The fraction that did not bind the periodate-treated blot of T. 
circumcincta L3 somatic extract was examined to establish whether the antibodies 
present were able to bind to L3 somatic antigens (Figure 4.6).      
 
Figure 4.6 Immunoblot of T. circumcincta L3 somatic extract probed with purified (antibodies 
were pre-purified against T. circumcincta L3 somatic antigens) antibodies from the abomasal 
mucus obtained from previously infected/challenged sheep.    
Lanes 2 and 3: probed with abomasal antibodies purified against glycans on T. circumcincta L3 somatic 
antigens through a double immunoblot purification procedure.  Lanes 1 and 4: no primary antibody 
controls.  All lanes were incubated with the appropriate secondary and tertiary antibodies for the isotype 
under investigation (lanes 1 and 2, IgG; lanes 3 and 4, IgA) and developed with SigmaFast DAB™.  Lane 
M. represents molecular weight markers given in kDa.  The red box surrounds the area of IgA reactivity 
(50-200kDa) in abomasal mucus of previously infected/challenged sheep after purification against T. 
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Purified abomasal antibodies bound antigens present in T. circumcincta L3 somatic 
extracts (Figure 4.6).  Numerous IgA-reactive bands were detected between 50 and 200 
kDa (Figure 4.6, Lane 3).  Little IgG reactivity was observed against T. circumcincta L3 
somatic antigen extracts in this fraction (Figure 4.6, Lane 2).  This purified, IgA-
enriched antibody preparation was used for biopanning the 7-mer phage display library 
to identify peptides sequences that potentially mimic the parasite’s structural epitopes.   
 
4.3.2 Biopanning of purified IgA against a 7-mer phage display library 
To determine phage enrichment after each round of panning the heptamer phage library 
with L3 antigen- reactive IgA, the titre of the amplified phage eluted was determined and 
quantified as plaque-forming units per ml (pfu/ml).  The amplified phage eluate from the 
first and second rounds of panning increased from 1.74 x 10
8
 plaque pfu/ml to 1.56 x 
10
10




Round Input phage (pfu/ml) Amplified phage eluted (pfu/ml) 
1 1.0 x 10
11
 1.74 x 10
8
 
2 1.0 x 10
11
 1.56 x 10
10
 
3 1.0 x 10
11
 1.31 x 10
6
* 
Table 4.2 Titres of input phage and the amplified phage eluted from each round of biopanning a 
heptamer phage display library with abomasal IgA purified against T. circumcincta L3 glycans.  
* denotes unamplified eluate.  Pfu/ml = plaque-forming units per ml. 
 
Following three rounds of screening, 50 phage clones with affinity for the purified IgA 
used in the panning experiments were selected at random from agar plates (Section 
4.2.2.1), phage DNA prepared and sequenced to enable the peptide sequences of the 
insert regions to be determined (Appendix 3 provides full list of translated sequences). 
Peptide sequences that were repeated (> 2 times) are shown in Table 4.3.  Bioinformatic 
analysis of these sequences revealed that two, HAIYPRH and LPLTPLP, were classified 
as “propagation target-unrelated peptides (TUPs)” and have been identified in previous 
studies (Brammer et al., 2008; Huang et al., 2011; Ru et al., 2010; Vodnik, 2011).  
These are phage clones that have a distinct growth advantage over other clones and as a 
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result are enriched during the amplification and propagation steps following phage 
selection.  This means that while they may be specifically bound by antibody in the 
panning stage, they are likely to be over-represented at the sequencing stage.   In the 
complete dataset, seven further TUPs were identified (Appendix 3); however, they were 
not as abundant as the two detailed above.  The control experiments using abomasal 
mucus from sheep exposed to a single challenge of T. circumcincta (“M-CO”, Table 4.1) 
resulted in the selection of three clones which also bound affinity-purified M-PI 
antibodies: HAIYPRH, KLPGWSG and YSIPKSS (Table 4.3 and Appendix 3).  














AKIDART 4    1 
LPLTPLP 2 Yes Yes  2 
SAPSSKN 2    3 
FMRSPPM 2    4 
SPSMLQK 2    5 
HAIYPRH 9 Yes Yes Yes 6 
KLPGWSG 2   Yes 7 
WPTLQWA 10    8  
GSHNPHL 2    9 
YGFVPSW 3    10  
Table 4.3 Frequency of repeated peptide sequences from phage clones. 
Clones were selected through panning a 7-mer phage display library with IgA purified against glycans on 
T. circumcincta L3 somatic antigens.  * Listed on the MimoDB search facility compiled of collated data 
from phage display library panning experiments. 
 
Analysis of the proportion of different classes of amino acids in the peptide sequences 
revealed that there were high proportions of amino acid residues belonging to the 
aromatic, hydrophobic and basic groups (Figure 4.7).  
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Figure 4.7 Frequency of amino acid groups in peptide sequences identified via biopanning a 
random heptamer phage display library with T. circumcincta L3 antigen selected IgA. 
Groups of amino acids:  
Small (Glycine, Alanine); Hydrophilic (Serine, Threonine, Cysteine); Hydrophobic (Valine, Leucine, 
Isoleucine, Methionine, Proline); Aromatic (Phenylalanie, Tyrosine, Tyrptophan); Acidic (Aspartic acid, 
Glutamic acid); Amine (Asparagine, Glutamine); Basic (Histidine, Lysine, Arginine). 
Percentage frequency of amino acid groups was calculated by assessing the total number of repetitions of 
individual amino acids in the sequence dataset as a proportion of the total number of amino acids.   
 
4.3.3 Binding of phage-displayed heptamer peptides by abomasal mucosal 
antibodies 
Twenty of the phage clones selected above were evaluated for immunoreactivity by 
ELISA by comparing the level of background (i.e. binding to uncoated wells) to the 
level of binding to purified IgA coated wells (Figure 4.8).  The antigen-specific IgA 
bound all twenty phage clones.  Clones 1, 2, 4, 6, 8 and 10 demonstrated the highest 
levels of binding (Figure 4.8).  Clones 2 and 6 bound IgA in the abomasal mucus of 
previously infected/challenged M-PI sheep (Figure 4.8): both clones are TUPs and clone 
6 was also bound by IgA from sheep exposed to a single challenge.  Thus, with the 

































Amino acid group 
Frequency of amino acids in repeated clones 
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peptide binding experiments (Clone 6, Figures 4.9 and 4.12), these clones were not 
analysed further. 
 
Figure 4.8 Screening ELISA used to investigate target specificity of twenty selected phage 
clones by comparison of the level of specific binding to IgA coated plates versus uncoated 
plates.  
Arrows denote clones selected for further investigation.  Clones 1, 2, 4, 6, 8 and 10 gave the highest OD 
values in the ELISA when the mean levels of binding in IgA-coated wells (blue bars) were compared to 
the uncoated wells (red bars). 
 
4.3.4 Immunoreactivity of selected peptide sequences through dot-blots probed 
with abomasal mucus 
An immunodotblot was used to investigate if IgA in abomasal mucus from sheep 
experimentally infected with T. circumcincta L3, through a trickle infection/challenge 
regime, bound to the peptide structures displayed by the phage clones (Figure 4.9).  All 
phage clones bound mucosal IgA from previously infected/challenged sheep (termed 
“M-PI”, as described in section 2.2.1.1) (Figure 4.9, Lanes 1-3).  IgA binding was not 
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helminth-naïve sheep (Figure 4.9, Lane 4).  No binding of mucus IgA from previously 
infected/challenged or helminth-naïve sheep (Table 4.1) to the bacterial expression strain 









Figure 4.9 Immuno-dotblot of selected phage clones probed for reactivity to mucus IgA from 
previously infected sheep.   
Four phage clones (5µl) were blotted onto a nitrocellulose membrane.  T. circumcincta L3 somatic extract 
(5µg) and E. coli ER2738 (5µl) were included as positive and negative controls, respectively.  Panel A, 
schematic illustration of locations of phage clones, T. circumcincta L3 somatic extract and E. coli 
ER2738.  Panel B, membrane strips probed with samples.  Lanes 1–3: Probed with abomasal mucus from 
previously infected/challenged sheep (“M-PI”) (n=3).  Lane 4: Probed with a pooled sample of abomasal 
mucus from helminth-naive sheep (“M-HF”) (n=4 in pool).  Lane 5: No primary antibody control.  
Following primary antibody incubations, all lanes were incubated with secondary and tertiary antibodies 
for detecting IgA binding as described in section 4.2.6).     
 
ELISAs were used to quantify IgA binding. A direct ELISA with phage coated onto the 
plate for ovine antibody binding and detection was used.  Checkerboard titrations of a 
range of reagents were used to determine the optimal concentrations for the reagents in 
the assay (data summarised in Table 4.4).   
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Reagent Range Percentage 
positivity* 






Positive pool:  
59% to 7% 
Negative pool: 
18% to 8% 
Positive pool:  
0.75 to 0.09 
Negative pool: 
0.24 to 0.10 
1:500 
Efferent gastric 





98% to 46% 
Negative pool: 
17% to 11% 
Positive pool:  
1.24 to 0.59 
Negative pool: 








40% to 6.5% 
Negative pool: 
14% to 5% 
Positive pool: 
0.318 to 0.083 
Negative pool: 




Table 4.4 Summarised data from the development and optimisation of reagants and detection 
antibodies used in the method of the phage ELISA.  
 
*Positive control: T. circumcincta L3 somatic extract (5µg) probed for IgA reactivity with abomasal 
mucus from previously infected/challenged sheep (termed “M-PI”).  Positive pool: Abomasal mucus from 
previously infected/challenged sheep (termed “M-PI”) (n=4).  Negative pool: Abomasal mucus from 
primary infected sheep (termed “M-CO”) (n=4). 
 
To maximize available reageants and to minimize background reactivity the following 
working concentrations and dilutions were used: secondary HRP-conjugated antibody at 
1:500, primary antibody at 1:20 and phage dilutions at 10
12
 pfu/ml (Table 4.4). The 
optimized ELISA was used to quantify binding of clone-specific IgA in abomasal mucus 
and efferent gastric lymph samples from sheep subjected to a trickle infection.  The 
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Figure 4.10 Levels of binding of IgA from abomasal mucus to the peptide structures displayed 
by two phage clones, WPTLQWA (Clone 8) and YGFVPSW (Clone 10), which were selected 
through panning a phage display library with purified IgA from sheep trickle-
infected/challenged with T. circumcincta L3.  
 
ELISA plates were coated with the two phage clones (1012 pfu/ml) and incubated with pooled samples of 
abomasal mucus from groups of sheep.  Previously infected/challenged (“M-PI”): abomasal mucus 
collected from sheep infected with an experimental trickle infection then challenge with 50,000 T. 
circumcincta L3; the abomasa were collected 2 dpv.  Helminth-naive (“M-HF”): Abomasal mucus 
collected from sheep reared under helminth-free conditions.  No primary control: Phage clones probed 
with developing anti-IgA antibodies only.   Results are presented as the median absorbance (n=9) for each 
group (± SEM).  Three independent repetitions of the assay were conducted.  ‘**’ denotes statistical 
significance (p<0.01) following comparison of the median OD values between groups. 
 
A generalised linear model (GLM) was used to analyse differences between the groups 
and the no primary antibody control.  This was used to analyse interactions between 
parasite challenge status, clone identity and inter-plate variability between plates.   There 
was a significant level of inter-plate variability (P=0.012). As a result, the statistical 
analysis was conducted on the data adjusted for plate variance.  The level of binding of 
IgA from abomasal mucus to the two phage clones was significantly higher (P=0.007) in 
previously infected/challenged sheep (termed “M-PI”) compared to helminth naive 
sheep (termed “M-HF”) and the no primary antibody control (Figure 4.10).   
Synthetic peptide versions of two of the heptamer sequences from selected phage clones 
































No primary control ** 
** 
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Figure 4.11  Levels of binding of IgA from efferent gastric lymph to two synthetic peptides 
(HAIYPRH and WPTLQWA) with purified IgA from sheep experimentally trickle-
infected/challenged with T. circumcincta L3. 
 
Streptavidin-coated ELISA plates were coated with the biotinylated synthetic peptides at 1:1000 and 
incubated with pooled samples of efferent gastric lymph from groups.  Previously infected/challenged 
(“G-PI”): pooled efferent gastric lymph collected over 6-10 dpc from previously infected sheep following 
a bolus challenge of 50,000 T. circumcincta L3.  Helminth-naive (“G-HF”): efferent gastric lymph 
collected from helminth-naive sheep and used as a “negative control”.  No primary control: Phage probed 
with anti-IgA developing antibodies only.  The sequence of the clones matched up to the following clone 
numbers: HAIYPRH = Clone 6 and WPTLQWA = Clone 8.  The level of IgA binding was detected by 
HRP-labelled developing antibodies.  Results are presented as the mean absorbance (n=6) for each group 
of sheep (± SEM).   
 
Levels of IgA binding in efferent gastric lymph to peptide sequences in two of the phage 
clones identified by biopanning were quantified. The samples were obtained from sheep 
with varying levels of T. circumcincta infection after L3 challenge.  Relationships 
between levels of IgA binding and parasitological and immunological parameters are 
summarized in Table 4.5. 
 Nematode 
burden 


























-0.498 0.030* 0.685 0.001** 0.617 0.005** 0.286 0.493 
YGFVPSW 
(Clone 10) 
-0.674 0.002** 0.777 0.000*** 0.573 0.010* -0.238 0.570 
 
Table 4.5 Summary of output from the statistical analysis of relationships between the levels of 
gastric lymph IgA binding to phage clones 8 and 10 to both the parasitological and immune 

































No primary control 
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For both phage clones, significant negative correlations (P=0.002 to P=0.03, rs = -0.498 
and -0.674) were observed following comparison of the phage clone-specific IgA 
responses in efferent gastric lymph samples to the nematode burdens at necropsy (Figure 
4.12; Table 4.5).   
 
 
Figure 4.12 Relationship between the level of gastric lymph IgA binding to peptides displayed 
by phage clones 8 and 10 selected by biopanning and the total nematode burden of sheep 
previously infected/challenged with T. circumcincta L3.   
 
Analysis of the association was conducted using Spearman correlation coefficients.  Data points represent 
absorbance (OD) values from individual gastric lymph samples (n=19).  Absorbance values were plotted 
against the total nematode burden for each individual.  The efferent gastric lymph was collected from 
sheep which had been previously infected with T. circumcincta L3 and subjected to a bolus challenge of 
50,000 T. circumcincta L3.  The gastric lymph samples used were all from a single time-point (7 dpc).  
The worm burden of the “GL-PI” sheep was assessed by counting the number of males, females and 
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Positive correlations (P<0.001, Rs = 0.685 and 0.777) were found between the level of 
ovine IgA binding specifically to the peptide structures displayed by the phage clones 




Figure 4.13 Relationship between levels of gastric lymph IgA binding to phage clones 8 and 10 
selected by biopanning and the total gastric lymph IgA concentration at 7 dpc of sheep 
previously infected/challenged with T. circumcincta L3.   
 
Analysis of the association was conducted as above.  Data points represent the absorbance values (OD) 
from individual gastric lymph samples (n=19).  The absorbance values were plotted against the total IgA 
concentrations for the individual samples. The efferent gastric lymph was collected from sheep which had 
been previously infected with T. circumcincta L3 and were subjected to a bolus challenge of 50,000 T. 
circumcincta L3 (“GL-PI”), as in Fig. 4.13.  Total IgA concentrations were published previously in 
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Significant positive correlations (P=0.005 to P=0.01, Rs = 0.573 and 0.617) were found 
between the level of IgA binding to the peptide structures displayed by both phage clone 
8 and 10 and the percentage of inhibited L4 present in the abomasa and its contents at 
necrospy (Figure 4.14, Table 4.5). 
 
Figure 4.14 Relationship between the levels of gastric lymph IgA binding to phage clone 8 and 
10 selected by biopanning and the percentage of inhibited T. circumcincta L4 in the abomasa of 
sheep previously infected/challenged with T. circumcincta.   
Analysis of the association was as in Fig 4.13.  Data points represent the absorbance values (OD) in 
individual gastric lymph samples (n=19).  The absorbance values were plotted against the percentage of 
inhibited L4.  Efferent gastric lymph was collected from individual sheep as detailed in Fig. 4.13.   The 
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4.4 Discussion  
Random peptide phage display libraries are useful in the identification of sequences that 
can mimic epitopes; these ‘mimotopes’ do not necessarily bear primary sequence 
homology to native protein antigens but have potential in the development of novel 
peptide-based vaccines because they have potential to induce an immune response that 
mimics the immune response that would be induced by native antigens (Demangel et al., 
1996; Narum et al., 2006).  Here, we used purified IgA preparations to screen phage 
display libraries to target potential protective epitopes in somatic extracts of T. 
circumcincta L3.  A panel of phage clones was selected through high affinity for the IgA 
and analysis revealed a range of peptide sequences.  These sequences had a number of 
characteristics which indicated that the peptides were potentially mimicking 
carbohydrate structures; aromatic ring structures, hydroxyl groups, hydrophobic 
residues.  Work presented in the earlier Chapters revealed the importance of glycans on 
L3 antigens in the immune response against T. circumcincta.  Carbohydrates contain 
hydroxyl groups and carbon-sugar hydrophobic rings (for example, pentose which is a 
five-sugar ring and hexose which is a six-sugar ring), which allow the molecules to form 
hydrogen bonds with their ligands.  For a peptide sequence to mimic the characteristics 
of carbohydrates it should contain residues with hydroxyl groups, hydrophobic residues 
and aromatic amino acids (Fukuda, 2006).  The peptide sequences selected here 
contained a high proportion of aromatic amino acids and hydrophobic residues.  Due to 
the molecular size and the hydrophobic properties of the aromatic ring this suggests that 
these peptides had the capability to form hydrogen bonds and therefore could emulate 
carbohydrate structures (Oldenburg et al., 1992; Scott et al., 1992).  Previous studies 
indicated that aromatic amino acids appear with high frequency in peptide mimics of 
carbohydrates (Lang et al., 2006; Oldenburg et al., 1992).  In a study which used phage 
display screening of a linear 7-mer library with a monoclonal antibody raised against the 
cross-reactive epitope (Gal-α1,3Gal) to identify peptide mimetics,  aromatic amino acids 
occurred in selected peptides with a proportionally high frequency of 33% 
(phenylalanine, tyrosine and tryptophan) as well as residues with hydroxyl groups 
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(serine and threnonine: 36%) (Lang et al., 2006).  In the human bacterial pathogen, 
Shigella flexneri (Phalipon et al., 1997), two monoclonal antibodies specific for the O-
antigen in lipopolysaccharide of human serotype 5a were used to pan a 9-mer phage 
display library and 19 clones isolated were used in an immunisation and challenge trial 
in mice.  In immunised mice, two of the clones induced anti-O-antigen-specific 
antibodies that were cross-reactive with S. flexneri native antigens (Phalipon et al., 
1997).  Taken together these results highlight the ability of phage display libraries to 
select peptide clones that mimic highly constrained structures such as carbohydrates.    
In vaccine development studies for the protozoan Entamoeba histolytica, monoclonal 
antibodies against surface proteophosphoglycans (PPGs), were used to pan six phage 
display libraries to reveal a single consensus motif (Gly-Thr-His-Pro-X-Leu) (Marinets 
et al., 1997; Melzer et al., 2002).  Clones encoding this motif were able to induce a 
serum IgG response, specific to membrane antigens of E. histolytica trophozoites, 
following immunisation of the mice with whole phage particles (Melzer et al., 2002).  
The consensus peptide, GTHPXL, was synthesised as a peptide, conjugated to keyhole 
limpet haemocyanin (KLH) and used to immunise mice (Melzer et al., 2002).  This 
construct induced high titres of anti-peptide antibodies and antibodies specific to E. 
histolytica PPGs and was protective against a challenge infection (Melzer et al., 2002).   
Here, a panel of phage-displayed peptide sequences with a high level of binding 
to the affinity-purified IgA from T. circumcincta infected sheep was selected.  Sequence 
analysis revealed that there were high proportions of aromatic and hydrophobic amino 
acid residues in these peptides, indicating that the peptide sequences might mimic 
carbohydrate structures on native antigens (Fukuda, 2006).  The immunoreactivity of the 
peptide structures displayed by two of the phage clones, clones 8 and 10, was 
investigated by comparing peptide-specific IgA responses to known correlates of 
immunity to T. circumcincta.  Mean clone 8 and 10 peptide-specific abomasal mucosal 
IgA levels were significantly higher (P<0.01) in the T. circumcincta trickle-
infected/bolus-challenged sheep (“M-PI”) compared to helminth-naive sheep (M-HF”).  
Positive associations for both clones were demonstrated between levels of peptide-
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specific lymph IgA and the total IgA concentration in efferent gastric lymph at 7 dpc 
(P<0.01) and the percentage of inhibited L4 present (P<0.01).  Importantly, significant 
negative correlations between levels of phage clone-specific lymph IgA and total T. 
circumcincta burden were observed (P<0.05). 
As polyclonal antibodies were used to screen the phage display library here, this 
was unlikely to result in the isolation of a single consensus sequence representing a 
conformational epitope (Prudencio et al., 2010; Tang et al., 2004). As expected, the 
peptide sequences obtained from biopanning (Table 4.2) did not contain a single 
consensus sequence or motif.  These findings are similar to others in which polyclonal 
antibodies were used in biopanning experiments:  for example in studies on the fluke, F. 
hepatica phage display panning of a 12-mer M13 filamentous library with polyclonal 
anti-F.hepatica native cathepsin L antibodies, a panel of seven clones was selected 
(Villa-Mancera et al., 2008).  Immunisation with all phage particles in combination, 
without inclusion of adjuvant, induced higher IgG titres and reduced fluke burdens by 
46-67%, compared to unvaccinated control sheep, after challenge with metacercariae 
(Villa-Mancera et al., 2008; 2010).  Two selected clones (from the panel of seven used 
in these vaccination studies) were searched against the available peptide sequences for 
F. hepatica cathepsin L1 and L2 and revealed no matches in sequence, suggesting that 
the peptides recognised by the antibodies might mimic structural epitopes (Villa-
Mancera et al., 2008; 2010). 
Here, two TUPs (Ru et al., 2010; Vodnik, 2011) were identified.  It is thought 
that such phage clones have accelerated growth and therefore dominate amplified phage.  
Two of the the TUP clones (2 and 6) were investigated for immunoreactivity: both 
bound IgA in abomasal mucus from previously infected/challenged sheep (Figure 4.8).  
Clone 6 was also bound by mucus IgA from sheep exposed to a single primary challenge 
infection of T. circumcincta.  The analysis subsequently focussed on non-TUP clones (8 
and 10) selected in the biopanning.  In this study, a direct phage ELISA was developed.  
However there was a degree of inconsistency in the results obtained from this ELISA as 
there was a significant level of inter-plate variability (P=0.012).  As a result, the direct 
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phage ELISA will require further optimisation to improve reliability and consistency 
between assay repetitions.   The IgA-immunoaffinity-purified phage clones expressing 
heptameric peptides representing glycans on L3 somatic antigens were used in ELISA 
experiments to assess the relationship between heptamer binding and correlates of 
immunity.  Four parameters were analysed; total nematode burden, percentage of 
inhibited L4, total IgA concentration in efferent gastric lymph and the lymphoblast 
response. Each of these has previously been correlated with development of protective 
immunity in T. circumcincta-infected sheep (Halliday et al., 2007).  IgA in efferent 
gastric lymph bound the peptide structures in clones 8 and 10.  IgA in these gastric 
lymph samples has been shown to bind L4 somatic antigens (Halliday et al., 2007) and 
work presented here showed that the IgA also binds to L3 antigens.  The efferent gastric 
lymph samples from trickle-infected/bolus-challenged and primary bolus-infected sheep 
used in these experiments were from one single time-point, 7 dpc.  This time-point 
corresponded to the peak in total IgA measured in these samples (Halliday et al., 2007).  
Here, significant positive correlations between total IgA concentration at 7 dpc and 
binding of heptamer-specific IgA to both phage clones 8 and 10 were evident (Figure 
4.14).  Previous studies into associations between the levels of T.circumcincta L3 
antigen-specific abomasal mucus IgA and parameters of the immune response revealed a 
positive relationship between IgA binding and percentage of inhibited L4 recovered from 
the abomasum (Beraldi et al., 2008; Stear et al., 1999).  In the work here, levels of 
gastric lymph IgA specific to clones 8 and 10 were significantly positively correlated 
with percentage of inhibited L4.  A greater proportion of inhibited L4 in the abomasa of 
sheep infected with T. circumcincta will lead to a reduction in egg output and the level 
of pasture contamination.  Therfore, a vaccination strategy directed to increasing the 
proportion of inhibited L4 and reducing establishment of larvae in the abomasum will 
reduce the level of parasite exposure and the impact of parasitism on lambs turned out 
onto pasture.   
In conclusion, two phage clones were selected that have the potential to mimic 
native epitopes on T. circumcincta L3 antigens.  The level of binding of efferent gastric 
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lymph IgA to the peptide structures displayed by both these phage clones was positively 
correlated to the percentage of inhibited L4 present in the abomasum and negatively 
correlated to the total nematode burden. These associations indicate that the peptide 
structures displayed by the phage clones may imitate the structure of native epitopes on 
T. circumcincta L3 antigens.  A vaccination trial with helminth-naïve sheep will be the 
necessary next step to assess the level of protection afforded by the two phage clones.  
The two phage clones could be administered together or in separate formulations to 
sheep and to assess the level of protection three parasitological factors should be 
assessed; total nematode burden, faecal egg ouput and percentage of inhibited L4, 
alongside the immunological parameters.   
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Chapter 5 : Structural epitope mimics of T. circumcincta L3 
native surface antigens 
5.1 Introduction 
In the development of a vaccine against parasitic nematodes, targeting incoming larvae 
is a sensible approach as this stage represents the parasites’ first point of contact with the 
host.  Studies suggest that antibodies in the local environment (i.e. abomasum) play an 
important role in naturally-induced immunity of sheep against Teladorsagia 
circumcincta (Balic et al., 2003; Bowles et al., 1995).  After ingestion from pasture, L3 
exsheath in the rumen of the sheep and then migrate to the abomasum within 3 dpi 
(Michel, 1974).  The surface of T. circumcincta L3 is therefore a major site for 
interactions between host defence mechanisms, such as local antibodies, and the 
incoming parasite (Ashman et al., 1995; Blaxter et al., 1992) and a potential focus for 
vaccine development as, theoretically, targeting this larval stage could reduce 
establishment of the parasite within the host (Meeusen, 1996; Newton and Meeusen, 
2003).   
Parasitic nematodes have an external surface structure, termed the cuticle, which 
is a complex multilayered structure with a unique composition (Blaxter et al., 1992).  
The epicuticle, the outermost layer, contains lipid components as well as proteins and 
glycoproteins, which are all accessible to antibody binding.   The biophysical properties 
of the lipid-rich epicuticle may be altered during the transition from pre- to post-parasitic 
state following changes in the physico-chemical environment (Proudfoot et al., 1990; 
1993).  A carbohydrate-rich surface coat, termed the ‘glycocalyx’, is associated with the 
epicuticle and has been implicated in immune evasion (Maizels et al., 1993).  Surface-
associated antigens of numerous parasites have been shown to be stage-specific, 
including the bovine lungworm, D. viviparus and the abomasal parasite, H. contortus 
(Britton et al., 1993; Raleigh et al., 1996).  Research into the cuticular proteins of T. 
circumcincta and O. ostertagi has revealed that, in all of the major developmental 
stages, surface polypeptides are expressed that are unique to each particular stage, 
suggesting that the cuticle is altered throughout the life cycle (Keith et al., 1990).  This 
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suggests that the act of cuticle moulting during the parasitic stages is a useful tool to 
change the surface antigens exposed to the host environment and its immune system 
(Raleigh et al., 1996).   
Surface antigens of T. circumcincta L3, have been stripped from the parasites 
using detergent and subsequently used in an immunisation trial to investigate their 
ability to induce a protective response in sheep against challenge (Wedrychowicz et al., 
1992; 1995).  Sheep vaccinated with L3 surface extracts in conjunction with a beryllium 
hydroxide adjuvant had a 72% reduction in worm burdens compared to the control sheep 
infected with a single bolus challenge of 50,000 L3 (Wedrychowicz et al., 1992; 1995).  
Vaccination with L3 surface extracts was also able to induce a humoral response, with 
vaccinated sheep having a higher level of L3 surface antigen-specific serum IgA and IgG 
compared to control sheep (Wedrychowicz et al., 1992).  In studies investigating the 
stage-specific expression of H. contortus antigens, antibody-secreting cell probes 
(ASCs) were generated from abomasal lymph nodes of sheep given an trickle infection 
with H. contortus L3 followed by a challenge “bolus” dose of 50,000 L3 (Bowles, 
Brandon and Meeusen, 1995).  The ASCs were used to probe an immunoblot of an 
extract of L3/L4 H. contortus and the ASCs, derived from lymph nodes collected at 5 
dpc, bound antigens present in the ranges 40-50 kDa and 70-83 kDa (Bowles, Brandon 
and Meeusen, 1995).  Further localisation and purification experiments revealed that the 
ASC probes bound a glycoprotein-containing complex, termed Hc-sL3, from the surface 
of live H. contortus L3 and that this complex could be shed from larvae following 
incubation with antibodies from the abomasum of sheep rendered immune by infection 
(Ashman et al., 1995; Bowles, Brandon and Meeusen, 1995).  In an immunisation trial 
where sheep were immunised with Hc-sL3, a significant response was measureable in 
immunised sheep following H. contortus L3 challenge, with a 54% reduction in FWEC 
of immunised animals compared with control, adjuvant-only, sheep (Jacobs, Ashman 
and Meeusen, 1995).  More recently, in a field trial sheep were immunised twice with 
Hc-sL3 in conjunction with an aluminium hydroxide adjuvant, 4 weeks apart, and 4 
weeks after the final immunisation were administered a challenge of 5000 H. contortus 
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L3 (Piedrafita et al., 2012).  Vaccination with the native Hc-sL3 antigen showed 
reductions of 61% and 69% in FWEC and adult worm burdens, respectively, in 
vaccinated sheep compared to the adjuvant-only control sheep (Piedrafita et al., 2012).  
There was no evidence of a mucus antibody response to the vaccine antigens as no 
differences were detected in the levels of Hc-sL3-specific antibodies, across all isotype 
groups, between immunised sheep and adjuvant-only control sheep (Piedrafita et al., 
2012).  In sheep which had been experimentally infected with a trickle infection and 
challenge regime with Trichostrongylus colubriformis, a specific, protective, mucus 
antibody response to the epicuticular glycan “CarLA” was evident (Harrison et al., 
2003a; 2003b).  CarLA homologues were subsequently found to be present on the 
exsheathed L3 surface of a number of additional nematode species, including T. 
circumcincta and H. contortus (Maass et al., 2007).  CarLA molecules have also been 
implicated in immune evasion (Maass et al., 2009).  These previous studies highlight the 
importance of antigens displayed on the surface of infective larvae and the identification 
of native epitopes on these antigens could provide a viable and novel vaccine candidate 
target.  Together, these studies highlight the potential of antigens present on the surface 
of parasitic nematode L3 as viable targets for vaccine development.          
As discussed in Chapter 4, phage display libraries are a useful tool in the 
identification of molecular interactions.  Due to the difficulty in identification of 
conformational epitopes which play a role in the development of immunity (as discussed 
in Chapter 3), phage display libraries have been used to identify structures which mimic 
conformational epitopes (Coley et al., 2001; Gazarian et al., 2003).  To date, a small 
number of studies have used phage display in the development of vaccines against 
parasitic helminths; for example, Trichinella spiralis (Gu et al., 2008) and Fasciola 
hepatica (Villa-Mancera et al., 2008).  The study employing random peptide display 
libraries for T. spiralis vaccine development used a mouse monoclonal antibody, raised 
against a lead vaccine candidate, Ts87, isolated from adult T. spiralis, to bio-pan the 
library.  It reported that immunisation of mice with two immunoreactive phage clones, 
followed by an oral challenge with 400 T. spiralis larvae 2 weeks after the final 
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immunisation, produced a significant reduction (29%) in worm burden compared to the 
unvaccinated animals (Gu et al., 2008).   In the work detailed in Chapter 4, random 
peptide phage display libraries were used to identify phage-displayed peptide sequences 
which may mimic the structure of conformational epitopes found on antigens present in 
T. circumcincta L3 somatic extract preparations.  Two phage clones displayed promise 
as novel vaccine candidates because the level of peptide-specific IgA binding was 
associated with the three main known manifestations of immunity (Smith et al., 2009); 
total IgA concentration, inhibited larval levels and a reduction in worm burden.     
The aims of the present Chapter were to: 
i) Develop an immunofluorescence assay to ascertain if abomasal mucus 
antibody probes, derived from sheep which had been previously exposed to T. 
circumcincta, were able to bind directly to the surface of live, exsheathed T. 
circumcincta L3. 
ii) Employ phage display libraries to identify peptide sequences which mimic 
native structural epitopes displayed on the surface of exsheathed T. circumcincta L3 by 
screening the libraries with  mucus antibody preparations enriched for those antibodies 
which bound native antigens on the surface of live, intact exsheathed T. circumcincta L3.   
iii) Assess the relative immunoreactivity of selected peptide sequences from the 
phage clones by examining local antibody responses to them in sheep of varying levels 
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5.2 Materials and methods 
 
5.2.1 Infection protocol for production of ovine abomasal mucus  
All sheep used were Scotch Mules (Blackface ewe X Blue-faced Leicester ram), and 
were 6 months-old at the start of the trickle infection and 10 months-old at necroscopy.  
The sheep were raised indoors to reduce the risk of helminth exposure until the start of 
the experimental trickle infection.  Lambs (n=4) were trickle-infected per os with 2,000 
T. circumcincta L3, three times per week for nine weeks (Figure 5.1).   
 
Figure 5.1 Design of experiment in sheep infected with T. circumcincta from which abomasal 
mucus was obtained for use as local antibody probes. 
1 Trickle infection: 2,000 T. circumcincta L3 three times per week for nine weeks (red arrow). 
2 Fenbendazole (5mg/kg) administered seven days before challenge.   
3 Bolus of 50,000 T. circumcincta L3 challenge administered on day 0. 
 
Faecal worm egg counts (FWEC, see section 5.2.2) were performed on samples taken 
three times per week from the sheep, starting at 17 dpc until the end of the experiment.  
The anthelmintic fenbendazole (5mg/kg) was administered to remove any residual 
worms from the sheep before bolus challenge.  Seven days later, the sheep were 
challenged per os with a single bolus dose of 50,000 T. circumcincta L3.  All animals 
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were killed by captive bolt and exsanguinated at 2 dpc, the abomasa were removed and 
processed for the collection of mucus as detailed in section 2.2.1.1.  
 
5.2.2 Faecal worm egg counts  
 
Faecal material was collected three times per week throughout the duration of the 
experiment.  Upon collection, the faecal material was weighed and suspended in 10 ml 
of dH2O per 10g of faeces.  The faecal mixture was homogenized using a Stomacher 
ensuring that the faecal sample was thoroughly resuspended.  A 10ml subsample was 
extracted, passed through a 1mm sieve into a pre-labelled beaker and the retentate 
washed through the sieve with 5 ml of dH2O.  The filtrate was transferred to a centrifuge 
tube and centrifuged at 112 g for 2 min to pellet the faecal material.  The supernatant 
was removed and the faecal pellets resuspended in 10 ml of a saturated NaCl solution. 
The pellet was gently resuspended by inversion and the samples were centrifuged at 112 
g for 2 min.  Artery forceps were used to clamp the centrifuge tube below the meniscus 
and the upper volume transferred into a cuvette for egg counting.  The upper chamber of 
the tube was rinsed with 1ml of saturated NaCl solution and this was also added to the 
cuvette.  The cuvette was inverted several times, and a syringe used to add NaCl solution 
to create a positive meniscus before fixing the cuvette lid in place.  Strongyloid eggs 
were counted with the aid of a graticule square across the transverse of the cuvette. The 
method for egg counting was as described in Christie and Jackson (1982) and is 
sensitive to 1 egg per gram (epg).   
 
5.2.3 Detection of specific antibodies by ELISA 
For a quantitative assessment of antigen-specific antibody responses in the previously 
infected sheep (section 5.2.1), the immunoreactivity of the abomasal mucus was 
investigated by ELISA.  The method used was similar to that described in section 2.2.8, 
with some modifications.  Briefly, microtitre plates were coated with 50µl of 5µg/ml T. 
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circumcincta extracts from L3 and L4 homogenates, in 50mM sodium bicarbonate, pH 
9.6, and incubated at 4°C overnight.  Plates were washed with PBST and blocked for 
non-specific binding as detailed in section 2.2.8.  After re-washing, plates were 
incubated with 50µl of primary antibody (abomasal mucus from individual sheep, n=4), 
diluted at 1:5 in TNTT, and incubated for 2 h at room temperature.  The secondary and 
tertiary antibody incubations were as detailed in section 2.2.8.  All samples were 
measured in triplicate on each plate and each plate was repeated on two independent 
occasions.  Negative controls omitting the primary antibody incubation step were 
included on each plate.  A pool of efferent gastric lymph collected from sheep 
experimentally infected by a trickle infection/challenge protocol (detailed in section 
2.2.1.2, termed GL-PI) was used as a positive control sample on all plates.  This efferent 
gastric lymph was pooled from samples at specific time-points corresponding to the 
peak total IgA concentration, 6-10 dpc, as published in Halliday et al. (2007). 
 
5.2.4 Western blotting 
SDS-PAGE (section 2.2.6) was performed on T. circumcincta L3 somatic extract 
(generated as described in section 2.2.4) and the separated proteins transferred by 
electroblotting onto a 0.45µM nitrocellulose membrane as described in section 2.2.7.  
The remaining steps in the blotting procedure were as in section 2.2.7 with the following 
modification: the primary antibody was sourced from abomasal mucus collected from 
each of the four sheep described in section 5.2.1.   
    
5.2.5 Detection of ovine antibody binding to the surface of T. circumcincta L3 
Live T. circumcincta L3 (c.10,000 larvae) were exsheathed by incubation in 750µl of 2% 
(w/v) sodium hypochlorite/16.5% sodium chloride for 3 min at room temperature.  A 
sub-sample of larvae was examined under a microscope to ensure that 90% had 
exsheathed prior to the removal of the sodium hypochlorite.  Exsheathed larvae were 
centrifuged at 112 g for 2 min.  The larval pellet was washed with 10 ml dH2O, 
centrifuged at 112 g for 2 min and the supernatant removed.  This washing procedure 
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was repeated three times in total.  Live exsheathed T. circumcincta L3 (c. 2000) were 
transferred into a 1.5 ml tube.  To block non-specific interactions, the larvae were 
incubated with 10% soya milk powder (Infasoy, Cow and Gate™) in PBS for 30 min at 
room temperature on a rotating roller mixer.  Following blocking, larvae were washed in 
PBST by incubation of the samples on a rotating roller mixer for 2 min, centrifuged at 
112 g for 3 min and the supernatant removed.  The samples were washed three times.  
Larvae were incubated with 250 µl of primary antibody (a neat antibody extract 
preparation from abomasal mucus) from trickle-infected/challenged sheep (generated as 
described in section 5.2.1) or helminth-naïve sheep (generated as described in Section 
2.2.1.1) for 90 min at 37°C on a rotating roller mixer.  Larvae were re-washed three 
times with PBST and incubated with the appropriate secondary antibody according to 
the specific antibody isotype under investigation (Table 5.1) for 90 min at room 
temperature.  The antibodies were diluted to the required concentration in PBST (Table 
5.1).  After the application of the final fluorescein isothiocyanate (FITC)-conjugated 
antibody (i.e. IgG, secondary; IgA, tertiary) larvae were rewashed in PBST (with 0.01% 
sodium azide).  The larval pellet was resuspended in 50 µl of PBST and examined under 
a UV fluorescent microscope.  Sheathed T. circumcincta L3 were also processed in the 
same manner for comparison.   
Isotype Secondary antibody Tertiary antibody 




















Sigma, F4891 1 in 100 N/A N/A N/A 
 
Table 5.1  Antibodies used for immunofluorescence assay investigating the immunoreactivity of 
T. circumcincta surface-exposed antigens against antibodies from abomasal mucus of sheep 
which had previously been infected with T. circumcincta. 
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5.2.6 Cross-reactivity of ovine abomasal mucus antibodies with other 
trichostrongylid nematodes 
The cross-reactivity of ovine abomasal mucus (collected from sheep trickle-
infected/challenged with T. circumcincta) against surface antigens from other nematode 
species was investigated using the immunofluorescence assay.  H. contortus (c. 10,000) 
and T. colubriformis (c. 10,000) were exsheathed following the method outlined in 
section 5.2.5.  Isolates of H. contortus and T. colubriformis larvae were kindly provided 
by Alison Morrison (Moredun Research Institute).  Larvae were incubated with the 
antibodies for detection of both IgA and IgG binding as detailed in section 5.2.5.   
 
5.2.7 Elution of L3 surface-bound antibodies  
Following the incubation of T. circumcincta L3 (c. 50,000) with 5 ml of primary 
antibody from trickle-infected/challenged sheep (sections 5.2.1 and 5.2.5) bound 
antibodies were eluted from the L3 surface.  Larvae were washed with PBST, 
centrifuged at 112 g for 3 min, rewashed in PBST and centrifuged again, then, following 
removal of the PBST, incubated with 500 µl of 0.1M glycine-HCl, 6M urea, pH 2.5 for 
5 min on a rotating rotary mixer.  The samples were centrifuged at 400 g for 2 min, the 
supernatant containing eluted antibodies transferred to a fresh 1.5 ml tube and the pH of 
the elution buffer immediately readjusted to pH7 with 75 µl of 1M Tris, pH 9.1.  Sub-
samples of larvae were taken pre- and post-elution and processed accordingly for the 
immunofluorescence assay to detect IgA and IgG binding to the surface antigens and to 
illustrate elution of the surface-bound antibodies.   
 
5.2.8 Confirmation of reactivity of antibodies purified directly against the 
surface of exsheathed T. circumcincta L3  
Binding of L3-surface purified antibodies (section 5.2.5 and 5.2.7) to antigens present in 
L3 extracts was investigated by immunoblotting.  Briefly, 5 µg/lane of T. circumcincta 
L3 S1 and S2 extracts (section 2.2.3) were run on 4-12% NuPAGE SDS gels under 
reducing conditions (section 2.2.4).  Once run, one lane of the gel was stained using 
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Simply Blue Stain and the remaining lanes electro-blotted onto a 0.45 µm nitrocellulose 
membrane (section 2.2.5).  To block non-specific binding sites, nitrocellulose 
membranes were incubated in TNTT overnight at 4°C. The appropriate lanes were then 
incubated with antibodies purified against the surface of exsheathed T. circumcincta L3 
(see section 5.2.7 and Table 5.2) for 2 h at room temperature.  Lanes were then washed 
in TNTT for 10 min, repeated 3 times.  Secondary and tertiary antibodies were then 
applied (Table 5.2) for 1 h at room temperature, prior to 3 x 10 min TNTT washes.  
Following the final wash after incubation with the HRP-conjugated antibody, detection 
was carried out using DAB (Sigma). 
Primary  Secondary  Tertiary  
 Dilution Description Manufacturer Dilution Description Manufacturer Dilution 
IgA
1







1 in 250 Polyclonal 













Sigma, A0452 1 in 
1000 
N/A N/A N/A 
 
Table 5.2 Antibodies used for the detection of ovine IgA and IgG on immunoblots.
 
1IgA and IgG in abomasal mucus of sheep with an experimental infection of Teladorsagia circumcincta. 
The antibodies in this mucus were purified directly against the surface of live exsheathed T. circumcincta 
L3. 
 
Immunofluorescence was used to confirm that the reactivity of antibodies purified from 
the surface of exsheathed T. circumcincta L3 was retained following the elution steps.  
Live, exsheathed T. circumcincta L3 (section 5.2.5) were processed for the larval 
immunofluorescence assay as detailed in section 5.2.5 with the following modification.  
Following the blocking steps and washing, larvae were incubated with 250 µl of 
antibodies purified directly against the surface of exsheathed T. circumcincta L3 
(generated as described in sections 5.2.5 and 5.2.7) for 90 min at 37°C on a rolling 
rotator mixer.  Following the primary antibody incubation step, the samples were 
incubated with the developing antibodies as outlined in section 5.2.5 and Table 5.2. 
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5.2.9 Phage display library panning 
Abomasal mucus antibodies purified against surface antigens on T. circumcincta L3 
were used for screening commercially available heptapeptide (PhD-7™) M13 pIII 
libraries (New England Biolabs Inc, USA).  L3-surface purified antibodies (10µg/ml), 
prepared as described in section 5.2.7, were diluted in coating buffer (0.1M sodium 
carbonate, pH 8.6) and used to coat a 90mm Petri dish. Phage binding was then 
performed according to the manufacturer’s instructions and as detailed in section 4.2.2.  
The eluted phage were amplified, as described in section 4.2.2.1, prior to use as the input 
phage for the subsequent rounds of panning with three complete rounds of panning 
conducted in total.    For calculation of the plaque-forming units for both the 
unamplified panning eluates and amplified phage culture supernatants, the phage were 
titrated in ER2738 as described in section 4.2.2.1.  Selected, antibody-binding, phage 
clones were used for DNA sequencing and for target specificity confirmation by phage 
ELISA.  Fifty clones were selected and isolated for initial DNA sequencing.  
Subsequently, 20 of these sequenced clones also had a phage stock prepared for 
assessment of target specificity by ELISA.  Individual phage clones were amplified from 
the phage stock in accordance to the protocol described in section 4.2.2.1 to generate 
material for the DNA preparation and phage ELISA.  Phage DNA sequencing templates 
for the fifty clones were prepared following the methods outlined in section 4.2.2.3.  The 
DNA sequences obtained from the sequence analysis of the immunoreactive 
heptapeptides were analysed as described in section 4.2.2.4.  Bioinformatic analysis of 
the resulting peptide sequences was also conducted as described in section 4.2.2.5. 
 
5.2.10 Assessment of specificity of phage clones for target antibodies by ELISA 
The target specificities of selected phage clones were assessed by distinguishing true 
target binding from background binding to both the plastic support and the BSA 
blocking agent.  This was achieved through comparison of the level of phage binding in 
uncoated wells of the 96-well plate to wells coated with the antibodies purified against 
L3 surface-exposed antigens (as illustrated in Figure 4.4).   The amplified phage stocks 
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of 20 clones (see section 5.2.9) were re-amplified to obtain sufficient quantities for the 
assays.  Amplification of the individual phage stocks was achieved by following the 
method outlined in section 4.2.5. The target specificities of the 20 individual phage 
clones were investigated by following the phage ELISA method detailed in section 
4.2.5.  Briefly, for each phage clone, three wells of the 96-well plate were coated with 
100 µl of L3-surface purified antibodies (purified by the method described in sections 
5.2.5 and 5.2.7) at 100µg/ml in 0.1M sodium carbonate, pH 8.6.  Three wells of the 96-
well plate were left uncoated for each clone and the plates were incubated overnight at 
4°C.  The following steps for washing, phage incubation and the detection of antibody-
phage binding were as detailed in section 4.2.5.  For each phage clone, the OD values 
obtained from the wells coated and uncoated with the target were compared.   
 
5.2.11 Phage ELISAs probed with efferent gastric lymph IgA from sheep with 
differing levels of immunity to T. circumcincta 
The ovine antibody probes from efferent gastric lymph used here were described in 
section 2.2.1.2 and had been collected from sheep which had received a trickle infection 
and bolus challenge of T. circumcincta L3 (see section 2.2.1.2). The codes used for these 
samples are detailed in Table 5.3. 
Sample  Infection status Abbreviation 






Table 5.3 Summary and abbreviations for samples used in immunoreactivity investigations. 
Key: GL = efferent gastric lymph; PI = previously infected by a trickle infection/challenge; CO = primary 
infection with a single bolus challenge; N = helminth-free naive sheep. 
 
Four phage clones (Clone 1, WTPSVRP; Clone 3, WPTLQWA; Clone 12, SWPQRTN; 
Clone 16, GWPKFTK) were investigated to quantify binding of IgA in efferent gastric 
lymph from previously infected/challenged sheep to the structures presented by the 
peptide sequences.  Further analysis was conducted to identify if binding to the peptide 
clones was related to known correlates of immunity: worm burden, percentage of 
inhibited T. circumcincta L3 and total concentration of IgA in efferent gastric lymph at 7 
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dpc.  Following the optimisation procedure described in section 4.2.7, the “Direct phage 
ELISA” was employed.  Briefly, microtitre plates were coated with an individual phage 
clone diluted to 10
12
 pfu/ml in coating buffer (50µl/well) overnight at 4°C.  Following 
washes in PBST, primary antibody incubations were conducted at room temperature for 
1 h.  The sources of primary antibodies were individual efferent gastric lymph samples 
collected at a single-time point during experimental infection: “G-PI” at 7 dpc, “GL-
CO” at 7 dpc and “GL-HF” at 0 dpc (Table 5.3).  All remaining procedures were as 
documented in the optimised direct phage ELISA described in section 4.2.7 (b).  All 
primary antibody sample/phage clone combinations were conducted in duplicate on each 
plate.  Each plate was repeated on three independent occasions.  The absorbance values 
presented were from data generated across the six readings and are presented as mean 
with the standard deviation.   
 
5.2.12 Statistical analysis of immunorecognition ELISAs – correlations 
The data obtained from both the assays investigating the level of ovine IgA binding to 
the four phage clones and the relationships between the level of IgA binding and known 
immune parameters were not normally distributed (Anderson Darling Test, p<0.05). The 
mean values obtained in the ELISAs investigating the level of ovine IgA binding to the 
four phage clones/peptide structures from the different infection groups were statistically 
evaluated by non-parametric ANOVA and a GLM. Relationships between the levels of 
IgA binding to the selected peptide sequences and known immune parameters were 
summarised by non-parametric correlation analysis using Spearman rank correlation 
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5.3 Results 
5.3.1 Parasitological and immune responses against larval antigens in 
abomasal mucus from donor sheep  
During the trickle infection programme the FWEC steadily decreased (Figure 5.2).  At 
day 61, an egg count of less than 50 eggs per gram (epg) was obtained in all animals.  








































Figure 5.2 Faecal egg counts in lambs experimentally infected with T. circumcincta L3 through 
an experimental trickle infection and in response to a single 50,000 L3 bolus challenge. 
FWEC were performed in duplicate for each animal and the mean value obtained as the eggs per gram of 
faeces is plotted for each individual animal.  The vertical black dashed line represents the point (“BZ” on 
the x axis) in the infection programme at which the trickle infection ceased and all of the animals (n=4) 
were administered the anthelmintic, fenbendazole (5mg/kg), to remove residual T. circumcincta.  The 
vertical orange dashed line represents the point at seven days post-treatment when all sheep were given a 
single bolus challenge of 50,000 T. circumcincta L3.  FWEC were then monitored for a further 6 days 
before the animals were euthanased to retrieve the abomasal mucus.  
 
ELISAs were used to investigate abomasal mucus antibody isotypes that bound the T. 
circumcincta L3 antigens.  Abomasal mucus IgA and IgG activity against L3 somatic 
antigens was detected in the samples collected from the four previously 
infected/challenged sheep (Figure 5.3), with some degree of individual variation 
between animals.   
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Figure 5.3 Teladorsagia circumcincta L3 somatic antigen-specific abomasal mucus IgA and IgG 
levels in sheep previously infected/challenged with the parasite in an experimental infection 
regime.  
The abomasal mucus samples were obtained from individual sheep which had received a trickle infection 
and single bolus challenge infection.  Group “GL-N” represents pooled efferent gastric lymph from 
helminth-naïve sheep and was used as a ‘negative control’.  The positive control was pooled efferent 
gastric lymph collected over 6-10 dpc from previously infected/challenged sheep.  The mean OD (± 
standard error of mean (SEM), n=6, results are expressed as a percentage of the positive control.   
 
 
5.3.2 Detection of ovine antibody binding to the surface of T. circumcincta L3  
 
Following incubation of live, ensheathed T. circumcincta L3 in the primary antibody 
source (i.e. abomasal mucus or PBS) for 90 min at 37°C, the majority of the larvae in the 
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observed in all the primary incubations conditions using (a) abomasal mucus from 
previously infected/challenged sheep, (b) abomasal mucus from helminth-naïve sheep 
and (c) no primary antibody control (PBS only).  As a result all subsequent assays to 
determine binding of ovine mucus antibodies to T. circumcincta larvae were conducted 
with T. circumcincta L3 which had previously been exsheathed with sodium 
hypochlorite (Section 5.2.5).  
 
 
Figure 5.4 Image of T. circumcincta L3 which had exsheathed during incubation with primary 
antibody source in PBS 
Live, sheathed T. circumcincta L3 were incubated at 37°C for 90 min in a 1.5ml Eppendorf tube with PBS.  
Following incubation, the larvae were examined under a microscope.  A representative example of larvae 
is shown and the arrow depicts the discarded sheath of T. circumcincta L3. 
 
IgA in abomasal mucus collected from sheep previously infected/challenged with T. 
circumcincta L3 bound antigens present on the surface of live, exsheathed T. 
circumcincta L3 (Figure 5.5, panel B).  No IgA binding was observed in mucus from 
helminth-naïve sheep or in the no primary antibody control (Figure 5.5, panels A and C, 
respectively).  T. circumcincta infective larvae showed a degree of internal 
autofluorescence at the emission and excitation wavelengths used to detect the FITC 
conjugated antibody; this autofluorescence was seen in the larvae incubated with PBS 
only (Figure 5.5, panel C).   
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Figure 5.5 Immunofluorescent staining of T. circumcincta L3 larvae with IgA from abomasal 
mucus obtained from both trickle-infected/challenged and helminth-naïve sheep 
Ovine IgA binding to T. circumcincta L3 surface antigens was detected with a combination of monoclonal 
mouse anti-bovine/ovine IgA and polyclonal anti-mouse immunoglobulins-FITC conjugated.  Exsheathed 
T. circumcincta L3 were incubated with mucus from (a) helminth-naïve sheep, (b) trickle-
infected/challenged sheep and (c) PBS only (no primary control).   
 
IgG in abomasal mucus obtained from sheep previously infected/challenged with T. 
circumcincta L3 bound the surface of exsheathed L3 (Figure 5.6, panel B).  T. 
circumcincta L3 incubated with abomasal mucus from helminth-naïve sheep or PBS did 
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Figure 5.6  Immunofluorescent staining of T. circumcincta L3 larvae with IgG from abomasal 
mucus obtained from both trickle-infected/challenged and helminth-naïve sheep. 
Ovine IgG binding to T. circumcincta L3 surface antigens was detected with a monoclonal mouse anti-
goat/sheep IgG-FITC antibody.  Exsheathed T. circumcincta L3 were reacted with mucus from (a) 
helminth-naïve sheep, (b) trickle-infected/challenged sheep and (c) PBS only (no primary control).  T. 
circumcincta L3 were exsheathed in vitro through exposure to sodium hypochlorite solution and were 
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5.3.3 Cross reactivity of ovine abomasal mucus antibodies with other 
trichostrongylid nematodes 
The immunofluorescence assay was adapted to investigate cross-reactivity of abomasal 
mucus IgA and IgG obtained from sheep previously infected with T. circumcincta L3 
with antigens on the surface of the L3 stages of other trichostrongylid nematode species. 
IgA in the abomasal mucus of sheep experimentally trickle-infected/bolus-challenged 
with T. circumcincta L3 displayed cross-reactivity to antigens present on the surface of 
exsheathed H. contortus (Figure 5.7, panel A) and T. colubriformis L3 (Figure 5.7, panel 
B).  There was no reactivity of abomasal IgA obtained from helminth-naïve sheep 
against L3 surface antigens of H. contortus (Figure 5.7, panel C) or T. colubriformis 
(Figure 5.7, panel D).  Again, exsheathed H. contortus and T. colubriformis L3 larvae 
expressed a degree of internal fluorescence when larvae were incubated with the no 
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Figure 5.7 Immunofluorescent staining of exsheathed H. contortus and T. colubriformis L3 with 
IgA from abomasal mucus collected from sheep which had been subjected to a trickle 
infection/challenge with T. circumcincta L3. 
Ovine IgA binding to trichostrongylid nematode surface antigens was detected with a combination of 
monoclonal mouse anti-bovine/ovine IgA and polyclonal anti-mouse immunoglobulins-FITC conjugated.  
Exsheathed H. contortus (A) and T. colubriformis (B) L3 were incubated with abomasal mucus from sheep 
subjected to an experimental trickle infection and a single bolus challenge of 50,000 T. circumcincta L3. 
Exsheathed H. contortus (C) and T. colubriformis (D) L3 were incubated with abomasal mucus from 
helminth-naïve sheep.  No primary antibody control: Samples of H. contortus (E) and T. colubriformis (F) 
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Abomasal IgG in sheep given an experimental trickle infection/challenge with T. 
circumcincta L3, also bound to antigens present on the surface of exsheathed H. 
contortus and T. colubriformis L3 (Figure 5.8, panels A and B).  No IgG binding was 
detected when H. contortus and T. colubriformis L3 were incubated with abomasal 
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Figure 5.8 Immunofluorescent staining of exsheathed H. contortus and T. colubriformis L3 with 
IgG in abomasal mucus from sheep subjected to a trickle infection/challenge with T. 
circumcincta L3. 
IgG binding to nematode surface antigens was detected with a combination of monoclonal mouse α-
bovine/ovine IgA and polyclonal anti-mouse immunoglobulins-FITC conjugated. Exsheathed H. contortus 
(A) and T. colubriformis (B) L3 were incubated with abomasal mucus from sheep subjected to an 
experimental trickle infection and a single bolus challenge of 50,000 T. circumcincta L3. Exsheathed H. 
contortus (C) and T. colubriformis (D) L3 were incubated with abomasal mucus from helminth-naïve 
sheep.  No primary antibody control: samples of H. contortus L3 (E) and T. colubriformis (F) were 







Chapter 5: Structural epitope mimics of T. circumcincta L3 surface antigens                                 197                                                                               197 
5.3.4 Elution of bound antibody from surface of exsheathed T. circumcincta L3 
To determine if the procedure used to elute antibody bound to the surface of exsheathed 
T. circumcincta L3 was successful, immunofluorescent labeling of antibodies on the 
larval surface before and after elution was performed. In Figure 5.9, panel A shows T. 
circumcincta L3 incubated with abomasal mucus from previously infected/challenged 
sheep (generated as detailed in Section 5.2.1) and subsequently probed with a FITC-
conjugated antibody to detect IgA binding to the L3 surface antigens.  In panel B, the 
larvae were incubated with the same primary antibody source used in panel A (i.e. 
abomasal mucus from previously infected/challenged sheep) and, following this 
incubation, bound antibodies were eluted as detailed in section 5.2.7, before incubation 
of the larvae with anti-ovine IgA or IgG FITC-conjugates.  The length of exposure for 
the capture of the immunofluorescence images was set to 13 secs for all samples to 
allow direct comparison of intensity of fluorescence between samples. Intensity of 
fluorescence on larvae probed for IgA binding post-elution was clearly reduced when 
compared with pre-elution L3 samples, demonstrating successful elution;  however, there 
was no obvious difference in immunofluorescence between pre- and post-elution L3 
when examined for IgG binding (Figure 5.9, panels C and D). 
  
 





Figure 5.9 Comparison of immunofluorescent staining of T. circumcincta L3 with abomasal 
mucus IgA and IgG obtained from sheep infected with T. circumcincta, pre- and post-elution of 
antibodies bound to surface antigens. 
Exsheathed T. circumcincta L3 were incubated with abomasal mucus from sheep subjected to an 
experimental trickle infection and single bolus L3 challenge and probed for IgA binding (A) and IgG 
binding (C).  Antibodies bound to the surface antigens of L3 were eluted with 0.1M glycine/6M urea 
buffer and then re-probed for IgA (B) and IgG binding (D).  Ovine IgA binding to T. circumcincta L3 
surface antigens was detected with a combination of monoclonal mouse anti-bovine/ovine IgA and 
polyclonal α-mouse immunoglobulins-FITC-conjugated antibodies. Ovine IgG binding was detected with 
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Following elution of antibodies, it was necessary to investigate if these were still able to 
bind to the surface of fresh exsheathed T. circumcincta L3, so a further round of 
incubation and immunofluorescent detection of antibody binding was undertaken using 
the surface-purified, eluted antibodies as the primary antibody source.  Surface-purified, 
eluted IgA was still able to bind T. circumcincta L3 surface antigens (Figure 5.10, panel 
A) and surface-purified, eluted IgG binding to T. circumcincta L3 was detected on some 





















Figure 5.10 Re-binding of T. circumcincta L3 surface-affinity purified abomasal mucus 
antibodies purified to exsheathed L3. 
Approximately 1,000 exsheathed T. circumcincta L3 were incubated with abomasal mucus antibodies 
purified against the surface of exsheathed T. circumcincta L3 and probed for IgA binding (panel A) and 
IgG binding (panel C).  No primary antibody controls contained approximately 1, 000 T. circumcincta L3 
incubated with PBS and probed for IgA (panel B) and IgG binding (panel D). Ovine IgA binding to T. 
circumcincta L3 surface antigens was detected with a combination of monoclonal mouse anti-bovine/ovine 
IgA and polyclonal anti-mouse immunoglobulins-FITC conjugates. Ovine IgG binding to T. circumcincta 
L3 surface antigens was detected with a monoclonal mouse anti-goat/sheep IgG-FITC antibody.     
A B 
C D 
REBOUND NO PRIMARY CONTROL 
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5.3.5 Binding of surface-purified, eluted antibody to T. circumcincta L3 antigens 
Immunoblotting demonstrated that IgA in the surface-purified, eluted antibodies (see 
Sections 5.3.4) bound antigens in T. circumcincta S1 and S2 somatic extracts (Figure 
5.11, Lanes 1 and 5, respectively).  In the lane of S1 extract probed with the surface 
purified antibodies, there were IgA reactive bands, weakly detected at approximately 60-
100 kDa (Figure 5.11, Lane 1).  In the lane of S2 extract probed with the surface-
purified antibodies, IgA reactive bands were detected at 30 kDa and in the range 80 kDa 
to >100 kDa (Figure 5.11, Lane 5).  Abomasal mucus IgA reactivity against both S1 and 
S2 antigens was detected, in the range of 20 kDa to >200 kDa, in the lanes probed with 
non-affinity purified antibodies from previously infected/challenged sheep (Figure 5.11, 
Lanes 3 and 7, respectively).  No abomasal IgA activity was detected in the lanes of S1 
and S2 extracts probed with antibodies generated from helminth-naïve sheep (Figure 
5.11, Lanes 2 and 6) or the no primary antibody controls (Figure 5.11, Lanes 4 and 7).   
 
Figure 5.11 Immunoblot of ovine IgA binding to T. circumcincta L3 extracts by probing with 
purified (affinity-purified against the surface of exsheathed T. circumcincta L3) antibodies from 
the abomasal mucus obtained from previously infected/challenged sheep.   
Lanes 1–4: T. circumcincta L3 S1 extract (5µg/lane). Lanes 5–8: T. circumcincta L3 S2 extract (5µg/lane).  
Lanes 1 and 5: probed with abomasal antibodies obtained from previously infected/challenged sheep and 
affinity purified using surface antigens on exsheathed T. circumcincta L3.  Lanes 2 and 6: probed with 
abomasal antibodies obtained from sheep reared in helminth-free conditions and purified against surface 
antigens on exsheathed T. circumcincta L3.  Lanes 3 and 7: probed with abomasal antibodies collected 
M 5 6 7 8
S2
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from sheep trickle-infected with T. circumcincta (the abomasa were collected at post mortem 2 days 
following a bolus challenge of 50,000 L3).  Lanes 4 and 8: no primary antibody controls.  All lanes were 
probed with the appropriate secondary and tertiary antibodies for IgA detection.  Lane M depicts standard 
molecular weight markers given in kDa.  
 
Sodium periodate treatment lead to a decrease in band density but it did not deplete the 
level of reactivity of the purified IgA to L3 antigens in S1 (Figure 5.12, Lane 3) and S2 
extracts (Figure 5.12, Lane 7). 
 
Figure 5.12 Immunoblots demonstrating the effect of sodium periodate treatment of T. 
circumcincta L3 extracts on their binding to abomasal IgA purified against surface antigens of T. 
circumcincta L3.    
Lanes 1–4: T. circumcincta L3 S1 extract (5µg/lane).  Lanes 5–8: T. circumcincta L3 S2 extract (5µg/lane).  
Lanes 1 and 5: No sodium periodate.  Lanes 2, 3, 6 and 7: antigens treated with 50mM sodium periodate 
prior to antibody probing. Lanes 1, 2, 5 and 6: probed with pool of abomasal mucus from sheep given a 
trickle infection/bolus challenge.  Lanes 3 and 7: probed with abomasal antibodies which were obtained 
from previously infected/challenged sheep and purified against surface antigens on exsheathed T. 
circumcincta L3.  Lanes 4 and 8: no primary antibody controls.  All lanes were incubated with the 
appropriate secondary and tertiary antibody for detection of IgA binding.  Lane M represents molecular 
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5.3.6 Biopanning of surface-purified, eluted IgA against a 7-mer phage display 
library 
To determine specific phage enrichment after each round of panning the heptamer phage 
library against the L3 surface-purified abomasal IgA, the titre of the amplified phage 
eluted from each round was determined and quantified as pfu/ml (Table 5.4).  
Round Input phage (pfu/ml) Amplified phage eluted (pfu/ml) 
1 1.0 x 10
11
 1.28 x 10
9
 
2 1.0 x 10
11
 1.71 x 10
13
 
3 1.0 x 10
11




Table 5.4 Titres of input phage and amplified phage eluted from each round of biopanning. 
A heptamer phage display library was biopanned with abomasal IgA purified against antigens on the 
surface of exsheathed T. circumcincta L3. * denotes unamplified eluate.  Pfu/ml = plaque-forming units 
per ml. 
 
Following three rounds of screening, 50 bound phage clones were randomly selected and 
the peptide sequences of the insert regions determined (see Appendix 3 for full list of 
sequences).  The peptide sequences that were highly repeated in the dataset are 
summarised in Table 5.5.   




















WTPSVRP 3     1 
WPTLQWA 5   Yes  2 
HAIYPRH 3 Yes Yes Yes Yes 3 
QPWPTSI 2     4 
SWPQRTN 2     5 
GWPKFTK 2     6 
ALGIDSG 2     7 
KLPGWSG 3     8 
Table 5.5 Frequency of repeated peptide sequences from phage clones. 
Phage clones were selected through panning a 7-mer phage display library with IgA purified against 
surface antigens on exsheathed T. circumcincta L3.  *Listed on the MimoDB search facility compiled of 
collated data from phage display library panning experiments 
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Bioinformatic analysis of the peptide sequences revealed that one of the repeated 
sequences, HAIYPRH, was classified as a target-unrelated peptide (TUP); this sequence 
had been identified in the previous panning experiments with L3 glycan and control 
antibodies (Section 4.3.2).  One of the sequences repeated more than twice in this 
dataset, WPTLQWA (referred to as clone 2 in current chapter), matched one of the 
sequences reported in the L3 glycan antibody panning (section 4.3.2; referred to as Clone 
8 in chapter 4).  
 
Figure 5.13 Frequency of amino acids in the peptide sequences identified by biopanning a 
random heptamer phage display library with affinity purified ovine IgA which binds to surface 
antigens on exsheathed T. circumcincta L3. 
Groups of amino acids: Small (Glycine, Alanine); Hydrophilic (Serine, Threonine, Cysteine); 
Hydrophobic (Valine, Leucine, Isoleucine, Methionine, Proline); Aromatic (Phenylalanie, Tyrosine, 
Tyrptophan); Acidic (Aspartic acid, Glutamic acid); Amine (Asparagine, Glutamine); Basic (Histidine, 
Lysine, Arginine). Percentage frequency of amino acid groups was calculated as the total number of 
repetitions of individual amino acids in the dataset (all amino acids in all bound phage) as a proportion of 
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Frequency of amino acids  
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Following sequence analysis of the peptide clones, the proportion of the different classes 
of amino acids in the sequences indicated that there were amino acid residues belonging 
to the hydrophobic, aromatic and hydrophilic groups (Figure 5.13). 
 
5.3.7 Target specificity of phage clones 
Eight of the phage clones selected by biopanning were evaluated by ELISA for their 
target antibody specificity by comparing the level of background binding with the level 
of binding to wells coated with antibodies purified against L3 surface antigens.  The 
results confirmed that the surface purified antibodies bound in a specific manner to all 
eight phage clones.  Clones 1, 2, 3, 5, 6 and 7 demonstrated the highest OD values in the 
ELISA when mean levels of IgA binding in antibody-coated wells were compared to the 
uncoated wells (Figure 5.14).  Clone 3 bound IgA in the antibodies purified against the 
surface of exsheathed T. circumcincta L3 (Figure 5.14) and also bound IgA from the 
abomasum of sheep exposed to a single primary challenge infection of T. circumcincta 
(section 4.3.3), but is a known target unrelated peptide (TUP), so was subsequently 
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Figure 5.14 Screening ELISA used to investigate the target specificity of eight selected phage 
clones by comparison of the level of specific binding to abomasal IgA to background.  
Arrows denote clones selected for further investigation.  Clones 1, 2, 5 and 6 gave the highest OD values 
in the ELISA when the mean levels of IgA binding in IgA coated wells were compared to those in the 
uncoated wells.  Clone 3 was not selected due to its identification as a target-unrelated peptide. There was 
an insufficient volume of phage supernatant for both clone 7 and 8 and as a result these were not further 
investigated.   
 
5.3.8 Phage ELISAs probed with efferent gastric lymph IgA from sheep with 
differing levels of acquired immunity to T. circumcincta 
The levels of IgA binding to peptide structures displayed by four of the phage clones 
identified by biopanning were quantified using gastric lymph obtained from sheep with 
varying levels of immunity to T. circumcincta.  Relationships between levels of IgA 
binding and parasitological and immunological parameters were investigated and are 
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 Nematode burden Total IgA in lymph % inhibited larvae 
Clone rs value P value rs value P value rs value P value 
1 -0.252 0.246 0.621 0.006* 0.458 0.028* 
2 -0.696 <0.001*** 0.836 <0.001*** 0.595 0.003** 
5 -0.646 <0.001*** 0.755 <0.01** 0.562 0.005** 
6 -0.528 <0.01** 0.814 <0.001*** 0.593 0.003** 
Table 5.6 Summary of the output from the statistical analysis of the relationships between the 
levels of gastric lymph IgA binding to four phage clones and parasitological and immune 
parameters. 
‘*’ and ‘*’ denote significance levels with p-values < 0.05 and <0.01, respectively.The association and 
relationships were tested by non-parametric analysis with Spearman correlation coefficient.  rs value 
indicates the strength of the relationship.   
 
For three of the four phage clones investigated, significant negative correlations 
(P<0.01, rs = -0.528 to -0.696) were observed between the peptide-specific IgA 
responses in efferent gastric lymph samples and nematode burdens at necropsy (Figure 
5.15, Table 5.6).  Clone 2 showed the strongest relationship between the level of binding 
of efferent gastric lymph IgA binding to the peptide and the total nematode burden at 
necropsy.   
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Figure 5.15 Relationship between the levels of gastric lymph IgA binding to four phage clones 
selected by biopanning and the nematode burden of sheep experimentally infected with T. 
circumcincta L3. 
 
Analysis of the association was conducted through use of Spearman correlation coefficients.  Data points 
represent the absorbance values from the individual sheep gastric lymph samples (n=19), reflecting the 
level of efferent gastric lymph IgA binding to the phage clone under investigation.  The absorbance values 
were plotted against the total nematode burden for each individual sheep.  The efferent gastric lymph was 
collected from individual sheep (“GL-PI” group) which had been previously infected with T. circumcincta 
L3 and were subjected to a bolus challenge of 50,000 L3.  The gastric lymph samples used were all from a 
single time-point of 7 dpc.  The worm burden of the “GL-PI” sheep was assessed by counting the number 
of males, females and inhibited L4 in a sub-sample of the digests of both the abomasal tissue and contents 




Significant positive correlations (P<0.05, rs = 0.458 to 0.595) existed between the level 
of IgA binding to all the four phage clones and the percentage of inhibited L4 present at 
necropsy (Figure 5.16, Table 5.6).  Clones 2 and 6 showed the stronger relationships 
between the level of IgA binding and the percentage of inhibited larvae recorded.  There 
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0 (Figure 5.16).  These are the data pertaining to both the helminth-naïve sheep and the 
sheep only exposed to a single bolus challenge of 50,000 L3.   
 
 
Figure 5.16 Relationship between the levels of gastric lymph IgA binding to four phage clones 
selected by biopanning a phage display library with L3 surface-purified ovine antibodies and 
percentage of inhibited T. circumcincta L4s present in the abomasa of sheep experimentally 
infected with T. circumcincta L3.   
 
Analysis of the association was conducted using spearman correlation coefficient.  Data points represent 
the absorbance values from the individual sheep gastric lymph samples (n=19), reflecting the level of 
efferent gastric lymph IgA binding to the phage clone under investigation.  The absorbance values were 
plotted against the percentage of inhibited L4.  The efferent gastric lymph was collected from individual 
sheep which had been previously infected with T. circumcincta L3 and were subjected to a bolus challenge 
of 50,000 T. circumcincta L3 (“GL-PI”).  The gastric lymph samples used were all from a single time-
point of 7 dpc.  The percentage of inhibited L4 present in the abomasum were estimated by directly 
measuring the length of L4 in a sub-sample and the percentage calculated from the total worm burden (as 
detailed in Halliday et al., 2007).   
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Strong positive correlations (P<0.01, rs = 0.621 to 0.836) were found between the level 
of ovine IgA binding specifically to all of the peptide sequences and the total IgA 
concentration in the efferent gastric lymph at 7 dpc (Figure 5.17, Table 5.6).  The 
relationship between the level of gastric lymph binding to clone 2 and the concentration 
of total IgA present in the efferent lymph was the strongest (Figure 5.17). 
 
Figure 5.17 Relationship between the levels of gastric lymph IgA binding to four phage clones 
selected by biopanning a phage display library with L3 surface-purified ovine antibodies and the 
total gastric lymph IgA concentration at 7 dpc of sheep previously infected/challenged with T. 
circumcincta.   
 
Analysis of the association was conducted using Spearman correlation coefficient.  Data points represent 
the absorbance values from the individual sheep gastric lymph samples (n=19), reflecting the level of 
efferent gastric lymph IgA binding to the phage clone under investigation.  The absorbance values were 
plotted against the total IgA concentrations for the individual sheep samples.  The efferent gastric lymph 
was collected from individual sheep which had been previously infected with T. circumcincta L3 and were 
subjected to a bolus challenge of 50,000 T. circumcincta L3 (“GL-PI”).  The gastric lymph samples used 
were all from a single time-point of 7 dpc.  The total IgA concentrations of the efferent gastric lymph of 
the previously infected/challenged sheep used in this current study were previously published in Halliday 
et al., (2007). 
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5.4 Discussion 
In the work presented in this chapter, immunofluorescent staining with abomasal mucus, 
collected from sheep which had been experimentally infected with a T. circumcincta 
trickle infection and bolus challenge regime, revealed that both abomasal mucus IgA and 
IgG were able to bind native antigens present on the surface of live, intact, exsheathed 
L3.  When eluted from the nematode larval surface and incubated with a random peptide 
phage display library to identify peptide sequences which mimic native structural 
epitopes on the surface of the larvae, specific peptide sequences which bound these 
affinity-purified antibodies were identified from the library.  The immunoreactivity of 
the peptide structures displayed by four of the phage clones selected by biopanning was 
also investigated by comparing peptide-specific IgA levels to known correlates of 
immunity to T. circumcincta in sheep with varying levels of immunity (Halliday et al., 
2007).  For three of the four clones subjected to further investigations, positive 
associations existed between the levels of peptide-specific lymph IgA and both the total 
IgA concentration in efferent gastric lymph at 7 dpc (p<0.01) and the percentage of 
inhibited L4 present (p<0.05).  In addition, significant negative correlations between the 
levels of peptide-specific lymph IgA and the total T. circumcincta burden were also 
observed (p<0.01) for the same three clones.    
Work presented in earlier Chapters indicated that mucus antibodies from the 
abomasum of immune sheep bind an array of antigens in somatic extracts of T. 
circumcincta larval stages.  Here, experiments focused specifically on antigens present 
on the surface of T. circumcincta L3 because previous studies demonstrated a degree of 
success in inducing protective immunity to T circumcincta using antigens purified from 
the L3 surface (Wedrychowicz et al., 1992; 1995), a phenomenon also demonstrated for 
other trichostrongylid nematode spp. (Ashman et al., 1995; Bowles, Brandon and 
Meeusen, 1995; Piedrafita et al., 2012).  Previously exsheathed T. circumcincta L3 were 
incubated with abomasal mucus from sheep which had received three truncated 
infections of 30,000 T. circumcincta L3 over 14 days, boosted with 3 separate bolus 
infections of 30,000 before necropsy 14 days later (Harrison et al., 2008).  In that study, 
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there was strong binding of mucus and serum IgG to the surface antigens.  However, in 
the work presented in this study, it was IgA in abomasal mucus which bound to surface 
antigens.  This difference in the isotype stimulated in the immune response could be 
explained by differences in the trickle infection programme.  As in the work presented 
here, sheep were exposed to a smaller dose of the parasite (c. 104,000 L3) and were 
continually trickle-infected over a nine-week period compared to exposure of the sheep 
to a larger dose (c. 180,000 L3) over the shorter four-week period in the work presented 
by Harrison et al. (2008).  Also in the latter study, surface antigens were prepared 
directly from T. circumcincta L3 through a reduction and centrifugation procedure 
whereas in the work presented in this thesis the aim was to retain the native 
conformation of the surface antigens so antibodies directly against the surface of 
exsheathed infective larvae were purified.   
Here, antigens present on the surface of exsheathed T. circumcincta, T. 
colubriformis and H. contrortus L3 all bound abomasal mucus IgA and IgG from sheep 
rendered immune to T. circumcincta.  This suggests that homologous immunoreactive 
surface antigens are present in these species. Cross-reactivity of mucus antibodies 
directed against surface antigens of nematodes has been seen against other 
truichostrongylid species.  Intestinal mucus IgG taken from sheep rendered immune to 
T. colubriformis infection reacted with antigens in larval extracts of both H. contortus 
and T. circumcincta (Harrison et al., 2003a).  Also, the monoclonal antibody specific to 
a L3 specific T colubriformis carbohydrate larval antigen, CarLA, showed cross-
reactivity against the surface of H. contortus and T. circumcincta L3 (Harrison et al., 
2003a; 2003b). This raises the possibility that developing a vaccine against surface 
antigens of T. circumcincta L3 could provide protection against other closely related 
nematodes. 
A surface antigen-specific to exsheathed L3 of H. contortus, Hc-sL3, has been 
characterised as a glycoprotein of approximately 70-90 kDa (Ashman et al., 1995; 
Bowles et al., 1996; Raleigh et al., 1996).  Following incubation of exsheathed H. 
contortus L3 with a rabbit monoclonal antibody specific to Hc-sL3, in 10-15 min larvae 
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were observed to have begun to shed the bound anti Hc-sL3 antibodies, and after 30 min 
of incubation all larvae had shed the antibodies indicating that the antigen is potentially 
involved in an immune evasion strategy (Ashman et al., 1995; Bowles et al., 1995).  A 
monoclonal antibody which bound Hc-sL3 was used to probe live H. contortus L3 and 
immunoblots of H. contortus and T. circumcincta surface extracts (Raleigh et al., 1996).  
In the T. circumcincta surface extract blot probed with the Hc-sL3 monoclonal antibody, 
antibody reactivity was evident at 95-100 kDa (Raleigh et al., 1996), and had a similar 
profile to the immunoreactivity to T. circumcincta extracts detected here. Vaccination 
studies with Hc-sL3 revealed that, when administered with an appropriate adjuvant, it is 
able to confer protective immunity in sheep against a challenge infection with H. 
contortus, with significant reductions in worm burdens (range, 45-69%) in vaccinated 
sheep compared to non-vaccinated controls (Jacobs et al., 1999; Piedrafita et al., 2012).  
The presence of homologous immunoreactive L3 surface antigens across trichostrongylid 
species has also been investigated through the use of ASCs generated by the in vitro 
culture of lymph nodes removed from sheep 5 days after administration of a trickle 
challenge (3,000 T. circumcincta L3 per week for nine-weeks) and then a bolus dose of 
50,000 T. circumcincta L3 (Balic et al., 2003).  Parasite extracts of soluble antigens 
prepared from L3 of H. contortus, Trichostrongylus vitrinus and T. circumcincta were 
incubated with antibodies secreted by the ASCs and a high molecular weight region of 
immunoreactivity was identified in each of the three species.  The regions of reactivity 
were, however, slightly different in each.  This reiterates the potential ability of 
antibodies against L3 antigens to cross-react with similar antigens in other nematode 
species.    
The purpose of using surface immunoaffinity purification of antibodies was to 
enrich the preparations for IgA which reacted with L3 surface antigens under native 
conditions, i.e. antibodies which reacted with the conformational structures of surface 
antigens.  Following probing of an immunoblot of T. circumcincta S1 and S2 antigen 
preparations with the affinity-purified antibodies, areas of IgA reactivity at 30-40 kDa 
and 70-100 kDa were detected in both antigen preparations.  This pattern of 
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immunoreactivity is similar to that displayed when T. circumcincta L3 preparations were 
probed with antibodies derived from ASCs which had been harvested from sheep 5 and 
10 dpc following a similar trickle infection regime (Balic et al., 2003).  However, the 
IgA reactivity at 30-40 kDa was not as clear here as that presented by Balic et al. (2003).  
One of the possible reasons for this is differences between the antigen preparations used 
in the studies:  here, two antigen extracts were used, a PBS-soluble extract (S1) and a 
membrane-associated extract (S2), whereas in Balic et al. (2003), a whole worm extract 
was prepared by heating the larvae in SDS buffer.   
The purified IgA was then used to pan a 7-mer phage display library and 
sequence analysis of the clones which bound the IgA showed that one peptide sequence, 
(WPTLQWA), was also identified using IgA which bound T. circumcincta L3 
carbohydrate epitope-containing somatic antigens (Chapter 4).  This clone, along with 3 
others, was used in ELISAs to assess the relationship between the level of phage clone 
binding by IgA from sheep rendered immune by experimental infection and correlates of 
immunity against T. circumcincta; worm burden, percentage inhibited L4 and total IgA 
concentration in efferent gastric lymph (Halliday et al., 2007).  Strong positive 
correlations existed between the total IgA concentration in gastric lymph of sheep 
rendered immune by experimental infection and binding of heptamer-specific IgA to 
three phage clones.  A positive correlation has been reported between the level of IgA 
binding to L4 somatic antigens and the percentage of inhibited T. circumcinta L4 
recovered from the ovine abomasum (Beraldi et al., 2008; Stear et al., 1998; 1999).  
Here, the levels of gastric lymph IgA binding to three phage clones were strongly 
positively correlated with the percentage of inhibited L4 recovered post mortem.  The 
relationships between the level of IgA binding of L3-surface purified antibodies to phage 
clones and the known correlates of immunity to T. circumcincta are similar to those 
reported in Chapter 4.  These findings suggest that the random peptide sequences 
expressed by the phage clones selected through panning the library with antibodies 
specific to antigens on the surface coat of exsheathed T. circumcincta L3 could be 
mimicking immunogenic structural epitopes on native T. circumcincta L3 antigens.  The 
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selected phage clones may therefore represent valid vaccine candidates if they could be 
presented to the ovine immune system in an appropriate fashion.  
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Chapter 6 : General Discussion 
Gastrointestinal nematode parasites are a major constraint to the sheep farming industry 
due to economic (mostly production-related) and welfare issues (Molento, 2009). 
Figures available in 2005 estimated that, collectively, gastrointestinal nematode 
infections cost the UK sheep farming industry in excess of £84 million per annum 
(Nieuwhof and Bishop, 2005).  In temperate regions, one of the most prevalent 
gastrointestinal nematodes of small ruminants is Teladorsagia circumcincta (Bartley et 
al., 2003).  This nematode is most commonly controlled using a combination of pasture 
management and treatment of animals with anthelmintics.  There are five classes of 
anthelmintics currently licensed in the UK for the control of gastrointestinal nematode 
infections in small ruminants; however, isolates of T. circumcincta resistant to three of 
these have emerged and resistance is now widespread (Bartley et al., 2003; 2004; 
Sargison et al., 2007), including reports of multiple drug class-resistance (Sargison et 
al., 2007).  With the emergence of anthelmintic-resistant parasites, this has created an 
interest in developing vaccines as an alternative means of control.  Vaccination is a 
possible option because protective immunity can be induced against T. circumcincta 
after repeated exposure to the parasite through natural exposure or experimental 
infection (Smith et al., 1983; Stear et al., 1997).  A number of studies have focused on 
the immunological basis of host resistance to T. circumcincta.  The majority of these 
have been experimental studies, which have been designed to mimic larval challenge on 
pasture (Beraldi et al., 2008).  From these, it is evident that a protective immune 
response can control T. circumcincta infection at several stages of its development 
(Halliday et al., 2007; Smith et al., 1985).  An ‘immediate hypersensitivity’ reaction has 
been implicated in the exclusion and expulsion of incoming T. circumcincta L3 in sheep 
which had been rendered immune through a previous experimental infection regime 
(Greer et al., 2008; Jackson et al., 2004; Seaton et al., 1989).  This ‘exclusion/expulsion’ 
response has been seen as early as 2 dpc in sheep exposed to a trickle infection of 10,000 
T. circumcincta L3 per week for a 9-week period and subsequently administered with a 
bolus of 50,000 L3 (Smith et al., 1984).  Host effects on larval establishment requires 
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multiple larval challenges to mediate the immediate hypersensitivity response which is 
mostly directed against incoming L3 (Balic et al., 2000).  The local IgA response in the 
abomasum has also been demonstrated to be an important component of immunity; for 
example, negative correlations have been found between L4 length and total lymph IgA 
concentrations in experimentally infected 5 month-old lambs (Smith et al., 1985) and 
after natural exposure on pasture in 6-7 month-old lambs (Strain et al., 2002).  In later 
studies, immunoblotting experiments demonstrated L3 and L4 antigen-specific IgA in the 
abomasal mucus of immune ewes and ELISA experiments indicated an inverse 
relationship between 3 dpi ES-specific abomasal IgA levels and worm burden following 
challenge with 50,000 L3 T. circumcincta (Smith et al., 2009).  Together, these studies 
demonstrate that sheep can develop natural immunity to T. circumcincta and strengthen 
the possibility of the development of a vaccine control method.     
   Historically, the biggest challenges in developing a vaccine against T. 
circumcincta have been the lack of knowledge regarding parasite antigens that stimulate 
protective immunity (for example, Wedrychowicz et al., 1992a; 1992b; Halliday and 
Smith, 2011).  Vaccine development strategies have involved either targeting molecules 
from different stages of the parasite’s life cycle, including the targeting of products 
excreted/secreted from worms or exposed on the parasite’s surface, using antibody 
probes or the identification of molecules with homology to other known promising 
vaccine candidates (Nisbet et al., 2010a; Smith et al., 2009).  In the case of T. 
circumcincta, ES molecules released by L4 have been targeted because they are thought 
to be readily accessible to the host immune response, are immunogenic and potentially 
have important functional roles in parasite survival (Nisbet et al., 2009; 2010; Redmond 
et al., 2006; Smith et al., 2009).  Due to its role in protective immunity against T. 
circumcincta, abomasal mucus IgA has been used to identify a number of possible 
protective antigens, including cathepsin-F (Tci-CF-1) (Redmond et al., 2006; Smith et 
al., 2009), activation-associated secreted protein-1 (Tci-ASP-1) (Nisbet et al., 2010a; 
Smith et al., 2009) and L3-surface-associated antigen (Tci-SAA-1) (Nisbet et al., 2009).  
Recently, recombinant protein versions of eight molecules identified through a 
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combination of bioinformatic, immunomodulatory and immune-recognition studies were 
administered to sheep in a single vaccine (Nisbet et al., 2013).  Vaccination induced a 
protective immune response to a subsequent challenge infection, with significant 
reductions in egg output and nematode burdens, in repeated trials, of 58-70% and 56-
75%, respectively, in vaccinates compared to control sheep which only received 
adjuvant (Nisbet et al., 2013).  Despite this recent success, there has been limited 
success in the development of recombinant subunit vaccines against other 
gastrointestinal nematodes of livestock (Ellis et al., 2012).  Of the potential reasons 
likely to underlie these failures, the most important may be incorrect protein folding and 
lack of glycosylation.  Vaccination trials with H. contortus compared the protective 
capacity of native cysteine proteases (purified from adult H. contortus extracts by 
affinity for thiol sepharose and cystatin) and a bacterial-expressed recombinant cocktail 
of three isoforms of the cysteine proteases (Redmond and Knox, 2004; 2006), which had 
been previously identified through thiol sepharose affinity chromatography of H. 
contortus adult extracts (Knox et al., 1995; Knox, Smith and Smith, 1999).   Sheep 
immunised with native cysteine proteases had reductions in faecal egg output and worm 
burden of 48% and 46%, respectively, following challenge compared to unvaccinated 
controls (Redmond and Knox, 2004).  In contrast, bacterial-expressed versions gave 
27% and 38% reductions in faecal egg output and worm burden, respectively (Redmond 
and Knox, 2004; 2006).  The suggested reason behind the failure of the recombinant 
proteins to reproduce the same level of protection as the native antigen was that some of 
the recombinant proteins produced by bacterial systems were expressed as insoluble 
forms and/or lacked appropriate glycosylation (Geldhof et al., 2007).   
Yeast and eukaryotic expression systems have the capability to glycosylate 
recombinant proteins but these can differ from nematode glycans.  An example of this is 
from a vaccination trial against Fasciola hepatica where two different recombinant 
protein expression systems were used to produce versions of a F. hepatica cathepsin L 
protease.  The protective capacity of a yeast-expressed version and a baculovirus-
expressed version of cathepsin L protease was assessed through an immunisation trial in 
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rats.  Briefly, rats were vaccinated with either of the recombinant antigens then 
subsequently challenged with 200 F. hepatica metacercariae (Reszka et al., 2005).  
Following challenge infection, the yeast-expressed version gave a reduction of 18% in 
fluke burden, whereas the baculovirus version gave a reduction of 52% in fluke burden, 
compared to unchallenged controls (Reszka et al., 2005).  Further investigations 
revealed that the yeast-expressed version was hyper-glycosylated, potentially masking 
protein/conformational epitopes, whereas the baculovirus-produced version had similar 
N-glycosylation sites to the native version of the cathepsin L (Reszka et al., 2005).  This 
study highlights that although some of the recombinant expression systems have the 
capability to glycosylate antigens, it may not be in the correct format for antibody 
binding. 
In an attempt to try to introduce the appropriate glycosylation (which is similar to 
that of the desired parasite antigen) on recombinant antigens, the free-living parasite 
Caenorhabditis elegans has been investigated for this purpose.  C. elegans glycosylation 
has high mannose content and complex N-glycans (Cipollo et al., 2002).   Also, as 
C.elegans is relatively close in evolutionary terms to the parasitic nematodes (Blaxter et 
al., 2000), this suggests it is a suitable vector for expression of recombinant antigens.  
Promising results have been obtained from the use of transgenic C. elegans to produce a 
recombinant version of a cathepsin L cysteine protease, from H. contortus (Murray et 
al., 2007).  C. elegans was used to express an enzymically active version of cathepsin L 
and administration of this C. elegans-expressed antigen in a vaccination trial showed a 
significant increase in total serum IgG titres post-challenge with 5,000 H. contortus L3 
(Murray et al., 2007).  Analsysis of the glycosylation patterns of the native cathepsin L 
antigens and the C. elegans-expressed version revealed that both shared the same N-
linked glycosylation site (Murray et al., 2007).         
The overall aim of the work presented in this thesis was to address these issues with 
recombinant antigen production by employing phage display libraries to identify peptide 
sequences that mimic the structure of native antigen epitopes in both somatic and surface 
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extract preparations of T. circumcincta L3.  In doing this, a number of techniques were 
employed; 
1) immuno-affinity purification of L3 antigens under native conditions followed by 
proteomic/bioinformatic identification of the purified material 
2) affinity purification of local antibody probes against L3 somatic and surface 
extracts  
3) biopanning of the purified antibodies against random peptide phage display 
libraries.   
At the outset, investigations of extracts of T. circumcincta, probed with abomasal mucus 
and gastric lymph generated from sheep which had been previously exposed to the 
parasite, were used to determine if carbohydrate moieties on larval antigens have a 
potential role in antibody binding.  The results (presented in Chapter 2) suggested that a 
proportion (approximately 25%) of local IgA reactivity was directed against glycans 
found on high molecular weight antigens.  The presence of glycans in parasite extracts 
and their capability for modulation of the host immune response is well described 
(Hokke and Deelder, 2001; Schallig and Leeuwen, 1996; Tawill et al., 2004; Vervelde et 
al., 2003).  In this thesis, the presence of immunoreactive glycans on parasite antigens 
was investigated through chemical disruption of their structure.  Glycan arrays have 
been developed that contain hundreds of defined biologically-important glycans 
(Aranzamendi et al., 2011; Blixt et al., 2004).  The arrays can be screened with 
antibodies to reveal the profile of glycans bound to the antibodies.  One of the first 
studies to investigate the application of glycan arrays in parasite vaccine development 
involved interrogating an array containing 264 glycan structures with serum from sheep 
that were immune to challenge infection following vaccination with H. contortus adult 
ES products (Van Stijn et al., 2010; Vervelde et al., 2003).  This approach identified a 
novel immunogenic glycan epitope, Galα1-3GalNAc-R, present on H. contortus adult 
ES products (Van Stijn et al., 2010).  Collectively, these studies show that glycans can 
be immunogenic.  These results from this current study highlight that the role of glycans 
in the immune response directed against T. circumcincta warrants further investigation 
in order to identify the specific glycan moieties.  
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The work described in Chapter 2 also demonstrated, for the first time with L3 antigens, 
that using efferent gastric lymph from two individual trickle-infected/bolus-challenged 
sheep as local antibody probes, there was a clear anamnestic IgA response to the 
antigens after the administration of an L3 bolus challenge.  Previous studies have shown 
that a local anamnestic IgA response to L4 antigens was evident as early as 5 dpc in 
gastric lymph obtained from trickle-infected/bolus-challenged sheep (Halliday et al., 
2007; Smith et al., 1983; 1984).  The results here using the same local antibody probes 
indicated that L3 antigen-specific IgA levels began to increase at an earlier time-point of 
4 dpc.  However, there are limitations to this result as gastric lymph samples across the 
time-frame of -2 to 10 dpc were only available from two sheep.  To strengthen this 
finding, one possible option is to repeat the model infection, focusing on a more defined 
time period, for example -1 to 5 dpc, to extend the number of sheep tested. 
T. circumcincta-L4 somatic antigen-specific IgA levels in ovine abomasal 
mucosa have been shown to have an inverse relationship with the length of L4 recovered 
from the abomasum at post mortem (Stear et al., 1998; 1999; 2004; Strain and Stear, 
1999).  In the study from which the gastric lymph samples used throughout this thesis 
were obtained (Halliday et al., 2007), the authors concluded that the peak in IgA 
concentration in lymph occurred too late to be associated with the parasite loss and 
arrested development that was seen by 5 dpc.  Here, we report a strong positive 
association between T. circumcincta L3 extract-specific IgA levels in the gastric lymph 
samples used in that study (Halliday et al., 2007) and the percentage of inhibited L4 in 
the abomasa of the sheep from which the lymph was derived.  This raises the possibility 
that although the peak IgA levels against L4-specific antigens occur later, i.e.  6-10 dpc, 
than the onset of inhibition of development at 5 dpc (Halliday et al., 2007), IgA specific 
to L3 antigens could be triggering the effect.  Therefore, L3-specific IgA levels could 
contribute to the inhibition of development of L4 in the abomasum.     
In the work presented in Chapter 3 of this thesis, immunoaffinity 
chromatography was used to purify IgA-reactive L3 somatic antigens under native 
conditions to retain epitope structure.  A proteomics approach was employed to identify 
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T. circumcincta proteins in the IgA-affinity purified L3 antigens.  The proteomic analysis 
identified seven antigenic molecules purified by IgA which were of interest as potential 
vaccine candidates; paramyosin, activation-associated secreted protein (ASP-2), fatty 
acid/retinol binding protein (FAR), superoxide dismutase, glutathione-S-transferase 
(GST), galectins and venom-like allergen protein (VAL).  Paramyosin is a component of 
muscular filaments and has been found to be immunogenic in a range of parasitic 
nematodes: Brugia malayi (Li et al., 1999), D. viviparus (Strube et al., 2009), T. 
colubriformis (Kiel et al., 2007) and T. spiralis (Wei et al., 2010).  ASPs are nematode-
specific members of a protein family and thought to have a key role in the establishment 
of parasites in the host (Hawdon et al., 1999).  For the first time, ASP-2 was identified in 
the L3 stages as previously only ASP-1 has been described from T. circumcincta L4 ES 
products (Nisbet et al., 2010a; Smith et al., 2009). These molecules are key vaccine 
candidates against hookworms in humans and are thought to be important in the 
establishment of parasites in the host (Hawdon et al., 1999; Tawe et al., 2000).  Another 
group of nematode-specific molecules are represented by the FARs; these are proposed 
to play a role in the sequestration of retinol/vitamin A which is essential for the 
maintenance of parasite growth (Basavaraju et al., 2003; Wolff and Scott, 1995).  
Sequestration of retinol/vitamin A by the parasite from the hosts’ reservoirs could 
thereby promote parasite survival.  The two detoxifying enzymes identified here, 
superoxide dismutase and GST, have previously been identified in the L3 stages of a 
number of gastrointestinal nematodes (Hadas and Stankiewicz, 1998; Knox and Jones, 
1992) and may have a function in counteracting oxidative stress associated with the 
mucosal inflammatory response during parasite invasion (LoVerde, 1998).  As the 
antioxidant activity of superoxide dismutase has been noted to be higher in L3 than in 
adult stages of a number of gastrointestinal parasitic nematode species, including T. 
circumcincta (Hadas and Stankiewicz, 1998; Knox and Jones, 1992), this suggests that 
they may be ideal vaccine candidates targeted towards L3.  Galectins represent a lectin 
family with high affinity for β-galactosidase and have been identified in a number of 
helminths: H. contortus (Greenhalgh et al., 2000; Newlands et al., 1999), T. 
circumcincta and T. colubriformis (Greenhalgh et al., 1999).  The roles of galectins in 
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parasitic nematodes are not fully understood, but there are suggestions that they 
modulate the immune response through mimicking host galectins to evade parasite 
binding (Vasta, 2009; Young and Meeusen, 2004).  It is possible that some of these 
antigens could be incorporated into future prototype sub-unit vaccines for T. 
circumcincta. 
Developing recombinant sub-unit vaccines against gastrointestinal nematodes is 
proving to be a difficult task, due to factors including complexity of parasite antigens, 
difficulty expressing recombinant versions which are homologous to native antigens, 
antigenic variation across different life-cycle stages and difficulty in stimulating local 
immune responses i.e. at the gut mucosa (Knox and Smith, 2001).  As discussed earlier, 
one of the most pressing issues in nematode vaccine development is the importance of 
structural epitopes of protective antigens.  Identification of structural, or conformational, 
epitopes is not straightforward because they are formed by post-translational 
modifications (for example, glycans) and/or amino acid residues on separate areas of the 
antigen which, when brought into close proximity during tertiary protein folding, form a 
three-dimensional epitope (Goldsby et al., 2003).  In this thesis, antibody panning of 
combinatorial random peptide phage display libraries was used in an attempt to target 
and identify structures that might mimic potential conformational epitopes of T. 
circumcincta L3 antigens.  The first pool of antibodies used in panning was affinity-
purified using the high molecular weight glycan moieties associated with L3 somatic 
antigens, while the second pool was affinity-purified directly against the surface of live, 
exsheathed T. circumcincta L3.  The first of these approaches used immunoblots, which, 
while retaining glycan structures intact, may have resulted in the loss of protein-folding-
dependent conformational epitopes due to denaturation in the electrophoresis steps.  In 
order to address this, the second approach was developed to retain the ‘native’ 
conformation of antigenic epitopes on the surface of the live, exsheathed T. circumcincta 
L3.  IgA antibodies, purified by both of these methods, bound phage-displayed 
heptameric peptides in the panning experiments and sequence analysis of the heptamers 
revealed that the most frequently repeated clone in both data sets was the peptide, 
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WPTLQWA.  This clone, to our knowledge, has not been identified in previous phage 
display biopanning studies and could represent a valid peptide sequence for inclusion in 
a novel epitope-based vaccine.  In addition to WPTLQWA, five IgA-binding phage 
clones expressing heptameric peptides, potentially representing epitopes of L3 somatic 
and surface antigens, were used in ELISA experiments to assess the relationship 
between IgA:heptamer binding and correlates of immunity in sheep.  IgA in the gastric 
lymph from these sheep has previously been shown to bind L4 somatic antigens 
(Halliday et al., 2007) and work presented here showed that IgA in these samples also 
binds to L3 antigens and to the selected phage clones expressing heptameric peptides 
potentially representing epitopes of T. circumcincta L3 somatic and surface antigens 
(Figure 4.8 and Figures 5.15-5.17).  Four quantitative parameters were analysed to 
establish the relationship between IgA:hepatmer binding and indicators of immunity.  
These were; 
1) total nematode burden,  
2) percentage of inhibited L4,  
3) total IgA concentration in efferent gastric lymph, and  
4) the lymphoblast response.  
Each of these measures has previously been associated with development of protective 
immunity in T. circumcincta infected sheep (Halliday et al., 2007).  The efferent gastric 
lymph samples from trickle-infected/bolus-challenged and primary bolus-infected sheep 
used in these experiments were from one single time-point, 7 dpc.  This time-point 
corresponded to the peak in total IgA measured in these samples (Halliday et al., 2007).  
Here, significant positive correlations between total IgA concentration at 7 dpc and 
binding of heptamer-specific IgA to six phage clones were evident (Figure 4.13 and 
Figure 5.17).  Levels of gastric lymph IgA specific to these six phage clones were also 
significantly positively correlated with percentage of inhibited L4.  In contrast, no 
correlations were found between the level of gastric lymph IgA specific to the phage 
clones and the lymphoblast response.  Collectively, these correlations between the 
known immune parameters and the level of peptide/phage clone binding strengthens the 
possibility that the structures formed by the display of the peptides on the phage surface 
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mimic those of structural immunoreactive epitopes found on native T. circumcincta L3 
antigens and warrants further investigation into their potential as vaccine candidates for 
teladorsagiosis.   
If a vaccine trial were to be conducted with the peptide sequences, careful 
consideration would need to be used in the design of the formulation, whether it be 
construction of the peptide sequences synthetically or using the phage vector to directly 
express the peptide sequence(s).  Administration of the peptides as surface-displayed 
antigens on the phage vector has previously been the preferred method of presentation, 
for example in a vaccine trial assessing the protective capacity of peptide mimics of 
cathepsin L epitopes to protect against fasciolosis in sheep (Villa-Mancera et al., 2008; 
2010).  This formulation, when administered to the sheep as a subcutaneous injection 
with no adjuvant, gave a significant reduction in mean fluke burdens (range 34-48%) 
compared to unvaccinated control sheep  following an experimental oral challenge with 
300 metacercariae (Villa-Mancera et al., 2008; 2010).  Given the complexity of the 
host:parasite interaction between sheep and T. circumcincta, it is likely that a multi-
component vaccine will be required (Nisbet et al., 2013), so a cocktail of the peptide 
sequences identified in this thesis may be preferable to a single peptide for protection 
against re-infection with the parasite.  If a cocktail of phage-displayed peptides were 
used in a vaccine, it may still be more cost effective and commercially attractive to 
produce, in comparison to the production of 8 recombinant proteins, due to the different 
vectors and expression systems required.  Also, the phage-displayed peptides could be 
administered with the vaccine currently under development (Nisbet et al., 2013).  Ovine 
abomasal mucus antibodies specific to each one of the 8 vaccine components could be 
screened against a phage display library in order to identify peptide sequences which 
represent structural epitopes on the recombinant versions of the cocktail vaccine 
antigens.  Recently, phage-based products have been approved for use in food safety by 
the US Food and Drug Administration, as a cocktail of several phage clones, termed 
ListShield™, targeting Listeria monocytogenes contaminants in meat and poultry 
products are now licensed for commerical use in the USA (Hunter, 2011).  The large-
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scale production of phage-displayed peptides on a large-scale through the cloning and 
purification protocols would be relatively simple and cost effective (Clark and March, 
2006).  These trials would need to evaluate what effect vaccinating with the phage 
display peptides had on worm burden, egg output, inhibition of development and 
specificity of the immune response generated.     
In conclusion, the work presented in this thesis has targeted the conformational 
epitopes on T. circumcincta L3 antigens through two avenues; (i) purification of ‘native’ 
L3 antigens retaining the structural epitopes and (ii) identification of phage-displayed 
peptide sequences with the potential to mimic structural epitopes.  Affinity purified L3-
antigen-specific IgA levels in sheep with varying levels of immunity to T. circumcincta 
were positively correlated with both the total IgA concentration in efferent gastric lymph 
after parasite challenge and with the percentage of inhibited L4 larvae present in the 
gastric glands of the immune hosts.  In contrast, there was a negative correlation 
between the level of affinity-purified L3 antigen-specific IgA and total T. circumcincta 
burden.  Proteomic analysis of the IgA-affinity purified L3 extract identified a number of 
proteins which are potential vaccine candidates; paramyosin, superoxide dismutase, 
galectin, activation-associated secreted proteins and FARs.  Due to the demonstrated 
immunoreactivity and the fact that some of the proteins are components of a vaccine 
under development, it strongly suggests that they could be components of a novel 
vaccine targeted towards T. circumcincta L3 to prevent their establishment in the ovine 
abomasum.   
As a first step towards the development of a novel vaccine based on IgA-
binding-peptide mimics of native structural epitopes, phage display libraries were used 
to screen antibodies, from sheep rendered immune to T. circumcincta by experimental 
infection. These antibodies were affinity-purified before use and specifically bound T. 
circumcincta L3 glycans or, alternatively, surface antigens on exsheathed T. 
circumcincta L3.  Six peptide sequences were identified and positive correlations existed 
between peptide-specific IgA levels and both the total IgA concentration in efferent 
gastric lymph after parasite challenge and the percentage of inhibited L4 present.  
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Collectively, this reveals the potential protective capacity of the phage clones selected 
for affinity to IgA, purified against somatic and surface L3 antigens, and shows that this 
study has identified peptide sequences which mimic conformational epitopes on T. 
circumcincta L3 antigens.  In future, a vaccine trial would be required to determine if the 
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Appendix 1: General solutions and buffers 
 
Nematode culture medium 
500ml of RPMI liquid culture medium, 1% (v/v) D-glucose, 2mM glutamine, 100 IU/ml 
penicillin, 100mg/ml streptomycin, 125 mg/ml gentamycin , 25mg/ml amphotericin B.  
Stored at 4°C until required. 
 
TNTT (for 1 litre) 
10mM Tris, 0.5 M Sodium chloride, 0.05% (v/v) Tween-20, 0.01% (w.v) Thiomersal 
pH 7.4 adjusted with HCl. 
 
LB broth 
10g Bacto-tryptone, 5g Bacto-yeast,5g sodium chloride, dissolved in 1 litre of dH2O .  
 
LB agar plates 
15g bacto-agar added to 1 litre of LB medium, autoclaved at 121ºC for 15 min. 
 
Phosphate buffered saline (PBS) 
Stock solution (10x) prepared with 80g sodium chloride, 2g potassium 
chloride, 11.5g di-sodium hydrogen orthophosphate and 2g potassium di-hydrogen 
orthophosphate in 1 litre of dH2O. A working solution was prepared by diluting 1:10 in 
dH2O. 
 
IPTG/Xgal stock [conc: 50mg/ml and 40mg/ml] 
800µl of Xgal [stock concentration 50mg/ml in dimethylformamide (DMF)] dissolved 
into 200µl DMF, 50mg IPTG into 1 ml of Xgal/DMF solution. 
 
LB/IPTG/Xgal plates 
To 1 litre of LB agar, 1 ml of IPTG/Xgal stock was added and poured into plates.  
 
Top Agar 
10g Bacto-tryptone, 5g yeast extract, 5g sodium chloride, 7g Bacto-agar – made up to 1 
litre with water, autoclaved at 121ºC for 15 min. 
 
Tetracycline stock (suspension) 
Dissolve 20 mg tetracycline dissolved in 500µl dH20: 500µl ethanol.   
 
LB+ Tetracycline plates 
To 1 litre of LB agar 1 ml of Tetracycline stock added and poured into plates. 
 
TBS 
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PEG/NaCl 
20% (w/v) polyethylene glycol-8000 dissolved in 100ml dH20.  Add 14.6g sodium 
chloride (2.5M).  Autoclaved at 121ºC for 15 min. 
 
Iodide buffer 
10mM Tris-HCl, 1mM EDTA, 4 M sodium iodide, pH adjusted to 8 with HCl.
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Appendix 2: Proteins identified by analysis of IgA-reactive antigens 
Protein ID Organism Accession number Peptides MW MOWSE Proposed function 
3_58 Teladorsagia 
circumcincta 
  3 70.1 144.4 Unknown 
14-3-3 Caenorhabditis 
remanei 
AAY52455 5 25.8 297.1 Metabolism (Amino acid) 
14-3-3 like protein Caenorhabditis 
elegans 
Q20655 7 56.9 372.9 Metabolism (Amino acid) 
14-3-3 protein  Angiostrongylus 
cantonensis 
AEK21299 3 45.8 160.9 Metabolism (Amino acid) 
14-3-3-like Ascaris suum ADY48800 5 23.8 354.9 Metabolism (Amino acid) 
3_75 Teladorsagia 
circumcincta 
  3 26.8 166.1 Unknown 
ASP-2 N. americanus AAP41952 13 26.8 166.1 Developmental 
(Reproduction/Transport) 
Alpha-2-macroglobulin 
domain containing protein 
Haemonchus 
contortus 








Q27864  2 49.5 76.1 Cellular (Transport) 
Aspartyl protease inhibitor Ostertagia 
ostertagi 
Q95PP1 2 36.9 75.9 Proteolytic enzyme 
(Aspartyl protease 
inhibitor) 
ASP-like protein   Cooperia punctata AAK35199  2 125.9 88.7 Developmental 
(Reproduction/Transport) 




XP_002639352 2 21.7 116.9 Cytoskeletal protein 
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Calponin Caenorhabditis 
elegans 
O01542 5 43.2 201.5 Cytoskeletal protein 
Calponin Haemonchus 
contortus 
CDJ87225 3 15.8 138.9 Cytoskeletal protein 
CBN-CUTL-23 Caernorhabditis 
brenneri 
EGT39830 2 37.5 85 Cytoskeletal protein 
CBR-PAR-5 Caernorhabditis 
briggsae 
XP_002633409 2 11.7 109.6 Developmental 
(Reproduction/Growth) 
CBR-UNC-15  Caenorhabditis 
remanei 
CB015261 5 76.9 288.7 Cytoskeletal protein 
CD109 antigen Ascaris suum ADY40184 2 137.5 41.2 Unknown 
CRE-ORA-1 Caernorhabditis 
remanei 
XP_003108375 6 49.5 319.2 Unknown 
C-type single domain 
activation ASP3 precursor  
Ostertagia 
ostertagi 









Brugia malayi XP_001896264 2 47.5 120.4 Developmental (Cuticle 
synthesis/protein folding) 
Cysteine protease inhibitor Heligmosomoides 
polygyrus 




(venom allergen like)  
Caenorhabditis 
brenneri  
EGT59294 9 66.6 441.1 Developmental 
(Reproduction/Transport) 
Cytochrome C Ascaris suum P92504 4 51.9 294.9 Metabolism (Electron 
transport) 









CAA86821 7 46 513.8 Unknown 
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Fatty acid binding protein Caenorhabditis 
elegans 
Q20224 4 54.1 172.8 Metabolism (Lipid 
binding/ Electron 
transport) 
Fatty acid binding protein Haemonchus 
contortus 
CDJ96356 4 12.4 272.8 Metabolism (Lipid binding 
/Electron transport) 


































XP_003110723 4 56.3 150.7 Metabolism (Amino acid) 
Fructose-bisphosphate 
aldolase 2  
Ascaris suum ADY45824 2 74.6 83.6 Metabolism (Amino acid) 
Galectin  Haemonchus 
contortus 




U67147 9 97.8 501 Metabolism (Carbohydrate 
binding) 
Galectin  1 Teladorsagia 
circumcincta 
AAD39095 9 91.4 533.1 Metabolism (Carbohydrate 
binding) 
Galectin 3a Haemonchus 
contortus 
AAF63405 3 54.2 113 Metabolism (Carbohydrate 
binding) 
Galectin 3b Haemonchus 
contortus 
AAF63406 3 205.6 130.8 Metabolism (Carbohydrate 
binding) 
Galectin 4   Angiostrongylus 
cantonensis 
AEK98126  4 84.8 217.8 Metabolism (Carbohydrate 
binding) 
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Galectin 4 Caenorhabditis 
elegans 
Q18625 9 58.6 491.9 Metabolism (Carbohydrate 
binding) 
Galectin 5 Angiostrongylus 
cantonensis 
AEK98127 7 56.2 296.4 Metabolism (Carbohydrate 
binding) 
Galectin 8 Caenorhabditis 
elegans 
Q0910 2 59.8 49.4 Metabolism (Carbohydrate 
binding) 
Globin like ES protein F6 Ostertagia 
ostertagi 
Q8WQ13 5 38 310.6 Unknown 
Glutathione S transferase Haemonchus 
contortus 
AAF81283 9 64.1 614.7 Metabolism 
(Detoxification) 
Glutathione S transferase Heligmosomoides 
polygyrus 
AAF36480 13 56.6 854.0 Metabolism 
(Detoxification) 
Glutathione S-transferase  Necator 
americanus  




CDJ97733 4 187.0 360.6 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
F57H12.3 2 48.6 45.2 Unknown 
Hypothetical protein  Caenorhabditis 
elegans 
CB038581 4 50.9 161.2 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
T27561  4 50.3 162.4 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
F57H12.3 4 48.6 267.4 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
Q23378 3 44.9 136 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
Q23642 5 33.3 205.8 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
Q10121 3 81.3 130.3 Unknown 
Hypothetical protein Caenorhabditis 
elegans 
Q9U315 3 36.1 80.3 Unknown 
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Hypothetical protein Caernorhabditis 
elegans 
Q9XW37 4 50.6 210.5 Unknown 
Hypothetical protein Caernorhabditis 
elegans 
Q23378 3 44.9 141.1 Unknown 
Hypothetical protein Caernorhabditis 
elegans 
CAB03140 3 48.1 81.2 Unknown 
Hypothetical protein Ostertagia 
ostertagi 
O16784 2 42 140.9 Unknown 
Hypothetical protein 
CAEBREN_10926   
Caenorhabditis 
brenneri 





EGT42038 6 49.6 297.4 Unknown 
Hypothetical protein 
CAEBREN_14566   
Caenorhabditis 
brenneri 













































XP_002636124  2 25.2 85.1 Unknown 
 








































XP_003112257 2 34.1 137.2 Unknown 
Hypothetical protein 
F55H12.4   
Caenorhabditis 
elegans 










 NP_502894 8 39.8 316.5 Unknown 
Hypothetical protein Caernorhabditis 
elegans 
CAB03140 2 48.1 86.3 Unknown 
Intermediate filament 
protein ifa-1  
Ascaris suum ADY43340 2 42.5 111.8 Cytoskeletal protein  
L3B25 Teladorsagia 
circumcincta 
AAM45145 7 68.6 371.7 Unknown 
Lactoylglutathione lyase    Brugia malayi  XP_001895191 2 79.7 75.3 Unknown 
Major epididymal 
secretory protein heh-1 
Ascaris suum ADY47453 2 14.1 113.6 Metabolism (Lipid 
binding) 
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Major epididymal 
secretory protein HEH-1  
Caenorhabditis 
remanei 
XP_003099554 6 59 393.4 Metabolism (Lipid 
binding) 
Myosin  Caenorhabditis 
briggsae 
CAP36983 12 159.6 733.4 Cytoskeletal protein 
Myosin heavy chain  Haemonchus 
contortus 
ABC40752 2 265.7 97.6 Cytoskeletal protein 
Nippocystatin Nippostrongylus 
brasiliensis 







NP_492761 6 48.9 390.9 Metabolism (ATP 
synthesis/Electron 
transport) 




CAP35226 3 60.8 63.4 Unknown 
Onchocerca related antigen  Caenorhabditis 
elegans 
CB038581/O45098 8 50.9 497.8 Unknown 
ORA-1 protein  Caenorhabditis 
briggsae  
CAP35226.2 6 33.7 274.8 Unknown 
Paramyosin Ancylostoma 
caninum 
ABC86903 6 101 502.9 Cytoskeletal protein 
Paramyosin   Dictyocaulus 
immitis 
P13392  7 66.3 447.8 Cytoskeletal protein 
Paramyosin Dictyocaulus 
viviparus 
ABO07440 8 100.8 598.4 Cytoskeletal protein 
Paramyosin  Haemonchus 
contortus 
CB016022 6 113.1 365.4 Cytoskeletal protein 
Peptidyl prolyl cis-trans 
isomerase 5   
Ostertagia 
ostertagi 












P52011 3 42.6 162.9 Developmental (Cuticle 
synthesis/Protein folding) 
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Phosphatidylethanolamine-
binding   
Caenorhabditis 
remanei 


















1   
Dictyocaulus 
viviparus 
Q24702 2 78.1 122.2 Unknown 
Profilin  Caenorhabditis 
elegans 
Q9XW16 6 55.7 292.8 Cytoskeletal protein (Actin 
binding) 
Profilin  Caenorhabditis 
remanei 




CDJ96632 2 13.2 161.1 Cytoskeletal protein (Actin 
binding) 
Protein disulfide-
isomerase 2   










ABC86956 2 148.8 66.6 Metabolism (Other) 
Protein NAS-28 Astacin Carnorhabditis 
elegans 
CCD65318 2 128.2 48.0 Developmental 
(Growth/Structural) 
Protein RO5A10 Caenorhabditis 
elegans 
NP_001255794 5 25.7 233.0 Unknown 
Putative cytochrome c  Haemonchus 
contortus 
ACG69807 5 39.3 229.4 Metabolism (Electron 
transport) 
Putative ES protein F7 Ostertagia 
ostertagi 
Q8WQ12 4 15.3 196.0 Metabolism (Lipid 
binding) 
Putative Lipid Binding 
Protein   
Angiostrongylus 
cantonensis 
CAR63537 6 28.5 393.4 Molecular (Lipid binding) 
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Putative major allergen  Angiostrongylus 
cantonensis 
CAR63553 5 88.3 251.9 Unknown 
Putative major allergen Haemonchus 
contortus 
CDJ89445. 3 27.4 256 Unknown 
Putative myoglobin  Trichinella spiralis XP_003374421 5 46.1 342.1 Metabolism (Lipid 
binding) 
Putative protein HEH-1 Caenorhabditis 
elegans 






Q9TZH6 4 35.7 224.7 Metabolism (Amino acid) 
Saposin type B  Haemonchus 
contortus 





NP_741465 2 37.3 71.3 Gut protein 
Secreted protein ASP-2  Necator 
americanus 
AAP41952 3 26.8 166.1 Developmental 
(Reproduction/Transport) 
Superoxide dismutase  Haemonchus 
contortus 












CDJ93215 3 15.3 109.9 Cellular (Transport) 
Thioredoxin like Caenorhabditis 
elegans 
NP_001022003 2 46.4 76.6 Cytoskeletal protein 
Thrombospondin Haemonchus 
contortus 
AF043121 9 171.8 468.2 Developmental 
(Reproduction/Growth) 
Thrombospondin  Haemonchus 
contortus 
AAB99830  3 33.1 120.3 Developmental 
(Reproduction/Growth) 
Transthyretin like Caenorhabditis 
brenneri 






ACI49119 4 37.4 224.1 Transport 
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Transthyretin like protein Caenorhabditis 
elegans 
NP_502060 3 93.8 153.6 Transport 
Transthyretin like protein Haemonchus 
contortus 
CDJ96905 2 15.7 143.2 Transport 
Transthyretin-related  Heligmosomoides 
polygyrus bakeri 
CCC54337  6 39.6 330.3 Transport 
Unnamed protein product Haemonchus 
contortus 





EGT59294 441.1 9 66.6 Developmental 
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Appendix 3: Phage clones identified by panning 7-mer phage 
display libraries 
L3 somatic antigens: 




1 AKIDART   
2 YGFVPSW   
3 YGFVPSW   
4 NDSVSLP   
5 SAPSSKN   
6 YGFVPSW   
7 STASYTR   
8 HAIYPRH Yes Yes 
9 KAVHPLR   
10 SPSMLQK   
11 WPTLQWA   
12 WPTLQWA   
13 HAIYPRH Yes  
14 YGDALFA   
15 HAIYPRH Yes  
16 GSHNPHL   
17 NGYSWTS   
18 WPTLQWA   
19 AKID*RT   
20 GSHNPHL   
21 THLPWQT  Yes 
22 KLPGWSG Yes  
23 KLPASLT  Yes 
24 HAIYPRH Yes  
25 WPTLQWA   
26 LPLTPLP  Yes 
27 WPTLQWA   
28 LMRSPDY   
29 HVPLLAT  Yes 
30 NTTPERS   
31 WPTLQWA   
32 WPTLQWA   
33 RLFTIPV   
34 HAIYPRH Yes  
35 TIEQHPP   
 







36 HAIYPRH Yes  
37 HAIYPRH Yes  
38 -   
39 AKIDART   
40 YLTMPTP  Yes 
41 WPTLQWA   
42 LTHPRWP  Yes 
43 SPYSLYA   
44 SPSMLQK   
45 QSPDEVW   
46 MVPKWVA   
47 WGIRYPA   
48 AKIDART   
49 GRLSYPP   
50 ITSRTAS   
51 FMRSPPM   
52 LPLTPLP  Yes 
53 TTSLLSD   
54 HAIYPRH Yes  
55 KLPGWSG Yes  
56 HAIYPRH Yes  
57 WPTLQWA   
58 WPTLQWA   
59 STVTLQV   
60 REIHARH   
61 QHPAKTA   
62 FMRSPPM   
63 SSHTISF  Yes 
64 YSIPKSS Yes  
65 VASAGPH   
66 SAPSSKN   
67 APYQLLV   
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L3 native surface antigens: 




1 SLLIKPR   
2 HTPSGVA   
3 SYVSPHN   
4 GPRLMDM   
5 TLEAQTH   
6 ANTSSLP   
7 LPSHALR   
8 SGSISSS   
9 MPSLPPP   
10 ELTHLK   
11 WTPSVRP   
12 SDLLGLP   
13 WPTLQWA   
14 TSPTSFD   
15 WPTLQWA   
16 IHMQRAI   
17 SILPYPY  Yes 
18 SLPTLTL  Yes 
19 HAIYPRH Yes Yes 
20 QHQLGLL   
21 QPWPTSI   
22 SWPQRTN   
23 WPTLQWA   
24 SPQMTLS   
25 KFLPVFT   
26 GWPKFTK   
27 ATLEMPP   
28 ALASVSI   
29 APPRLLY   
30 WTPSVRP   
31 TPRLQSS   
32 KLPGWSG Yes Yes 
33 ALIPKPR   
34 ALTGIDS   
35 GTWLSR   
36 QLKTGLA  Yes 
37 QPWPTSI   
38 FGHQQKM   
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39 GNTPSRA  Yes 
40 NPPSGRP   
41 ALTGIDS   
42 HAIYPRH Yes Yes 
43 ALTPTPP   
44 ASTLKWA   
45 SILPYPY  Yes 
46 SWPQRTN   
47 WPTLQWA   
48 GWPKFTK   
49 WTPSVRP   
50 HAIYPRH Yes Yes 
51 QSIDMWI   
52 WPTLQWA   
53 QSPVSTQ   
54 SHVPMNP   
55 NPPSRHP   
56 KLPGWSG Yes Yes 
57 KLPGWSG Yes Yes 
58 THVMQTL   
59 GNTLAVQ   
60 EPLQLKM   
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